hpt的个人主页 - 老虎社区

hpt

hpt

暂无个人介绍

IP属地：未知

357关注

20粉丝

0主题

0勋章

2021-12-30

Good

EV Stocks Rallied in Morning Trading

2021-12-29

Ok

U.S. Stock Futures Edge Up in Thin Holiday Trading

2021-12-28

Oh no

Novavax shares dropped another 4% in premarket trading

2021-12-27

Good

3 Stocks that Beat the Market in 2021 and Could Do It Again in 2022

2021-12-26

Good

2 Top Tech Stocks to Buy During a Recession

2021-12-25

Ok

Japan health panel approves Merck's oral COVID-19 treatment

2021-12-24

Ok

The Fed Has Created the Monster Market: What's in Store for 2022?

2021-12-23

Ok

Grab Stock May Be Down But It Isn’t Out

2021-12-22

Ok

Tesla's Musk says he sold 'enough stock'; slams California for 'overtaxation'

2021-12-21

Good

Palantir: 3 Reasons Against It And Why It's Still A Buy

2021-12-19

Good

5 Growth Stocks to Buy Now for 2022

2021-12-17

Good

Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list

2021-12-16

Good

抱歉，原内容已删除

2021-12-15

Ok

Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%

2021-12-14

Ok

U.S.Stocks open lower after PPI reading as investors await Fed

2021-12-13

Good

抱歉，原内容已删除

2021-12-12

Good

Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035

2021-12-11

Good

TSMC stock rose slightly by 0.5% in premarket trading

2021-12-10

Good

Is It Time to Buy the Dow's 3 Worst Performing Stocks This Year?

2021-12-09

Ok

UiPath stock dropped more than 4% in premarket trading

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":3579759306103275,"uuid":"3579759306103275","gmtCreate":1617096910706,"gmtModify":1622705498426,"name":"hpt","pinyin":"hpt","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":20,"headSize":357,"tweetSize":154,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-2","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"资深虎友","description":"加入老虎社区1000天","bigImgUrl":"https://static.tigerbbs.com/0063fb68ea29c9ae6858c58630e182d5","smallImgUrl":"https://static.tigerbbs.com/96c699a93be4214d4b49aea6a5a5d1a4","grayImgUrl":"https://static.tigerbbs.com/35b0e542a9ff77046ed69ef602bc105d","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.12.26","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"228c86a078844d74991fff2b7ab2428d-1","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资经理虎","description":"证券账户累计交易金额达到10万美元","bigImgUrl":"https://static.tigerbbs.com/c8dfc27c1ee0e25db1c93e9d0b641101","smallImgUrl":"https://static.tigerbbs.com/f43908c142f8a33c78f5bdf0e2897488","grayImgUrl":"https://static.tigerbbs.com/82165ff19cb8a786e8919f92acee5213","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.10.29","exceedPercentage":"60.82%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.65%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":692186412,"gmtCreate":1640875462759,"gmtModify":1640875463023,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/692186412","repostId":"1132789312","repostType":4,"repost":{"id":"1132789312","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640875231,"share":"https://www.laohu8.com/m/news/1132789312?lang=&edition=full","pubTime":"2021-12-30 22:40","market":"us","language":"en","title":"EV Stocks Rallied in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1132789312","media":"Tiger Newspress","summary":"EV stocks rallied in morning trading.Lucid, Nio, Xpeng Motors, Li Auto, Fisker, Nikola, Canoo, Farad","content":"<html><head></head><body><p>EV stocks rallied in morning trading.Lucid, Nio, Xpeng Motors, Li Auto, Fisker, Nikola, Canoo, Faraday Future, Workhorse and Lordstown climbed between 1% and 4%.While Tesla fell more than 2% after the company filed a recall of over 475,000 vehicles..</p><p><img src=\"https://static.tigerbbs.com/c5dbbcef1922d3641650b829b9b76c56\" tg-width=\"415\" tg-height=\"718\" referrerpolicy=\"no-referrer\"/><img src=\"https://static.tigerbbs.com/694f72dfeead61c37c1d280c0e9f4433\" tg-width=\"421\" tg-height=\"246\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV Stocks Rallied in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV Stocks Rallied in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-30 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>EV stocks rallied in morning trading.Lucid, Nio, Xpeng Motors, Li Auto, Fisker, Nikola, Canoo, Faraday Future, Workhorse and Lordstown climbed between 1% and 4%.While Tesla fell more than 2% after the company filed a recall of over 475,000 vehicles..</p><p><img src=\"https://static.tigerbbs.com/c5dbbcef1922d3641650b829b9b76c56\" tg-width=\"415\" tg-height=\"718\" referrerpolicy=\"no-referrer\"/><img src=\"https://static.tigerbbs.com/694f72dfeead61c37c1d280c0e9f4433\" tg-width=\"421\" tg-height=\"246\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKLA":"Nikola Corporation","LCID":"Lucid Group Inc","FFIE":"Faraday Future","TSLA":"特斯拉","XPEV":"小鹏汽车","LI":"理想汽车","NIO":"蔚来","GOEV":"Canoo Inc.","WKHS":"Workhorse Group, Inc.","NIU":"小牛电动","RIVN":"Rivian Automotive, Inc.","FSR":"菲斯克"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132789312","content_text":"EV stocks rallied in morning trading.Lucid, Nio, Xpeng Motors, Li Auto, Fisker, Nikola, Canoo, Faraday Future, Workhorse and Lordstown climbed between 1% and 4%.While Tesla fell more than 2% after the company filed a recall of over 475,000 vehicles..","news_type":1},"isVote":1,"tweetType":1,"viewCount":429,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696752535,"gmtCreate":1640778785457,"gmtModify":1640778785765,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/696752535","repostId":"1163774092","repostType":4,"repost":{"id":"1163774092","pubTimestamp":1640774706,"share":"https://www.laohu8.com/m/news/1163774092?lang=&edition=full","pubTime":"2021-12-29 18:45","market":"us","language":"en","title":"U.S. Stock Futures Edge Up in Thin Holiday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1163774092","media":"Wall Street Journal","summary":"U.S. stock futures rose Wednesday amid lower liquidity in the last days of the year.Futures tied to ","content":"<html><head></head><body><p>U.S. stock futures rose Wednesday amid lower liquidity in the last days of the year.</p><p>Futures tied to the S&amp;P 500 added 0.2% after the broad-market index closed down 0.1% on Tuesday but still notched its second-highest closing level. Nasdaq-100 futures climbed 0.4%, suggesting gains for technology stocks after the opening bell. Dow Jones Industrial Average futures ticked up 0.2%.</p><p>Stocks have largely edged up in recent days as markets look ahead to the new year, with many expecting a continued economic recovery and strong earnings from companies. Trading volumes reached the lowest level all year on Tuesday, according to a composite metric that includes the New York Stock Exchange and the Nasdaq.</p><p>Investors say they are becoming increasingly comfortable with the theory that the Omicron variant may not lead to harsh restrictions on commerce and movement as more information emerges. State governors are implementing light-touch measures to try to avoid disruptions.</p><p>“There’s an element of positivity. The data continues to suggest that the disease itself caused by Omicron is materially less severe than the variants which have preceded it,” said James Athey, an investment manager at Abrdn. “That’s always been the endgame for the pandemic.”</p><p>Oil prices ticked up. Global benchmark Brent crude added 0.4%, trading at $78.97 a barrel, driven by expectations of a demand recovery in the new year and a drawdown of global inventories, according to analysts at Mizuho Bank.</p><p>The yield on the benchmark 10-year Treasury note ticked down to 1.474% from 1.480% on Tuesday. Shorter-dated bond yields also edged down, with the 2-year yield declining to 0.738% after notching a 52-week high the day before.</p><p>Fresh data on the housing market is slated to go out at 10 a.m. ET when the National Association of Realtors puts out a report on U.S. pending home sales in November. Economists are forecasting a slowdown from the previous month.</p><p>Tesla rose 2.3% in premarket trading. Chief Executive Elon Musk exercised the final batch of a package of vested stock options, a series of transactions that have boosted his stake in the company.</p><p>Shares in egg producer Cal-Maine Foods sank 7.7% in out-of-hours trading after the company reported a decline in profit, citing higher costs.</p><p>Bitcoin stabilized after the biggest drop in nearly a month, rising 0.5% compared with its level at 5 p.m. ET on Tuesday. It traded around $47,800 after sliding as low as $47,318.93 the previous day.</p><p>Overseas, the pan-continental Stoxx Europe 600 rose 0.2%, rising for a third straight day and trading close to its all-time high. The FTSE 100 advanced 1.1% on the first day of trading this week after U.K. markets were closed for bank holidays.</p><p>The Turkish lira weakened for the third consecutive day, depreciating 2.5% against the dollar and trading at 12 lira to $1. The currency had strengthened following an economic rescue plan put forward by President Recep Tayyip Erdogan last week.</p><p>“I have a fair degree of skepticism about the policies that have been announced. It’s like treating symptoms, not causes,” Mr. Athey said. “The underlying dynamics are still pressuring the currency weaker and inflation higher.”</p><p>In Asia, most major benchmarks slid. The Shanghai Composite Index retreated 0.9% and Japan’s Nikkei 225 closed down 0.6%. Hong Kong’s Hang Seng Index fell 0.8%, led by declines in technology stocks. E-commerce giants Alibaba slipped 2.6% and Meituan is down 3.4%.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. Stock Futures Edge Up in Thin Holiday Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. Stock Futures Edge Up in Thin Holiday Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-29 18:45 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.wsj.com/articles/global-stock-markets-dow-update-12-29-2021-11640767527?mod=markets_lead_pos1><strong>Wall Street Journal</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>U.S. stock futures rose Wednesday amid lower liquidity in the last days of the year.Futures tied to the S&P 500 added 0.2% after the broad-market index closed down 0.1% on Tuesday but still notched ...</p>\n\n<a href=\"https://www.wsj.com/articles/global-stock-markets-dow-update-12-29-2021-11640767527?mod=markets_lead_pos1\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"https://www.wsj.com/articles/global-stock-markets-dow-update-12-29-2021-11640767527?mod=markets_lead_pos1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163774092","content_text":"U.S. stock futures rose Wednesday amid lower liquidity in the last days of the year.Futures tied to the S&P 500 added 0.2% after the broad-market index closed down 0.1% on Tuesday but still notched its second-highest closing level. Nasdaq-100 futures climbed 0.4%, suggesting gains for technology stocks after the opening bell. Dow Jones Industrial Average futures ticked up 0.2%.Stocks have largely edged up in recent days as markets look ahead to the new year, with many expecting a continued economic recovery and strong earnings from companies. Trading volumes reached the lowest level all year on Tuesday, according to a composite metric that includes the New York Stock Exchange and the Nasdaq.Investors say they are becoming increasingly comfortable with the theory that the Omicron variant may not lead to harsh restrictions on commerce and movement as more information emerges. State governors are implementing light-touch measures to try to avoid disruptions.“There’s an element of positivity. The data continues to suggest that the disease itself caused by Omicron is materially less severe than the variants which have preceded it,” said James Athey, an investment manager at Abrdn. “That’s always been the endgame for the pandemic.”Oil prices ticked up. Global benchmark Brent crude added 0.4%, trading at $78.97 a barrel, driven by expectations of a demand recovery in the new year and a drawdown of global inventories, according to analysts at Mizuho Bank.The yield on the benchmark 10-year Treasury note ticked down to 1.474% from 1.480% on Tuesday. Shorter-dated bond yields also edged down, with the 2-year yield declining to 0.738% after notching a 52-week high the day before.Fresh data on the housing market is slated to go out at 10 a.m. ET when the National Association of Realtors puts out a report on U.S. pending home sales in November. Economists are forecasting a slowdown from the previous month.Tesla rose 2.3% in premarket trading. Chief Executive Elon Musk exercised the final batch of a package of vested stock options, a series of transactions that have boosted his stake in the company.Shares in egg producer Cal-Maine Foods sank 7.7% in out-of-hours trading after the company reported a decline in profit, citing higher costs.Bitcoin stabilized after the biggest drop in nearly a month, rising 0.5% compared with its level at 5 p.m. ET on Tuesday. It traded around $47,800 after sliding as low as $47,318.93 the previous day.Overseas, the pan-continental Stoxx Europe 600 rose 0.2%, rising for a third straight day and trading close to its all-time high. The FTSE 100 advanced 1.1% on the first day of trading this week after U.K. markets were closed for bank holidays.The Turkish lira weakened for the third consecutive day, depreciating 2.5% against the dollar and trading at 12 lira to $1. The currency had strengthened following an economic rescue plan put forward by President Recep Tayyip Erdogan last week.“I have a fair degree of skepticism about the policies that have been announced. It’s like treating symptoms, not causes,” Mr. Athey said. “The underlying dynamics are still pressuring the currency weaker and inflation higher.”In Asia, most major benchmarks slid. The Shanghai Composite Index retreated 0.9% and Japan’s Nikkei 225 closed down 0.6%. Hong Kong’s Hang Seng Index fell 0.8%, led by declines in technology stocks. E-commerce giants Alibaba slipped 2.6% and Meituan is down 3.4%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":577,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696662446,"gmtCreate":1640684786487,"gmtModify":1640685634556,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696662446","repostId":"1138246031","repostType":4,"repost":{"id":"1138246031","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640683578,"share":"https://www.laohu8.com/m/news/1138246031?lang=&edition=full","pubTime":"2021-12-28 17:26","market":"us","language":"en","title":"Novavax shares dropped another 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1138246031","media":"Tiger Newspress","summary":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy ","content":"<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Why Novavax Stock Is Sinking</b></p>\n<p>The company didn't announce any new developments. So what's behind the big decline?</p>\n<p>Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p>\n<p>Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p>\n<p>CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p>\n<p><b>So what</b></p>\n<p>Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p>\n<p>But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p>\n<p><b>Now what</b></p>\n<p>Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares dropped another 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares dropped another 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-28 17:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Why Novavax Stock Is Sinking</b></p>\n<p>The company didn't announce any new developments. So what's behind the big decline?</p>\n<p>Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p>\n<p>Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p>\n<p>CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p>\n<p><b>So what</b></p>\n<p>Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p>\n<p>But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p>\n<p><b>Now what</b></p>\n<p>Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138246031","content_text":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy Novavax Stock Is Sinking\nThe company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.\nInstead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.\nCEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"\nSo what\nYet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.\nBut it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.\nNow what\nInvestors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":781,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696074081,"gmtCreate":1640587558648,"gmtModify":1640587558926,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696074081","repostId":"2194775951","repostType":4,"repost":{"id":"2194775951","pubTimestamp":1640573216,"share":"https://www.laohu8.com/m/news/2194775951?lang=&edition=full","pubTime":"2021-12-27 10:46","market":"us","language":"en","title":"3 Stocks that Beat the Market in 2021 and Could Do It Again in 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2194775951","media":"Motley Fool","summary":"Winners tend to keep on winning.","content":"<p>When looking for investment ideas for 2022, it pays to look at those stocks that have beaten the market in 2021. Savvy investors know that winners tend to keep on winning, so picking stocks that are already in the market-beating category can increase your odds of investing success.</p>\n<p>We asked three longtime investors to pick their favorite market-beating stock from this year that has a great chance of repeating its performance. They picked <a href=\"https://laohu8.com/S/ASAN\"><b>Asana</b> </a>, <a href=\"https://laohu8.com/S/DOCN\"><b>DigitalOcean</b> </a>, and <a href=\"https://laohu8.com/S/AAPL\"><b>Apple</b> </a>.</p>\n<h2>Asana: Helping coordinate tasks in a hybrid work environment</h2>\n<p><b>Brian Withers (Asana): </b>Asana is a software-as-a-service company that helps teams and enterprises coordinate who's doing what and by when. As employers are trying to figure out how to manage a remote or hybrid workforce long-term, this work management software may just be the ticket. The stock has taken off this year, more than doubling since the beginning of the year. Let's take a look at the most recent quarter to see why.</p>\n<table>\n <thead>\n  <tr>\n   <th><p><b>Metric</b></p></th>\n   <th><p><b>Q3 2020</b></p></th>\n   <th><p><b>Q2 2021</b></p></th>\n   <th><p><b>Q3 2021&nbsp;</b></p></th>\n   <th><p><b>Change (QOQ)</b></p></th>\n   <th><p><b>Change (YOY)</b></p></th>\n  </tr>\n </thead>\n <tbody>\n  <tr>\n   <td><p>Revenue</p></td>\n   <td><p>$59 million</p></td>\n   <td><p>$80 million</p></td>\n   <td><p>$100 million</p></td>\n   <td><p>26%</p></td>\n   <td><p>70%</p></td>\n  </tr>\n  <tr>\n   <td><p>Total paying customers</p></td>\n   <td><p>89,000</p></td>\n   <td><p>107,000</p></td>\n   <td><p>114,000</p></td>\n   <td><p>7%</p></td>\n   <td><p>28%</p></td>\n  </tr>\n  <tr>\n   <td><p>Customers paying &gt; $5,000 annually</p></td>\n   <td><p>8,938</p></td>\n   <td><p>12,806</p></td>\n   <td><p>14,143</p></td>\n   <td><p>10%</p></td>\n   <td><p>58%</p></td>\n  </tr>\n </tbody>\n</table>\n<p>Data source: Company earnings reports. QOQ = quarter over quarter. YOY = year over year.</p>\n<p>The top line is growing at a blistering 70% year over year and 26% quarter over quarter. The total number of paying customers has grown to 114,000, a 28% gain from the previous year. Since customers aren't growing as fast as the top line, that means existing customers are spending more. That is supported by the large customers (who pay more than $5,000 annually) growing at 58% year over year and Asana's dollar-based net retention rate consistently at 115% or better.</p>\n<p>These results are impressive and support the tremendous growth of the stock so far, but what could make this a market beater again in the coming year? First of all, the company is just getting started. Almost 100,000 of its customers are paying less than $5,000 annually. This is a massive opportunity to land and expand with its existing customer base. This should be aided by the fact an effective team-based collaboration tool is more useful when used as part of a larger team effort. With 739 of its customers spending more than $50,000 annually, it's clear that companies have benefited by expanding to more employees across the enterprise.</p>\n<p>Secondly, the market for collaborative applications and project and program management tools is huge. Management estimates the market could reach over $50 billion by 2025. With an annual run rate of $400 million, it has less than 1% of the market share.</p>\n<p>This stock is not without its risks, though. It has experienced a significant pullback and is now more than 40% off its high from earlier in the year. Even with the pullback, the stock is valued at a 35 price-to-sales ratio. The company will have to continue to put up solid growth numbers to support its valuation. But given the stickiness and growth of its powerful platform, you would be smart to pick up this gem as this market-beater could be up for another year of great performance.</p>\n<h2>DigitalOcean: Earn big returns by serving small businesses</h2>\n<p><b>Will Healy</b> <b>(DigitalOcean): </b>DigitalOcean has successfully targeted a segment of the cloud industry ignored by the largest players. It offers cloud infrastructure services to small and medium-sized enterprises (SMEs), companies often too small to support a full-fledged IT department.</p>\n<p>However, its most compelling competitive advantage may come from the DigitalOcean community. Developers within this community can receive and give support to <a href=\"https://laohu8.com/S/AONE.U\">one</a> another to address various challenges. This is invaluable for the one-person IT departments its product supports and gives these clients a good reason to bypass large providers like <b>Amazon </b>and <b>Microsoft</b>.</p>\n<p>Straightforward pricing is another advantage. This makes dealing with DigitalOcean much easier for its nearly 600,000 customers in 185 countries. Also, with the acquisition of Nimbella, DigitalOcean can now offer serverless computing. This will eliminate server management needs and allow one-click deployment of APIs, software that enables apps to communicate with one another.</p>\n<p>Investors have also taken to the company. Despite a steep decline in recent weeks, DigitalOcean stock has risen by over 90% since its March initial public offering. The financials have likely helped, with revenue for the first nine months of 2021 coming in at $309 million, 34% higher than in the first three quarters of 2020. Also, it lost $7 million during that period, a considerable improvement from the first nine months of 2020 when the company lost $30 million.</p>\n<p>Moreover, the company forecasts between $426 million and $428 million in revenue in 2021. Analysts believe that number could reach $563 million on a consensus basis in fiscal 2022, an increase of 32% if the predictions hold. Thus, the financials could continue to push DigitalOcean stock higher.</p>\n<p>Admittedly, even after the stock fell 40% from its high, its price-to-sales (P/S) ratio stands at 19. That comes in higher than the Microsoft sales multiple of 14 or Amazon's ratio of 4.</p>\n<p>Nonetheless, even with the higher valuation, selling may be the worst mistake DigitalOcean investors can make right now, as SMEs make up 99.7% of all businesses in the U.S. alone. This leaves the company with a tremendous addressable market that could benefit from a cloud product oriented toward such enterprises.</p>\n<h2>Apple: Bucking the tech downtrend</h2>\n<p><b>Danny Vena (Apple):</b> In a year when high-growth tech stocks had difficulty keeping pace with the broader market, it seemed there was a flight to bigger, safer, more established companies -- and Apple certainly qualified on all counts.</p>\n<p>The tech giant maintained the title of the largest publicly traded company on the planet. Apple's market cap grew to $2.86 trillion (as of this writing) and market watchers are taking bets as to whether or not the stock will surpass the $3 trillion benchmark before the clock winds down on 2021.</p>\n<p>There were plenty of reasons investors seeking a safe haven flocked to the iPhone maker.</p>\n<p>Apple has more than 1 billion active iPhones worldwide, giving the company a captive audience for its services, including Apple TV+, Apple Music, Apple News+, and Apple Card. These relatively recent additions join perennial favorites like iTunes, the App Store, and iCloud, just to name a few. This growing list of services generated more than $68 billion last year, up 27%, and representing nearly 19% of Apple's revenue in fiscal 2021.</p>\n<p>iPhone sales were the headline in fiscal 2021, growing 39% year over year and generating revenue of nearly $192 billion. It's also worth mentioning that there are an estimated 25% of active iPhones in the upgrade window, putting Apple squarely in the much-vaunted multi-year \"super cycle.\" Brisk demand for the iPhone 13 suggests it's the device many have been waiting for, which would no doubt push Apple's results higher. The holiday season is often the company's biggest quarter for sales and business is booming, with reports of strong demand and growing wait times.</p>\n<p>Not only that, but iPhone accessories are big business. This includes companion products like the Apple Watch and AirPods. The company's wearables, home, and accessories segment has become an important part of its business, generating sales of $38 billion, up 25%, and generating more than 10% of Apple's revenue last year.</p>\n<p>There are other reasons investors sought shelter in Apple this year. It has a rock solid balance sheet with nearly $66 billion in net cash. The company also has a profit margin that exceeds 25%, and its strong net income fuels its ever growing dividend, which has grown more than 130% since 2012. Add to that a payout ratio of just 15% and it's clear that even in tough times, Apple's dividend is as secure as it gets.</p>\n<p>Given the strong, continuing demand for its flagship iPhone and its steadily growing ancillary businesses, it's easy to see why Apple stock gained 31% so far in 2021 (as of this writing), surpassing the 24% gains of the <b>S&amp;P 500</b>.&nbsp;I believe that not only will Apple surpass a $3 trillion market cap in short order, but will beat the market <i>again</i> in 2022.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Stocks that Beat the Market in 2021 and Could Do It Again in 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Stocks that Beat the Market in 2021 and Could Do It Again in 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-27 10:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/26/3-stocks-that-beat-the-market-in-2021-and-could-do/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When looking for investment ideas for 2022, it pays to look at those stocks that have beaten the market in 2021. Savvy investors know that winners tend to keep on winning, so picking stocks that are ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/26/3-stocks-that-beat-the-market-in-2021-and-could-do/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ASAN":"阿莎娜","AAPL":"苹果","DOCN":"DigitalOcean Holdings, Inc."},"source_url":"https://www.fool.com/investing/2021/12/26/3-stocks-that-beat-the-market-in-2021-and-could-do/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2194775951","content_text":"When looking for investment ideas for 2022, it pays to look at those stocks that have beaten the market in 2021. Savvy investors know that winners tend to keep on winning, so picking stocks that are already in the market-beating category can increase your odds of investing success.\nWe asked three longtime investors to pick their favorite market-beating stock from this year that has a great chance of repeating its performance. They picked Asana , DigitalOcean , and Apple .\nAsana: Helping coordinate tasks in a hybrid work environment\nBrian Withers (Asana): Asana is a software-as-a-service company that helps teams and enterprises coordinate who's doing what and by when. As employers are trying to figure out how to manage a remote or hybrid workforce long-term, this work management software may just be the ticket. The stock has taken off this year, more than doubling since the beginning of the year. Let's take a look at the most recent quarter to see why.\n\n\n\nMetric\nQ3 2020\nQ2 2021\nQ3 2021 \nChange (QOQ)\nChange (YOY)\n\n\n\n\nRevenue\n$59 million\n$80 million\n$100 million\n26%\n70%\n\n\nTotal paying customers\n89,000\n107,000\n114,000\n7%\n28%\n\n\nCustomers paying > $5,000 annually\n8,938\n12,806\n14,143\n10%\n58%\n\n\n\nData source: Company earnings reports. QOQ = quarter over quarter. YOY = year over year.\nThe top line is growing at a blistering 70% year over year and 26% quarter over quarter. The total number of paying customers has grown to 114,000, a 28% gain from the previous year. Since customers aren't growing as fast as the top line, that means existing customers are spending more. That is supported by the large customers (who pay more than $5,000 annually) growing at 58% year over year and Asana's dollar-based net retention rate consistently at 115% or better.\nThese results are impressive and support the tremendous growth of the stock so far, but what could make this a market beater again in the coming year? First of all, the company is just getting started. Almost 100,000 of its customers are paying less than $5,000 annually. This is a massive opportunity to land and expand with its existing customer base. This should be aided by the fact an effective team-based collaboration tool is more useful when used as part of a larger team effort. With 739 of its customers spending more than $50,000 annually, it's clear that companies have benefited by expanding to more employees across the enterprise.\nSecondly, the market for collaborative applications and project and program management tools is huge. Management estimates the market could reach over $50 billion by 2025. With an annual run rate of $400 million, it has less than 1% of the market share.\nThis stock is not without its risks, though. It has experienced a significant pullback and is now more than 40% off its high from earlier in the year. Even with the pullback, the stock is valued at a 35 price-to-sales ratio. The company will have to continue to put up solid growth numbers to support its valuation. But given the stickiness and growth of its powerful platform, you would be smart to pick up this gem as this market-beater could be up for another year of great performance.\nDigitalOcean: Earn big returns by serving small businesses\nWill Healy (DigitalOcean): DigitalOcean has successfully targeted a segment of the cloud industry ignored by the largest players. It offers cloud infrastructure services to small and medium-sized enterprises (SMEs), companies often too small to support a full-fledged IT department.\nHowever, its most compelling competitive advantage may come from the DigitalOcean community. Developers within this community can receive and give support to one another to address various challenges. This is invaluable for the one-person IT departments its product supports and gives these clients a good reason to bypass large providers like Amazon and Microsoft.\nStraightforward pricing is another advantage. This makes dealing with DigitalOcean much easier for its nearly 600,000 customers in 185 countries. Also, with the acquisition of Nimbella, DigitalOcean can now offer serverless computing. This will eliminate server management needs and allow one-click deployment of APIs, software that enables apps to communicate with one another.\nInvestors have also taken to the company. Despite a steep decline in recent weeks, DigitalOcean stock has risen by over 90% since its March initial public offering. The financials have likely helped, with revenue for the first nine months of 2021 coming in at $309 million, 34% higher than in the first three quarters of 2020. Also, it lost $7 million during that period, a considerable improvement from the first nine months of 2020 when the company lost $30 million.\nMoreover, the company forecasts between $426 million and $428 million in revenue in 2021. Analysts believe that number could reach $563 million on a consensus basis in fiscal 2022, an increase of 32% if the predictions hold. Thus, the financials could continue to push DigitalOcean stock higher.\nAdmittedly, even after the stock fell 40% from its high, its price-to-sales (P/S) ratio stands at 19. That comes in higher than the Microsoft sales multiple of 14 or Amazon's ratio of 4.\nNonetheless, even with the higher valuation, selling may be the worst mistake DigitalOcean investors can make right now, as SMEs make up 99.7% of all businesses in the U.S. alone. This leaves the company with a tremendous addressable market that could benefit from a cloud product oriented toward such enterprises.\nApple: Bucking the tech downtrend\nDanny Vena (Apple): In a year when high-growth tech stocks had difficulty keeping pace with the broader market, it seemed there was a flight to bigger, safer, more established companies -- and Apple certainly qualified on all counts.\nThe tech giant maintained the title of the largest publicly traded company on the planet. Apple's market cap grew to $2.86 trillion (as of this writing) and market watchers are taking bets as to whether or not the stock will surpass the $3 trillion benchmark before the clock winds down on 2021.\nThere were plenty of reasons investors seeking a safe haven flocked to the iPhone maker.\nApple has more than 1 billion active iPhones worldwide, giving the company a captive audience for its services, including Apple TV+, Apple Music, Apple News+, and Apple Card. These relatively recent additions join perennial favorites like iTunes, the App Store, and iCloud, just to name a few. This growing list of services generated more than $68 billion last year, up 27%, and representing nearly 19% of Apple's revenue in fiscal 2021.\niPhone sales were the headline in fiscal 2021, growing 39% year over year and generating revenue of nearly $192 billion. It's also worth mentioning that there are an estimated 25% of active iPhones in the upgrade window, putting Apple squarely in the much-vaunted multi-year \"super cycle.\" Brisk demand for the iPhone 13 suggests it's the device many have been waiting for, which would no doubt push Apple's results higher. The holiday season is often the company's biggest quarter for sales and business is booming, with reports of strong demand and growing wait times.\nNot only that, but iPhone accessories are big business. This includes companion products like the Apple Watch and AirPods. The company's wearables, home, and accessories segment has become an important part of its business, generating sales of $38 billion, up 25%, and generating more than 10% of Apple's revenue last year.\nThere are other reasons investors sought shelter in Apple this year. It has a rock solid balance sheet with nearly $66 billion in net cash. The company also has a profit margin that exceeds 25%, and its strong net income fuels its ever growing dividend, which has grown more than 130% since 2012. Add to that a payout ratio of just 15% and it's clear that even in tough times, Apple's dividend is as secure as it gets.\nGiven the strong, continuing demand for its flagship iPhone and its steadily growing ancillary businesses, it's easy to see why Apple stock gained 31% so far in 2021 (as of this writing), surpassing the 24% gains of the S&P 500. I believe that not only will Apple surpass a $3 trillion market cap in short order, but will beat the market again in 2022.","news_type":1},"isVote":1,"tweetType":1,"viewCount":595,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698480892,"gmtCreate":1640491838420,"gmtModify":1640491963942,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698480892","repostId":"2193781141","repostType":4,"repost":{"id":"2193781141","pubTimestamp":1640485676,"share":"https://www.laohu8.com/m/news/2193781141?lang=&edition=full","pubTime":"2021-12-26 10:27","market":"us","language":"en","title":"2 Top Tech Stocks to Buy During a Recession","url":"https://stock-news.laohu8.com/highlight/detail?id=2193781141","media":"Motley Fool","summary":"Market crashes are inevitable, but they're the perfect time to buy great businesses at a discount.","content":"<p>We're days away from the end of 2021, and the <b>S&amp;P 500</b> has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% this year, more than double its long-term historical average.</p>\n<p>Yet that just means we're another day closer to the inevitable market correction. Just as night follows day, a stock market crash is inevitable because market declines are a natural part of the normal business and investment cycle. No <a href=\"https://laohu8.com/S/AONE.U\">one</a> can forecast exactly when it will strike, but smart investors realize it's best to prepare for the eventuality.</p>\n<p>For as long as people have been investing, stretching even as far back to the Dutch tulip mania in the 1600s, busts have followed booms. And what a boom we've enjoyed! Since the bottom of the Great Recession, the S&amp;P 500 has quadrupled in value.</p>\n<p>2020's pandemic-driven 34% drop in the stock indexes within the span of just a few weeks was the worst on record. But savvy investors don't have to worry. These events are not a problem when you're invested in the right companies. Being prepared for the worst and hoping for the best means when the next stock market crash or correction occurs, you'll want to have your money invested in stocks that will help lead the way forward. Here are two tech stocks you'll want to buy.</p>\n<h2>1. Apple</h2>\n<p>The burden that inflation is imposing on consumers also poses a threat to some of the biggest, best-run businesses, like <b>Apple</b> (NASDAQ:AAPL), which is currently benefiting from the smartphone upgrade cycle and the rollout of 5G network infrastructure. Any attempt by the Federal Reserve to raise interest rates to contain runaway inflation could cause an economic slowdown by making money more expensive to borrow. Stock valuations would also turn lower.</p>\n<p>That's not necessarily bad news for investors who might find Apple's $2.8 trillion valuation a bit rich to buy into at the moment. The stock trades at 30 times trailing earnings, or about double its typical multiple. A correction would bring Apple back into the realm of the attainable, even as its business continues jogging forward.</p>\n<p>Sales of the iPhone 13 are outpacing those of the iPhone 12 at the same time, but Apple reportedly warned suppliers that demand is waning as the calendar year progresses. It's not necessarily for a lack of consumer desire, but rather the global supply chain constraints that have made it difficult to find the product. Apple previously cut its iPhone production target by 10 million units from its original goal of 90 million.</p>\n<p>Analysts think many consumers may choose to forgo the iPhone 13 and wait for the next upgrade. Coupled with a market crash, that could put Apple stock at a very attractive entry point with pent-up demand for the next iteration of the iPhone.</p>\n<h2>2. Amazon</h2>\n<p>Few companies are as essential to the working of the U.S. economy as <b>Amazon</b>&nbsp;(NASDAQ:AMZN). It will account for 41.4% of all online spending in the U.S. this year, according to eMarketer estimates. At the same time, Amazon Web Services (AWS), its cloud infrastructure business, is on track to generate over $60 billion in annual revenue in 2021 based on its year-to-date performance. The company is responsible for thousands of web-based businesses and the federal government's ability to remain online, making Amazon crucial to a well-functioning economy.</p>\n<p>That won't change if the stock market collapses. Its share of U.S. retail e-commerce sales will be more than 50% larger than the shares of the next nine e-commerce companies combined. Amazon's piece of the online market is nearly six times more than <b>Walmart</b>'s second-place share at just 7.2%, and 10 times greater than third-place <b><a href=\"https://laohu8.com/S/EBAY\">eBay</a></b>. E-commerce data tracker Edge by Ascential expects Amazon will see $26.7 billion just in online grocery sales five from now years, or nearly double its current amount.</p>\n<p>Amid rising prices and supply chain woes, Amazon has become a lifeline for many, and that will continue long after any financial restructuring. The stock gained 76% during the first year of the pandemic and took a breather during the reopening of the economy. Amazon shares have been relatively flat all year long. A correction would allow investors to buy a tech stock at a more reasonable valuation even as its crucial role only gets reinforced.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Top Tech Stocks to Buy During a Recession</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Top Tech Stocks to Buy During a Recession\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-26 10:27 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>We're days away from the end of 2021, and the S&P 500 has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4501":"段永平概念","BK4559":"巴菲特持仓","BK4527":"明星科技股","BK4538":"云计算","BK4550":"红杉资本持仓","BK4503":"景林资产持仓","AMZN":"亚马逊","BK4122":"互联网与直销零售","BK4551":"寇图资本持仓","BK4561":"索罗斯持仓","BK4505":"高瓴资本持仓","BK4170":"电脑硬件、储存设备及电脑周边","BK4548":"巴美列捷福持仓","AAPL":"苹果","BK4515":"5G概念","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4553":"喜马拉雅资本持仓","BK4534":"瑞士信贷持仓","BK4507":"流媒体概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4566":"资本集团","BK4524":"宅经济概念","BK4535":"淡马锡持仓"},"source_url":"https://www.fool.com/investing/2021/12/24/2-top-tech-stocks-to-buy-during-a-recession/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193781141","content_text":"We're days away from the end of 2021, and the S&P 500 has put on a master class in outperforming expectations. Even with its pullback in recent days, the broad market index has gained nearly 30% this year, more than double its long-term historical average.\nYet that just means we're another day closer to the inevitable market correction. Just as night follows day, a stock market crash is inevitable because market declines are a natural part of the normal business and investment cycle. No one can forecast exactly when it will strike, but smart investors realize it's best to prepare for the eventuality.\nFor as long as people have been investing, stretching even as far back to the Dutch tulip mania in the 1600s, busts have followed booms. And what a boom we've enjoyed! Since the bottom of the Great Recession, the S&P 500 has quadrupled in value.\n2020's pandemic-driven 34% drop in the stock indexes within the span of just a few weeks was the worst on record. But savvy investors don't have to worry. These events are not a problem when you're invested in the right companies. Being prepared for the worst and hoping for the best means when the next stock market crash or correction occurs, you'll want to have your money invested in stocks that will help lead the way forward. Here are two tech stocks you'll want to buy.\n1. Apple\nThe burden that inflation is imposing on consumers also poses a threat to some of the biggest, best-run businesses, like Apple (NASDAQ:AAPL), which is currently benefiting from the smartphone upgrade cycle and the rollout of 5G network infrastructure. Any attempt by the Federal Reserve to raise interest rates to contain runaway inflation could cause an economic slowdown by making money more expensive to borrow. Stock valuations would also turn lower.\nThat's not necessarily bad news for investors who might find Apple's $2.8 trillion valuation a bit rich to buy into at the moment. The stock trades at 30 times trailing earnings, or about double its typical multiple. A correction would bring Apple back into the realm of the attainable, even as its business continues jogging forward.\nSales of the iPhone 13 are outpacing those of the iPhone 12 at the same time, but Apple reportedly warned suppliers that demand is waning as the calendar year progresses. It's not necessarily for a lack of consumer desire, but rather the global supply chain constraints that have made it difficult to find the product. Apple previously cut its iPhone production target by 10 million units from its original goal of 90 million.\nAnalysts think many consumers may choose to forgo the iPhone 13 and wait for the next upgrade. Coupled with a market crash, that could put Apple stock at a very attractive entry point with pent-up demand for the next iteration of the iPhone.\n2. Amazon\nFew companies are as essential to the working of the U.S. economy as Amazon (NASDAQ:AMZN). It will account for 41.4% of all online spending in the U.S. this year, according to eMarketer estimates. At the same time, Amazon Web Services (AWS), its cloud infrastructure business, is on track to generate over $60 billion in annual revenue in 2021 based on its year-to-date performance. The company is responsible for thousands of web-based businesses and the federal government's ability to remain online, making Amazon crucial to a well-functioning economy.\nThat won't change if the stock market collapses. Its share of U.S. retail e-commerce sales will be more than 50% larger than the shares of the next nine e-commerce companies combined. Amazon's piece of the online market is nearly six times more than Walmart's second-place share at just 7.2%, and 10 times greater than third-place eBay. E-commerce data tracker Edge by Ascential expects Amazon will see $26.7 billion just in online grocery sales five from now years, or nearly double its current amount.\nAmid rising prices and supply chain woes, Amazon has become a lifeline for many, and that will continue long after any financial restructuring. The stock gained 76% during the first year of the pandemic and took a breather during the reopening of the economy. Amazon shares have been relatively flat all year long. A correction would allow investors to buy a tech stock at a more reasonable valuation even as its crucial role only gets reinforced.","news_type":1},"isVote":1,"tweetType":1,"viewCount":648,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698589877,"gmtCreate":1640447629416,"gmtModify":1640447629722,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698589877","repostId":"2193127176","repostType":4,"repost":{"id":"2193127176","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640345481,"share":"https://www.laohu8.com/m/news/2193127176?lang=&edition=full","pubTime":"2021-12-24 19:31","market":"us","language":"en","title":"Japan health panel approves Merck's oral COVID-19 treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2193127176","media":"Reuters","summary":"TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COV","content":"<p>TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck &amp; Co Inc , part of plans by Prime Minister Fumio Kishida to roll out new treatments by yearend as concerns rise about the Omicron variant.</p>\n<p>The panel decision sets the stage for shipments of 200,000 doses across the country from this weekend, based on preparations announced earlier by Kishida.</p>\n<p>Japan is betting heavily on oral treatments to keep serious infections and deaths at bay should a feared sixth wave of the pandemic emerge. The government agreed last month to pay Merck and its partner Ridgeback Biotherapeutics about $1.2 billion for 1.6 million courses of their drug molnupiravir.</p>\n<p>In addition, Kishida announced last week a deal to procure 2 million doses of a separate antiviral pill&nbsp;developed by Pfizer Inc. And Japan's Shionogi &amp; Co is expected to soon file for approval of its own treatment&nbsp;supplying another 1 million doses by early next year.</p>\n<p>U.S. regulators on Thursday authorized the Merck pill for certain high-risk adult patients.</p>\n<p>Countries rushed to buy Merck's molnupiravir after very promising initial results, but subsequent company data in late November indicated the drug was markedly less effective than previously thought. France cancelled its order on Wednesday.</p>\n<p>Japan this week confirmed the first known cases of Omicron infections that could not be traced back to overseas travelers. Community transmissions of the variant have now been found in the western cities of Osaka and Kyoto, and a suspected case was announced in Tokyo on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan health panel approves Merck's oral COVID-19 treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan health panel approves Merck's oral COVID-19 treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-24 19:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck &amp; Co Inc , part of plans by Prime Minister Fumio Kishida to roll out new treatments by yearend as concerns rise about the Omicron variant.</p>\n<p>The panel decision sets the stage for shipments of 200,000 doses across the country from this weekend, based on preparations announced earlier by Kishida.</p>\n<p>Japan is betting heavily on oral treatments to keep serious infections and deaths at bay should a feared sixth wave of the pandemic emerge. The government agreed last month to pay Merck and its partner Ridgeback Biotherapeutics about $1.2 billion for 1.6 million courses of their drug molnupiravir.</p>\n<p>In addition, Kishida announced last week a deal to procure 2 million doses of a separate antiviral pill&nbsp;developed by Pfizer Inc. And Japan's Shionogi &amp; Co is expected to soon file for approval of its own treatment&nbsp;supplying another 1 million doses by early next year.</p>\n<p>U.S. regulators on Thursday authorized the Merck pill for certain high-risk adult patients.</p>\n<p>Countries rushed to buy Merck's molnupiravir after very promising initial results, but subsequent company data in late November indicated the drug was markedly less effective than previously thought. France cancelled its order on Wednesday.</p>\n<p>Japan this week confirmed the first known cases of Omicron infections that could not be traced back to overseas travelers. Community transmissions of the variant have now been found in the western cities of Osaka and Kyoto, and a suspected case was announced in Tokyo on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","BK4516":"特朗普概念","BK4007":"制药","MRK":"默沙东","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4559":"巴菲特持仓","BK4534":"瑞士信贷持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193127176","content_text":"TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck & Co Inc , part of plans by Prime Minister Fumio Kishida to roll out new treatments by yearend as concerns rise about the Omicron variant.\nThe panel decision sets the stage for shipments of 200,000 doses across the country from this weekend, based on preparations announced earlier by Kishida.\nJapan is betting heavily on oral treatments to keep serious infections and deaths at bay should a feared sixth wave of the pandemic emerge. The government agreed last month to pay Merck and its partner Ridgeback Biotherapeutics about $1.2 billion for 1.6 million courses of their drug molnupiravir.\nIn addition, Kishida announced last week a deal to procure 2 million doses of a separate antiviral pill developed by Pfizer Inc. And Japan's Shionogi & Co is expected to soon file for approval of its own treatment supplying another 1 million doses by early next year.\nU.S. regulators on Thursday authorized the Merck pill for certain high-risk adult patients.\nCountries rushed to buy Merck's molnupiravir after very promising initial results, but subsequent company data in late November indicated the drug was markedly less effective than previously thought. France cancelled its order on Wednesday.\nJapan this week confirmed the first known cases of Omicron infections that could not be traced back to overseas travelers. Community transmissions of the variant have now been found in the western cities of Osaka and Kyoto, and a suspected case was announced in Tokyo on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698874017,"gmtCreate":1640354933902,"gmtModify":1640354934137,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/698874017","repostId":"1168664020","repostType":4,"repost":{"id":"1168664020","pubTimestamp":1640339173,"share":"https://www.laohu8.com/m/news/1168664020?lang=&edition=full","pubTime":"2021-12-24 17:46","market":"us","language":"en","title":"The Fed Has Created the Monster Market: What's in Store for 2022?","url":"https://stock-news.laohu8.com/highlight/detail?id=1168664020","media":"Realmoney","summary":"The year 2021 should be labeled as the one that confounded even the most experienced of investors. T","content":"<p>The year 2021 should be labeled as the one that confounded even the most experienced of investors. Two years after the pandemic where the global central banks flushed the market with unimaginable liquidity in a short period of time to boost an economy that came to a grinding halt, one wonders why the U.S. central bank is still adding net liquidity to the market today, albeit at a slower pace. The Fed's mantra all throughout 2021 has been that \"inflation is transitory.\" But up until recently, when inflation is seen in everything from milk, coffee, rents, lumber, gas, construction, steel... to anything consumer related, even the Fed cannot use this word with a straight face. Using the word transitory loosely can still work if the horizon is anywhere from three months to two years. It seems the bond and rates markets have now forced the hand of the Fed to realize that inflation is certainly not transitory and they need to do something about it.</p>\n<p>The last two years has seen an \"everything bubble.\" Whether we like to believe it or not, all asset classes have risen with the same tide that the Fed created via its liquidity injection, some just a bit more based on beta and leverage. Many fund managers can use the word \"alpha\" to justify their returns, but in short, this Fed liquidity has distorted a host of asset prices and taking some of the larger ones way beyond their own fundamental value given what real yields and rates had done. A good example is the ARK Next Generation Internet ETF (ARKW) and racy tech growth stocks, after rallying in excess of 100%+, they have all now fallen over 50%+ the past few months, when the fundamental picture has not changed.</p>\n<p>And the simple reason is that liquidity is getting less and less in the market as the Fed is slowing down its asset purchases. Most emerging markets central banks and some developed ones have started raising rates, yet the Fed is still buying up to $90B-$100B of assets each month, two years after the pandemic. This at a time when jobless claims are at lows and the economy has recovered close to pre-pandemic levels from the demand side, if not from the employment side. The Fed's target for QE was to get employment back to pre Covid levels, but that goal post is much further now as participation rate has lagged. A lot of people have permanently retired from the workforce and this is something that the Fed is realizing just now.</p>\n<p>The latest FOMC meeting presided by the Fed announced that they would reduce their asset purchases even more aggressively by $30B per month instead of $15B. At this rate, the Fed will end its QE around March 2022. The bigger question now is how soon and how fast will the Fed start to raise rates? The market is pricing in about three rate hikes just in 2022 alone. If supply chain shortages persist, inflation is not expected to come down any time soon. As we enter 2022, we are entering an economy that is robust but at risk of plateauing post the liquidity induced demand surge, and with heightened inflation not seen since the 1980s! The year over year CPI rate is averaging between 6%-7% now, and it is at an alarmingly uncomfortable level. We are entering 2022 in a slight stagflationary environment, one that has not been seen or traded by the majority of traders that now exist in the market.</p>\n<p>At the moment, there is still net liquidity being added to the market, and that could be one of the main reasons why the S&amp;P 500 will hold up well here, but one wonders whether it can hold these levels in Q1 when fed balance sheet stops increasing altogether. Perhaps it is time for investors to stop focusing on Meme stocks or bankrupt stocks trying \"to make a quick buck\", squeezing out shorts via buying upside calls. Perhaps the market will return to some sort of rational behavior and display some economics 101 characteristics. One thing is for sure, asset allocation will need to shift into assets that are more inflation protected, hard assets like precious metals. Will 2022 finally be the year for gold?</p>","source":"lsy1619508253632","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>The Fed Has Created the Monster Market: What's in Store for 2022?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nThe Fed Has Created the Monster Market: What's in Store for 2022?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-24 17:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://realmoney.thestreet.com/investing/the-fed-has-created-the-monster-market-what-s-in-store-for-2022--15869560><strong>Realmoney</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The year 2021 should be labeled as the one that confounded even the most experienced of investors. Two years after the pandemic where the global central banks flushed the market with unimaginable ...</p>\n\n<a href=\"https://realmoney.thestreet.com/investing/the-fed-has-created-the-monster-market-what-s-in-store-for-2022--15869560\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".DJI":"道琼斯",".IXIC":"NASDAQ Composite"},"source_url":"https://realmoney.thestreet.com/investing/the-fed-has-created-the-monster-market-what-s-in-store-for-2022--15869560","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168664020","content_text":"The year 2021 should be labeled as the one that confounded even the most experienced of investors. Two years after the pandemic where the global central banks flushed the market with unimaginable liquidity in a short period of time to boost an economy that came to a grinding halt, one wonders why the U.S. central bank is still adding net liquidity to the market today, albeit at a slower pace. The Fed's mantra all throughout 2021 has been that \"inflation is transitory.\" But up until recently, when inflation is seen in everything from milk, coffee, rents, lumber, gas, construction, steel... to anything consumer related, even the Fed cannot use this word with a straight face. Using the word transitory loosely can still work if the horizon is anywhere from three months to two years. It seems the bond and rates markets have now forced the hand of the Fed to realize that inflation is certainly not transitory and they need to do something about it.\nThe last two years has seen an \"everything bubble.\" Whether we like to believe it or not, all asset classes have risen with the same tide that the Fed created via its liquidity injection, some just a bit more based on beta and leverage. Many fund managers can use the word \"alpha\" to justify their returns, but in short, this Fed liquidity has distorted a host of asset prices and taking some of the larger ones way beyond their own fundamental value given what real yields and rates had done. A good example is the ARK Next Generation Internet ETF (ARKW) and racy tech growth stocks, after rallying in excess of 100%+, they have all now fallen over 50%+ the past few months, when the fundamental picture has not changed.\nAnd the simple reason is that liquidity is getting less and less in the market as the Fed is slowing down its asset purchases. Most emerging markets central banks and some developed ones have started raising rates, yet the Fed is still buying up to $90B-$100B of assets each month, two years after the pandemic. This at a time when jobless claims are at lows and the economy has recovered close to pre-pandemic levels from the demand side, if not from the employment side. The Fed's target for QE was to get employment back to pre Covid levels, but that goal post is much further now as participation rate has lagged. A lot of people have permanently retired from the workforce and this is something that the Fed is realizing just now.\nThe latest FOMC meeting presided by the Fed announced that they would reduce their asset purchases even more aggressively by $30B per month instead of $15B. At this rate, the Fed will end its QE around March 2022. The bigger question now is how soon and how fast will the Fed start to raise rates? The market is pricing in about three rate hikes just in 2022 alone. If supply chain shortages persist, inflation is not expected to come down any time soon. As we enter 2022, we are entering an economy that is robust but at risk of plateauing post the liquidity induced demand surge, and with heightened inflation not seen since the 1980s! The year over year CPI rate is averaging between 6%-7% now, and it is at an alarmingly uncomfortable level. We are entering 2022 in a slight stagflationary environment, one that has not been seen or traded by the majority of traders that now exist in the market.\nAt the moment, there is still net liquidity being added to the market, and that could be one of the main reasons why the S&P 500 will hold up well here, but one wonders whether it can hold these levels in Q1 when fed balance sheet stops increasing altogether. Perhaps it is time for investors to stop focusing on Meme stocks or bankrupt stocks trying \"to make a quick buck\", squeezing out shorts via buying upside calls. Perhaps the market will return to some sort of rational behavior and display some economics 101 characteristics. One thing is for sure, asset allocation will need to shift into assets that are more inflation protected, hard assets like precious metals. Will 2022 finally be the year for gold?","news_type":1},"isVote":1,"tweetType":1,"viewCount":463,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691772419,"gmtCreate":1640252639399,"gmtModify":1640253062489,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691772419","repostId":"1184389618","repostType":4,"repost":{"id":"1184389618","pubTimestamp":1640230223,"share":"https://www.laohu8.com/m/news/1184389618?lang=&edition=full","pubTime":"2021-12-23 11:30","market":"us","language":"en","title":"Grab Stock May Be Down But It Isn’t Out","url":"https://stock-news.laohu8.com/highlight/detail?id=1184389618","media":"InvestorPlace","summary":"When Southeast Asian ride-hailing and delivery company Grab Holdings(NASDAQ:GRAB) completed a revers","content":"<p>When Southeast Asian ride-hailing and delivery company&nbsp;<b>Grab Holdings</b>(NASDAQ:<b><u>GRAB</u></b>) completed a reverse merger with special purpose acquisition company Altimeter Growth Corp. in early December it made history as the largest company to go public via a SPAC merger. Yet, this didn’t stop GRAB stock from&nbsp;plummeting more than 20%&nbsp;on the day of the merger.</p>\n<p>Since then, investors have continued to give GRAB stock the cold shoulder, with shares falling another 16% to trade at $7.34 at the time of this writing.</p>\n<p>Now, before you write off an investment in Grab Holdings, consider that the company is still in the early innings and let’s consider where GRAB stock could go from here.</p>\n<p><b>What’s Behind Grab’s Cool Reception?</b></p>\n<p>Grab is the largest ride-hailing and delivery company in Southeast Asia, with&nbsp;operations in Singapore,&nbsp;Malaysia, Cambodia,&nbsp;Indonesia, Myanmar,&nbsp;Philippines,&nbsp;Thailand and Vietnam and serving more than 187 million users.</p>\n<p>There are a number of plausible explanations for why GRAB stock has not been well-received by investors.</p>\n<p>For starters, growth estimates for the Southeast Asian region have been lowered recently primarily due to the coronavirus pandemic. In September, the Asian Development Bank&nbsp;dropped its 2021 growth forecast&nbsp;for the region to 3.1% from 4.4% previously.</p>\n<p>Widespread lockdowns in the region due to recurring waves of COVID-19 have hurt demand for Grab’s ride-hailing services and weighed on revenue despite an increase in food-delivery volumes.</p>\n<p>Grab reported its&nbsp;third-quarter results&nbsp;on Nov. 11. Revenue fell 9% year over year to $157 million, with the company citing “a decline in mobility due to the severe lockdowns in Vietnam.” Falling revenue is obviously not something investors want to see, especially from a company that has yet to turn a profit.</p>\n<p>Yet, the company did report a 32% year-over-year increase in gross merchandise value, with the dollar value of transactions from Grab’s services rising to $4.04 billion thanks to strength in the company’s deliveries segment.</p>\n<p><b>There’s Reason for Optimism</b></p>\n<p>The deal to go public through the merger with Altimeter Growth Corp. valued Grab at close to $40 billion, which as I mentioned, was a record. The fact that three weeks later GRAB stock has a market cap of about $27.5 billion tells us that perhaps things got a bit too heated. However, there is reason for optimism.</p>\n<p>The ride-hailing platform has secured the backing of significant players across related industries, including&nbsp;<b>DiDi Global</b>(NYSE:<b><u>DIDI</u></b>),<b>Toyota</b>(NYSE:<b><u>TM</u></b>) and&nbsp;<b>SoftBank’s</b>(OTCMKTS:<b><u>SFTBY</u></b>) Vision Fund.</p>\n<p>Grab Holdings also has some positive catalysts on the horizon. For example, the company recently announced that it&nbsp;will be purchasing&nbsp;<b>Jaya Grocer</b>, a premium supermarket chain in Malaysia.</p>\n<p>This acquisition fits nicely with the ride-hailing and delivery business model the company seeks to expand. Management refers to the model as a “superapp” focus, whereby users can access multiple services in a single, convenient location.</p>\n<p><b>The Bottom Line on GRAB Stock</b></p>\n<p>I can’t say Grab Holdings can immediately turn things around. But its potential in the burgeoning Southeast Asian market means it remains relevant and has a long runway.</p>\n<p>Of the six analysts following GRAB stock, two rate it a “buy” and there are no “sell” ratings,according to&nbsp;<i>The Wall Street Journal</i>. Meanwhile, the consensus price target stands at $12.25, which represents upside of 67% from current levels.</p>\n<p>GRAB stock is very cheap now, so it’s hardly a dangerous speculative play. There’s a good argument to be made for investing now and hoping that the company continues to expand its footprint. Profitability should follow.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab Stock May Be Down But It Isn’t Out</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab Stock May Be Down But It Isn’t Out\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 11:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/grab-stock-may-be-down-but-it-isnt-out/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When Southeast Asian ride-hailing and delivery company Grab Holdings(NASDAQ:GRAB) completed a reverse merger with special purpose acquisition company Altimeter Growth Corp. in early December it made ...</p>\n\n<a href=\"https://investorplace.com/2021/12/grab-stock-may-be-down-but-it-isnt-out/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"source_url":"https://investorplace.com/2021/12/grab-stock-may-be-down-but-it-isnt-out/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184389618","content_text":"When Southeast Asian ride-hailing and delivery company Grab Holdings(NASDAQ:GRAB) completed a reverse merger with special purpose acquisition company Altimeter Growth Corp. in early December it made history as the largest company to go public via a SPAC merger. Yet, this didn’t stop GRAB stock from plummeting more than 20% on the day of the merger.\nSince then, investors have continued to give GRAB stock the cold shoulder, with shares falling another 16% to trade at $7.34 at the time of this writing.\nNow, before you write off an investment in Grab Holdings, consider that the company is still in the early innings and let’s consider where GRAB stock could go from here.\nWhat’s Behind Grab’s Cool Reception?\nGrab is the largest ride-hailing and delivery company in Southeast Asia, with operations in Singapore, Malaysia, Cambodia, Indonesia, Myanmar, Philippines, Thailand and Vietnam and serving more than 187 million users.\nThere are a number of plausible explanations for why GRAB stock has not been well-received by investors.\nFor starters, growth estimates for the Southeast Asian region have been lowered recently primarily due to the coronavirus pandemic. In September, the Asian Development Bank dropped its 2021 growth forecast for the region to 3.1% from 4.4% previously.\nWidespread lockdowns in the region due to recurring waves of COVID-19 have hurt demand for Grab’s ride-hailing services and weighed on revenue despite an increase in food-delivery volumes.\nGrab reported its third-quarter results on Nov. 11. Revenue fell 9% year over year to $157 million, with the company citing “a decline in mobility due to the severe lockdowns in Vietnam.” Falling revenue is obviously not something investors want to see, especially from a company that has yet to turn a profit.\nYet, the company did report a 32% year-over-year increase in gross merchandise value, with the dollar value of transactions from Grab’s services rising to $4.04 billion thanks to strength in the company’s deliveries segment.\nThere’s Reason for Optimism\nThe deal to go public through the merger with Altimeter Growth Corp. valued Grab at close to $40 billion, which as I mentioned, was a record. The fact that three weeks later GRAB stock has a market cap of about $27.5 billion tells us that perhaps things got a bit too heated. However, there is reason for optimism.\nThe ride-hailing platform has secured the backing of significant players across related industries, including DiDi Global(NYSE:DIDI),Toyota(NYSE:TM) and SoftBank’s(OTCMKTS:SFTBY) Vision Fund.\nGrab Holdings also has some positive catalysts on the horizon. For example, the company recently announced that it will be purchasing Jaya Grocer, a premium supermarket chain in Malaysia.\nThis acquisition fits nicely with the ride-hailing and delivery business model the company seeks to expand. Management refers to the model as a “superapp” focus, whereby users can access multiple services in a single, convenient location.\nThe Bottom Line on GRAB Stock\nI can’t say Grab Holdings can immediately turn things around. But its potential in the burgeoning Southeast Asian market means it remains relevant and has a long runway.\nOf the six analysts following GRAB stock, two rate it a “buy” and there are no “sell” ratings,according to The Wall Street Journal. Meanwhile, the consensus price target stands at $12.25, which represents upside of 67% from current levels.\nGRAB stock is very cheap now, so it’s hardly a dangerous speculative play. There’s a good argument to be made for investing now and hoping that the company continues to expand its footprint. Profitability should follow.","news_type":1},"isVote":1,"tweetType":1,"viewCount":658,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691160599,"gmtCreate":1640150402618,"gmtModify":1640150402899,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691160599","repostId":"2193167797","repostType":4,"repost":{"id":"2193167797","pubTimestamp":1640149696,"share":"https://www.laohu8.com/m/news/2193167797?lang=&edition=full","pubTime":"2021-12-22 13:08","market":"us","language":"en","title":"Tesla's Musk says he sold 'enough stock'; slams California for 'overtaxation'","url":"https://stock-news.laohu8.com/highlight/detail?id=2193167797","media":"StreetInsider","summary":"By Hyunjoo Jin\nSan Francisco (Reuters) - Tesla CEO Elon Musk said he had sold \"enough stock\" to reac","content":"<p><img src=\"https://static.tigerbbs.com/9efa7579eff10d0a2edd8fa3cf3fa5ad\" tg-width=\"200\" tg-height=\"133\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>By Hyunjoo Jin</p>\n<p>San Francisco (Reuters) - Tesla CEO Elon Musk said he had sold \"enough stock\" to reach his plan to sell 10% of his shares in the world's most valuable car company, according to an interview released on Tuesday.</p>\n<p>The billionaire, who moved the company's headquarters from California to Texas this month after his personal move last year, also slammed California for \"overtaxation.\"</p>\n<p>Tesla shares, which had hovered near record-highs, lost about a quarter of their value after Musk said on Nov. 6 he would sell 10% of his stake if <a href=\"https://laohu8.com/S/TWTR\">Twitter</a> users agreed.</p>\n<p>On Tuesday, Musk sold another 583,611 shares, bringing the total number of shares he has offloaded to 13.5 million - about 80% of what he had planned to sell.</p>\n<p>\"I sold enough stock to get to around 10% plus the option exercise stuff and I tried to be extremely literal here,\" he said in the interview with satirical website Babylon Bee.</p>\n<p>When asked whether he sold the stock because of the Twitter poll, he said he needed to exercise stock options that are expiring next year \"no matter what.\" He also added that he sold an additional \"incremental stock\" to get near 10%.</p>\n<p>Out of the 13.5 million shares sold, 8.06 million were sold to pay taxes related to his options exercise.</p>\n<p>Musk said on Sunday on Twitter that he would pay more than $11 billion in taxes this year.</p>\n<p>\"California used to be the land of opportunity and now it is... becoming more so the land of sort of overregulation, overlitigation, overtaxation,\" he said, adding that it is \"increasingly difficult to get things done\" in California.</p>\n<p>(Reporting by Hyunjoo Jin. Editing by Gerry Doyle)</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla's Musk says he sold 'enough stock'; slams California for 'overtaxation'</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla's Musk says he sold 'enough stock'; slams California for 'overtaxation'\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-22 13:08 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=19381699><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>By Hyunjoo Jin\nSan Francisco (Reuters) - Tesla CEO Elon Musk said he had sold \"enough stock\" to reach his plan to sell 10% of his shares in the world's most valuable car company, according to an ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=19381699\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.streetinsider.com/dr/news.php?id=19381699","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193167797","content_text":"By Hyunjoo Jin\nSan Francisco (Reuters) - Tesla CEO Elon Musk said he had sold \"enough stock\" to reach his plan to sell 10% of his shares in the world's most valuable car company, according to an interview released on Tuesday.\nThe billionaire, who moved the company's headquarters from California to Texas this month after his personal move last year, also slammed California for \"overtaxation.\"\nTesla shares, which had hovered near record-highs, lost about a quarter of their value after Musk said on Nov. 6 he would sell 10% of his stake if Twitter users agreed.\nOn Tuesday, Musk sold another 583,611 shares, bringing the total number of shares he has offloaded to 13.5 million - about 80% of what he had planned to sell.\n\"I sold enough stock to get to around 10% plus the option exercise stuff and I tried to be extremely literal here,\" he said in the interview with satirical website Babylon Bee.\nWhen asked whether he sold the stock because of the Twitter poll, he said he needed to exercise stock options that are expiring next year \"no matter what.\" He also added that he sold an additional \"incremental stock\" to get near 10%.\nOut of the 13.5 million shares sold, 8.06 million were sold to pay taxes related to his options exercise.\nMusk said on Sunday on Twitter that he would pay more than $11 billion in taxes this year.\n\"California used to be the land of opportunity and now it is... becoming more so the land of sort of overregulation, overlitigation, overtaxation,\" he said, adding that it is \"increasingly difficult to get things done\" in California.\n(Reporting by Hyunjoo Jin. Editing by Gerry Doyle)","news_type":1},"isVote":1,"tweetType":1,"viewCount":465,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693472176,"gmtCreate":1640071934596,"gmtModify":1640071938258,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/693472176","repostId":"1117226796","repostType":4,"repost":{"id":"1117226796","pubTimestamp":1640057164,"share":"https://www.laohu8.com/m/news/1117226796?lang=&edition=full","pubTime":"2021-12-21 11:26","market":"us","language":"en","title":"Palantir: 3 Reasons Against It And Why It's Still A Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=1117226796","media":"Seeking Alpha","summary":"Summary\n\nPalantir Technologies is a battleground stock. Listening to the bears' arguments is a good ","content":"<p><b>Summary</b></p>\n<ul>\n <li>Palantir Technologies is a battleground stock. Listening to the bears' arguments is a good idea for bulls.</li>\n <li>PLTR dilutes its shareholders, but that is not necessarily a huge problem.</li>\n <li>Despite some interest rate headwinds, PLTR seems like a good investment to me, thanks to a strong moat and great growth outlook.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/7230cdd890b86f9941b99b1503d04049\" tg-width=\"1536\" tg-height=\"1044\" width=\"100%\" height=\"auto\"><span>spxChrome/E+ via Getty Images</span></p>\n<p><b>Article Thesis</b></p>\n<p>Palantir Technologies (PLTR) is an embattled growth stock, and in recent weeks, bears have been winning as shares continued to decline. There are, indeed some important bear arguments, such as dilution, reliance on government contracts, and rising interest rates. I do, however, still believe that Palantir Technologies is an attractive long-term investment, due to the act that its technology could lead to massive growth for many years to come.</p>\n<p><b>3 Issues Brought Up By Bears</b></p>\n<p>Palantir is a growth stock that brings out highly convinced bulls as well as highly convinced bears. Generally, I am in the bullish camp here, but taking a look at the bear arguments can be a good idea as well. Three of the most common arguments against Palantir are the following ones:</p>\n<p><b>1. Shareholder Dilution</b></p>\n<p>Growth on a company-wide basis is important, but growth on a per-share basis is even more important. There are many examples that show that changes in a company's share count can create or destroy a lot of shareholder value. Apple (AAPL), for example, has seen its net income grow by roughly 190% over the last decade:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2b5263c8346cfbbb898f1d1ac9a5bead\" tg-width=\"635\" tg-height=\"433\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>Thanks to a declining share count, its earnings per share rose by a much more attractive 350%, however -- buybacks created a lot of shareholder value. There are also examples where a rising share count destroyed a lot of shareholder value, e.g. at Citigroup (C):</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/fc39008812f5e2d0082dedc95b025c68\" tg-width=\"635\" tg-height=\"433\" width=\"100%\" height=\"auto\"><span>Data by YCharts</span></p>\n<p>Massive share issuance during the Great Recession has resulted in a 75% earnings per share decline since 2007, even though net profits were up over the same time frame. Looking at the changes in a company's share count thus makes sense, as those changes can have a large impact in the long run. At Palantir, we see that the share count has been rising considerably since the company went public. During the most recent quarter, Palantir's share count looked like this:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/917ca4d7a390ced61d7c92d528f84fc1\" tg-width=\"640\" tg-height=\"539\" width=\"100%\" height=\"auto\"><span>Source: Palantir Press Release</span></p>\n<p>Compared to the second quarter, Palantir's average share count was&nbsp;1.895 billion, which makes for a 3.5% quarterly increase, which pencils out to an annual growth rate in the mid-teens. That is, of course, not negligible at all, and bears to have an argument when they state that shareholders get diluted at a meaningful pace. On the other hand, Palantir's business growth rate is way higher than 3% per quarter, as the company has guided for ~40% revenue growth this year, and since Palantir should also deliver outsized business growth in the coming years. Even if Palantir's share count were to climb by 10%-15% a year going forward, revenue per share would still climb by 25%+ a year thanks to the fact that PLTR is growing rapidly. I also believe that dilution will, over the years, decline. Not only has this been the case at many other growth companies, e.g. Amazon (AMZN), Alphabet (GOOG), or Meta (FB), but it is also logical from an option rewards perspective. Option rewards are especially generous when a company is not yet publicly traded and when its future is still more uncertain, but as a company matures, employees get more comfortable as risks for the company decline, and they do not demand large option packages any longer. Last but not least, Palantir also generates strong free cash flows that should allow the company to do share buybacks in the future, which should help improve the dilution rate as well.</p>\n<p><b>2. Reliance on government contracts</b></p>\n<p>In a recent bearish&nbsp;article, fellow Seeking Alpha contributor On The Pulse argued that Palantir was overvalued and that its reliance on government contracts was an issue. Palantir Technologies is, indeed, reliant on government contracts to a large degree today, but I do not believe that this is a major issue. First, Palantir has diversified away from government contracts in the recent past, thanks to massive growth in its commercial business:</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/de23409915ee3811691b986a42ece899\" tg-width=\"640\" tg-height=\"308\" width=\"100%\" height=\"auto\"><span>Source: Palantir Technologies presentation</span></p>\n<p>In fact, Palantir's commercial business has been growing much faster than its government business in the recent past, which shows that commercial customers from all kinds of industries apparently see a lot of value in Palantir's technology -- otherwise, they wouldn't be buying at a rapid pace. With</p>\n<p>With the commercial business growth rate outpacing the government business growth rate, Palantir will, over the years, become a company that is less and less dependent on government contracts, and that will ultimately turn into a B2B-focused software/technology player. Even if Palantir were to remain a government-focused company forever, which seems unlikely based on the current growth rates of the individual business units, that would not necessarily be an issue. Working for the government means that there is very little counterparty risk and that existing relations can easily be used to get future contracts. Last but not least, with government budgets rising relatively steadily, good government connections allow for considerable growth opportunities -- especially in the defense tech/security tech space Palantir is active in, as there is a huge need for further investments in this space.</p>\n<p>The claim that a government focus leads to lacking scalability is also false, I believe. Per Palantir's most recent quarterly report (linked above), its operating expenses rose by $9 million between Q3 2020 and Q3 2021 -- whereas revenues rose by $103 million in the same time frame. This backs out changes in share-based compensation. If one were to include those SBC expenses, Palantir's expenses actually<i>declined</i>year-over-year while the company managed to grow its revenue by close to 40%. The claim that Palantir will not generate any scale advantages over the years thus seems to be unfounded, I believe. Instead, the data suggest that Palantir will be able to grow its margins considerably -- the company was able to grow its adjusted gross profit by a massive $90 million while growing its adjusted operating expenses by just $9 million -- making for excellent operating leverage.</p>\n<p><b>3. Exposure to rising rates</b></p>\n<p>Massive inflation will force the Fed to raise rates in 2022 and beyond, and that could be an issue for growth stocks. Companies that are not profitable today, or that have the vast majority of their profits in the distant future, are more exposed to a rising discount rate compared to companies that have low or no growth and that generate a large amount of all future profits in the near term. This could result in outperformance of value stocks versus growth stocks in the coming years, I believe. Palantir, which is not profitable yet, naturally belongs in the \"growth\" bucket that could see an above-average impact from rising interest rates. There is no real counter-argument here, I believe -- it is indeed true that the impact of rising rates on Palantir, all else equal, will be larger compared to a value stock like AbbVie (ABBV), for example.</p>\n<p>This being an incremental negative for Palantir doesn't mean that shares have to be avoided under any circumstances, however. Indeed, even despite some potential headwinds from rising rates, Palantir could still be an attractive investment if other arguments have a larger weight -- I believe this to be true, as I see PLTR's massive growth potential and huge moat outweighing some near-term headwinds from rising rates.</p>\n<p><b>Why Palantir Is Still Attractive</b></p>\n<p>Bears bring up a range of arguments against Palantir, and as shown above, those can have merit. I believe that they might be overblown in some cases, but taking a look at the bear's arguments doesn't hurt -- in fact, it seems like a good idea to look at both sides in order to make a more informed decision. Dilution is indeed an issue, although I do not believe that this will be too much of a headwind, since PLTR's business growth easily outpaces dilution and since dilution, overall, should slow down over the years. Government reliance will wane over the years due to an above-average commercial business growth rate, and in general, doing business with the government is not a bad thing anyway. The claim that PLTR lacks scalability seems to be false, from what I see in PLTR's data.</p>\n<p>Palantir is, despite these arguments, attractive, I believe: The company is growing rapidly, has decades-long growth potential in both its government business as well as on the commercial side, and Palantir seems to have a very wide moat. This combination could turn Palantir into one of the largest and most important companies eventually -- although investors shouldn't expect this to happen in the very near term. Instead, I believe that there is a good chance that Palantir will grow at a considerable rate throughout the 2020s and beyond, as our world becomes ever more data-hungry -- both governments, as well as enterprises, will try to get the most value out of all of this data, and Palantir, with its tailored solutions, will be there to offer that value to its customers. With new tools such as the recently-showcased&nbsp;Foundry&nbsp;for crypto, Palantir is at the forefront of all kinds of emerging technologies. Thanks to the fact that Palantir has access to top talent -- the result of SBC and of an&nbsp;excellent working environment-- I believe that there is a good chance that Palantir will be able to be highly competitive in all kinds of future markets in the Big Data/AI space that may not even exist yet.</p>\n<p><b>Takeaway</b></p>\n<p>In general, I am not much of a growth investor -- instead, I primarily focus on attractively priced stocks with strong cash flows, oftentimes those that pay dividends. Palantir, however, is somewhat of an outlier in my portfolio -- it's a growth stock, it is not really profitable yet, and most of its potential is years away. Due to the highly attractive combination of a massive market opportunity, excellent talent, and a wide moat, Palantir still seems like an attractive long-term investment to me. This isn't a stock that will make investors rich quickly, but I believe that there is a very good chance that Palantir will turn into a very dominant, important company over the next 10+ years. At 19x next year's revenue, PLTR is not cheap, but when we expect that the company will grow at a strong rate for many years, that also doesn't seem outlandish to me at all. It makes sense to listen to the bears' arguments, but I believe that the pros outweigh the cons here.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Palantir: 3 Reasons Against It And Why It's Still A Buy</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPalantir: 3 Reasons Against It And Why It's Still A Buy\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-21 11:26 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4475960-palantir-3-reasons-against-it-and-why-its-still-a-buy><strong>Seeking Alpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nPalantir Technologies is a battleground stock. Listening to the bears' arguments is a good idea for bulls.\nPLTR dilutes its shareholders, but that is not necessarily a huge problem.\nDespite ...</p>\n\n<a href=\"https://seekingalpha.com/article/4475960-palantir-3-reasons-against-it-and-why-its-still-a-buy\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PLTR":"Palantir Technologies Inc."},"source_url":"https://seekingalpha.com/article/4475960-palantir-3-reasons-against-it-and-why-its-still-a-buy","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117226796","content_text":"Summary\n\nPalantir Technologies is a battleground stock. Listening to the bears' arguments is a good idea for bulls.\nPLTR dilutes its shareholders, but that is not necessarily a huge problem.\nDespite some interest rate headwinds, PLTR seems like a good investment to me, thanks to a strong moat and great growth outlook.\n\nspxChrome/E+ via Getty Images\nArticle Thesis\nPalantir Technologies (PLTR) is an embattled growth stock, and in recent weeks, bears have been winning as shares continued to decline. There are, indeed some important bear arguments, such as dilution, reliance on government contracts, and rising interest rates. I do, however, still believe that Palantir Technologies is an attractive long-term investment, due to the act that its technology could lead to massive growth for many years to come.\n3 Issues Brought Up By Bears\nPalantir is a growth stock that brings out highly convinced bulls as well as highly convinced bears. Generally, I am in the bullish camp here, but taking a look at the bear arguments can be a good idea as well. Three of the most common arguments against Palantir are the following ones:\n1. Shareholder Dilution\nGrowth on a company-wide basis is important, but growth on a per-share basis is even more important. There are many examples that show that changes in a company's share count can create or destroy a lot of shareholder value. Apple (AAPL), for example, has seen its net income grow by roughly 190% over the last decade:\nData by YCharts\nThanks to a declining share count, its earnings per share rose by a much more attractive 350%, however -- buybacks created a lot of shareholder value. There are also examples where a rising share count destroyed a lot of shareholder value, e.g. at Citigroup (C):\nData by YCharts\nMassive share issuance during the Great Recession has resulted in a 75% earnings per share decline since 2007, even though net profits were up over the same time frame. Looking at the changes in a company's share count thus makes sense, as those changes can have a large impact in the long run. At Palantir, we see that the share count has been rising considerably since the company went public. During the most recent quarter, Palantir's share count looked like this:\nSource: Palantir Press Release\nCompared to the second quarter, Palantir's average share count was 1.895 billion, which makes for a 3.5% quarterly increase, which pencils out to an annual growth rate in the mid-teens. That is, of course, not negligible at all, and bears to have an argument when they state that shareholders get diluted at a meaningful pace. On the other hand, Palantir's business growth rate is way higher than 3% per quarter, as the company has guided for ~40% revenue growth this year, and since Palantir should also deliver outsized business growth in the coming years. Even if Palantir's share count were to climb by 10%-15% a year going forward, revenue per share would still climb by 25%+ a year thanks to the fact that PLTR is growing rapidly. I also believe that dilution will, over the years, decline. Not only has this been the case at many other growth companies, e.g. Amazon (AMZN), Alphabet (GOOG), or Meta (FB), but it is also logical from an option rewards perspective. Option rewards are especially generous when a company is not yet publicly traded and when its future is still more uncertain, but as a company matures, employees get more comfortable as risks for the company decline, and they do not demand large option packages any longer. Last but not least, Palantir also generates strong free cash flows that should allow the company to do share buybacks in the future, which should help improve the dilution rate as well.\n2. Reliance on government contracts\nIn a recent bearish article, fellow Seeking Alpha contributor On The Pulse argued that Palantir was overvalued and that its reliance on government contracts was an issue. Palantir Technologies is, indeed, reliant on government contracts to a large degree today, but I do not believe that this is a major issue. First, Palantir has diversified away from government contracts in the recent past, thanks to massive growth in its commercial business:\nSource: Palantir Technologies presentation\nIn fact, Palantir's commercial business has been growing much faster than its government business in the recent past, which shows that commercial customers from all kinds of industries apparently see a lot of value in Palantir's technology -- otherwise, they wouldn't be buying at a rapid pace. With\nWith the commercial business growth rate outpacing the government business growth rate, Palantir will, over the years, become a company that is less and less dependent on government contracts, and that will ultimately turn into a B2B-focused software/technology player. Even if Palantir were to remain a government-focused company forever, which seems unlikely based on the current growth rates of the individual business units, that would not necessarily be an issue. Working for the government means that there is very little counterparty risk and that existing relations can easily be used to get future contracts. Last but not least, with government budgets rising relatively steadily, good government connections allow for considerable growth opportunities -- especially in the defense tech/security tech space Palantir is active in, as there is a huge need for further investments in this space.\nThe claim that a government focus leads to lacking scalability is also false, I believe. Per Palantir's most recent quarterly report (linked above), its operating expenses rose by $9 million between Q3 2020 and Q3 2021 -- whereas revenues rose by $103 million in the same time frame. This backs out changes in share-based compensation. If one were to include those SBC expenses, Palantir's expenses actuallydeclinedyear-over-year while the company managed to grow its revenue by close to 40%. The claim that Palantir will not generate any scale advantages over the years thus seems to be unfounded, I believe. Instead, the data suggest that Palantir will be able to grow its margins considerably -- the company was able to grow its adjusted gross profit by a massive $90 million while growing its adjusted operating expenses by just $9 million -- making for excellent operating leverage.\n3. Exposure to rising rates\nMassive inflation will force the Fed to raise rates in 2022 and beyond, and that could be an issue for growth stocks. Companies that are not profitable today, or that have the vast majority of their profits in the distant future, are more exposed to a rising discount rate compared to companies that have low or no growth and that generate a large amount of all future profits in the near term. This could result in outperformance of value stocks versus growth stocks in the coming years, I believe. Palantir, which is not profitable yet, naturally belongs in the \"growth\" bucket that could see an above-average impact from rising interest rates. There is no real counter-argument here, I believe -- it is indeed true that the impact of rising rates on Palantir, all else equal, will be larger compared to a value stock like AbbVie (ABBV), for example.\nThis being an incremental negative for Palantir doesn't mean that shares have to be avoided under any circumstances, however. Indeed, even despite some potential headwinds from rising rates, Palantir could still be an attractive investment if other arguments have a larger weight -- I believe this to be true, as I see PLTR's massive growth potential and huge moat outweighing some near-term headwinds from rising rates.\nWhy Palantir Is Still Attractive\nBears bring up a range of arguments against Palantir, and as shown above, those can have merit. I believe that they might be overblown in some cases, but taking a look at the bear's arguments doesn't hurt -- in fact, it seems like a good idea to look at both sides in order to make a more informed decision. Dilution is indeed an issue, although I do not believe that this will be too much of a headwind, since PLTR's business growth easily outpaces dilution and since dilution, overall, should slow down over the years. Government reliance will wane over the years due to an above-average commercial business growth rate, and in general, doing business with the government is not a bad thing anyway. The claim that PLTR lacks scalability seems to be false, from what I see in PLTR's data.\nPalantir is, despite these arguments, attractive, I believe: The company is growing rapidly, has decades-long growth potential in both its government business as well as on the commercial side, and Palantir seems to have a very wide moat. This combination could turn Palantir into one of the largest and most important companies eventually -- although investors shouldn't expect this to happen in the very near term. Instead, I believe that there is a good chance that Palantir will grow at a considerable rate throughout the 2020s and beyond, as our world becomes ever more data-hungry -- both governments, as well as enterprises, will try to get the most value out of all of this data, and Palantir, with its tailored solutions, will be there to offer that value to its customers. With new tools such as the recently-showcased Foundry for crypto, Palantir is at the forefront of all kinds of emerging technologies. Thanks to the fact that Palantir has access to top talent -- the result of SBC and of an excellent working environment-- I believe that there is a good chance that Palantir will be able to be highly competitive in all kinds of future markets in the Big Data/AI space that may not even exist yet.\nTakeaway\nIn general, I am not much of a growth investor -- instead, I primarily focus on attractively priced stocks with strong cash flows, oftentimes those that pay dividends. Palantir, however, is somewhat of an outlier in my portfolio -- it's a growth stock, it is not really profitable yet, and most of its potential is years away. Due to the highly attractive combination of a massive market opportunity, excellent talent, and a wide moat, Palantir still seems like an attractive long-term investment to me. This isn't a stock that will make investors rich quickly, but I believe that there is a very good chance that Palantir will turn into a very dominant, important company over the next 10+ years. At 19x next year's revenue, PLTR is not cheap, but when we expect that the company will grow at a strong rate for many years, that also doesn't seem outlandish to me at all. It makes sense to listen to the bears' arguments, but I believe that the pros outweigh the cons here.","news_type":1},"isVote":1,"tweetType":1,"viewCount":586,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693018529,"gmtCreate":1639926450163,"gmtModify":1639926450395,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693018529","repostId":"2192903795","repostType":4,"repost":{"id":"2192903795","pubTimestamp":1639880431,"share":"https://www.laohu8.com/m/news/2192903795?lang=&edition=full","pubTime":"2021-12-19 10:20","market":"us","language":"en","title":"5 Growth Stocks to Buy Now for 2022","url":"https://stock-news.laohu8.com/highlight/detail?id=2192903795","media":"Motley Fool","summary":"Can these five stock picks boost your 2022 gains?","content":"<p>Today, I provide five growth stocks that I think will perform well in 2022 and beyond. These stock picks cover enormous secular growth trends that should flourish over the long term.</p>\n<p><a href=\"https://laohu8.com/S/NVDA\"><b>Nvidia</b> </a> is the first stock on the list. It's easy to see why some investors would shy away from Nvidia at these levels. The stock price has delivered over 67,000% returns since going public in 1999. A $10,000 investment would be worth approximately $6.7 million today. But the company is firing on all cylinders, and when you look under the hood, you will find that its future looks very bright, which can arguably justify the premium share price. Nvidia has its hands in nearly every secular tailwind imaginable:</p>\n<ul>\n <li>Data centers</li>\n <li>Cloud computing</li>\n <li>Cybersecurity&nbsp;</li>\n <li>Space exploration</li>\n <li>Video gaming</li>\n <li>Online gambling</li>\n <li>Augmented reality (AR)</li>\n <li>Virtual reality (VR)</li>\n <li>Mixed reality (MR)</li>\n <li>Autonomous driving</li>\n <li>Electric vehicles</li>\n <li>Genomics</li>\n <li>Esports</li>\n <li>5G</li>\n <li>E-commerce</li>\n <li>Cryptocurrency</li>\n <li>Artificial intelligence (AI)</li>\n <li>Metaverse</li>\n <li>Big data</li>\n</ul>\n<p><a href=\"https://laohu8.com/S/TSLA\"><b>Tesla</b> </a> has made a historic run over the past couple of years, but with Elon Musk at the helm, the future still looks very bright. The company continues to grow rapidly while improving net profit margins and cash flows. The EV super cycle is just getting started, and Tesla is poised to be top dog. Not only is Tesla a top autonomous and electric vehicle manufacturer, it is, in my opinion, also the best artificial intelligence company in the world.&nbsp;</p>\n<p><b><a href=\"https://laohu8.com/S/SNOW\">Snowflake</a></b> offers what it calls a \"data warehouse-as-a-service\" (DaaS), a cloud-based data storage and analytics solution. Think \"big data.\" Interestingly, Snowflake is not a SaaS company since its revenue is over 90% consumption based. Snowflake reduces cost and improves agility. Its data platform is unique in that it is not built on an existing big data platform. In addition to big data and analytics, I believe Snowflake is positioned well to create a unique digital advertising moat, which I discuss in detail here.&nbsp;I have been a fan of this stock since pre-IPO, and I have high conviction long term.</p>\n<p><a href=\"https://laohu8.com/S/U\"><b>Unity Software</b>&nbsp;</a>&nbsp;is best known for gaming. It provides tools and software to assist developers in game creation and marketing. In 2019, over 50% of the top 1,000 mobile games were created using Unity. Unity has players in 195 countries, so it's literally a global company. Unity powers billon-dollar mobile games like <i>Pokémon Go</i> and <i>Angry Birds</i>.&nbsp;</p>\n<p>But augmented reality (AR) and virtual reality (VR) are why I personally own the stock. Think metaverse! However, Unity is actually quite diverse in terms of its offerings and industry segments. Here are some other areas Unity works in outside of gaming:</p>\n<ul>\n <li>Automotive, transportation, and manufacturing</li>\n <li>Film, animation, and cinematics</li>\n <li>Architecture, engineering, and construction</li>\n <li>Government and aerospace</li>\n <li>Gambling</li>\n</ul>\n<p><b><a href=\"https://laohu8.com/S/PATH\">UiPath</a></b> (NYSE:PATH) is a global software company focused on robotic process automation, also called RPA. The company's software enables organizations to automate data entry and repetitive tasks. RPA technology makes it simple for businesses to build, deploy, and manage bots. These software robots emulate human actions and provide many benefits. Examples include:</p>\n<ul>\n <li>Increased production times</li>\n <li>Reduction of costs</li>\n <li>Increased employee creativity and innovation</li>\n <li>Improved efficiency</li>\n <li>Increased employee happiness and retention</li>\n <li>Improved process quality</li>\n <li>Higher employee productivity</li>\n <li>Improved customer service</li>\n</ul>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Growth Stocks to Buy Now for 2022</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Growth Stocks to Buy Now for 2022\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-19 10:20 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/18/5-growth-stocks-to-buy-now-for-2022/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Today, I provide five growth stocks that I think will perform well in 2022 and beyond. These stock picks cover enormous secular growth trends that should flourish over the long term.\nNvidia  is the ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/18/5-growth-stocks-to-buy-now-for-2022/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PATH":"UiPath","U":"Unity Software Inc.","BK4534":"瑞士信贷持仓","BK4567":"ESG概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4555":"新能源车","SNOW":"Snowflake","TSLA":"特斯拉","BK4535":"淡马锡持仓","BK4559":"巴菲特持仓","BK4543":"AI","BK4527":"明星科技股","BK4116":"互联网服务与基础架构","BK4550":"红杉资本持仓","BK4141":"半导体产品","BK4503":"景林资产持仓","BK4551":"寇图资本持仓","BK4561":"索罗斯持仓","BK4505":"高瓴资本持仓","BK4097":"系统软件","NVDA":"英伟达","BK4099":"汽车制造商","BK4549":"软银资本持仓","VR":"GLOBAL X METAVERSE ETF","BK4548":"巴美列捷福持仓","BK4529":"IDC概念","BK4213":"石油与天然气的勘探与生产","BK4539":"次新股","BK4528":"SaaS概念","BK4023":"应用软件","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓"},"source_url":"https://www.fool.com/investing/2021/12/18/5-growth-stocks-to-buy-now-for-2022/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2192903795","content_text":"Today, I provide five growth stocks that I think will perform well in 2022 and beyond. These stock picks cover enormous secular growth trends that should flourish over the long term.\nNvidia  is the first stock on the list. It's easy to see why some investors would shy away from Nvidia at these levels. The stock price has delivered over 67,000% returns since going public in 1999. A $10,000 investment would be worth approximately $6.7 million today. But the company is firing on all cylinders, and when you look under the hood, you will find that its future looks very bright, which can arguably justify the premium share price. Nvidia has its hands in nearly every secular tailwind imaginable:\n\nData centers\nCloud computing\nCybersecurity \nSpace exploration\nVideo gaming\nOnline gambling\nAugmented reality (AR)\nVirtual reality (VR)\nMixed reality (MR)\nAutonomous driving\nElectric vehicles\nGenomics\nEsports\n5G\nE-commerce\nCryptocurrency\nArtificial intelligence (AI)\nMetaverse\nBig data\n\nTesla  has made a historic run over the past couple of years, but with Elon Musk at the helm, the future still looks very bright. The company continues to grow rapidly while improving net profit margins and cash flows. The EV super cycle is just getting started, and Tesla is poised to be top dog. Not only is Tesla a top autonomous and electric vehicle manufacturer, it is, in my opinion, also the best artificial intelligence company in the world. \nSnowflake offers what it calls a \"data warehouse-as-a-service\" (DaaS), a cloud-based data storage and analytics solution. Think \"big data.\" Interestingly, Snowflake is not a SaaS company since its revenue is over 90% consumption based. Snowflake reduces cost and improves agility. Its data platform is unique in that it is not built on an existing big data platform. In addition to big data and analytics, I believe Snowflake is positioned well to create a unique digital advertising moat, which I discuss in detail here. I have been a fan of this stock since pre-IPO, and I have high conviction long term.\nUnity Software  is best known for gaming. It provides tools and software to assist developers in game creation and marketing. In 2019, over 50% of the top 1,000 mobile games were created using Unity. Unity has players in 195 countries, so it's literally a global company. Unity powers billon-dollar mobile games like Pokémon Go and Angry Birds. \nBut augmented reality (AR) and virtual reality (VR) are why I personally own the stock. Think metaverse! However, Unity is actually quite diverse in terms of its offerings and industry segments. Here are some other areas Unity works in outside of gaming:\n\nAutomotive, transportation, and manufacturing\nFilm, animation, and cinematics\nArchitecture, engineering, and construction\nGovernment and aerospace\nGambling\n\nUiPath (NYSE:PATH) is a global software company focused on robotic process automation, also called RPA. The company's software enables organizations to automate data entry and repetitive tasks. RPA technology makes it simple for businesses to build, deploy, and manage bots. These software robots emulate human actions and provide many benefits. Examples include:\n\nIncreased production times\nReduction of costs\nIncreased employee creativity and innovation\nImproved efficiency\nIncreased employee happiness and retention\nImproved process quality\nHigher employee productivity\nImproved customer service","news_type":1},"isVote":1,"tweetType":1,"viewCount":180,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":699374571,"gmtCreate":1639753137495,"gmtModify":1639753137723,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/699374571","repostId":"1155244596","repostType":4,"repost":{"id":"1155244596","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639752003,"share":"https://www.laohu8.com/m/news/1155244596?lang=&edition=full","pubTime":"2021-12-17 22:40","market":"us","language":"en","title":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list","url":"https://stock-news.laohu8.com/highlight/detail?id=1155244596","media":"Tiger Newspress","summary":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emerg","content":"<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-17 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax continued to jump nearly&nbsp;5% in morning trading as its vaccine had been included on the&nbsp;emergency use list.<img src=\"https://static.tigerbbs.com/6e0b5588f7377a98c70179cdc8612b3f\" tg-width=\"765\" tg-height=\"561\" width=\"100%\" height=\"auto\">The World Health Organization has included&nbsp;its&nbsp;vaccine NVX-CoV2373 on the emergency use list,and its&nbsp;original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1155244596","content_text":"Novavax continued to jump nearly 5% in morning trading as its vaccine had been included on the emergency use list.The World Health Organization has included its vaccine NVX-CoV2373 on the emergency use list,and its original drug called nuvaxovidtm is currently undergoing evaluation by the European Medicines Agency.","news_type":1},"isVote":1,"tweetType":1,"viewCount":300,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690654737,"gmtCreate":1639665982473,"gmtModify":1639666001035,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690654737","repostId":"1103611253","repostType":4,"isVote":1,"tweetType":1,"viewCount":113,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607440513,"gmtCreate":1639581173341,"gmtModify":1639581199423,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607440513","repostId":"1149717556","repostType":4,"repost":{"id":"1149717556","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639579526,"share":"https://www.laohu8.com/m/news/1149717556?lang=&edition=full","pubTime":"2021-12-15 22:45","market":"us","language":"en","title":"Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149717556","media":"Tiger Newspress","summary":"Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax risi","content":"<p>Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%.<img src=\"https://static.tigerbbs.com/9fe6a9d4d67542197b8f5233dddb808c\" tg-width=\"287\" tg-height=\"246\" width=\"100%\" height=\"auto\">Vir Biotechnology (VIR) unveiled late Tuesday new preclinical data that demonstrates the impact of the \"significant antigenic shift\" of the new SARS-CoV-2 Omicron variant on neutralizing activity of monoclonal antibodies.</p>\n<p>The company said a \"significant\" reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-15 22:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%.<img src=\"https://static.tigerbbs.com/9fe6a9d4d67542197b8f5233dddb808c\" tg-width=\"287\" tg-height=\"246\" width=\"100%\" height=\"auto\">Vir Biotechnology (VIR) unveiled late Tuesday new preclinical data that demonstrates the impact of the \"significant antigenic shift\" of the new SARS-CoV-2 Omicron variant on neutralizing activity of monoclonal antibodies.</p>\n<p>The company said a \"significant\" reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","VIR":"Vir Biotechnology, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149717556","content_text":"Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%.Vir Biotechnology (VIR) unveiled late Tuesday new preclinical data that demonstrates the impact of the \"significant antigenic shift\" of the new SARS-CoV-2 Omicron variant on neutralizing activity of monoclonal antibodies.\nThe company said a \"significant\" reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.","news_type":1},"isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607340550,"gmtCreate":1639493186905,"gmtModify":1639493187132,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/607340550","repostId":"1179453620","repostType":4,"repost":{"id":"1179453620","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639492308,"share":"https://www.laohu8.com/m/news/1179453620?lang=&edition=full","pubTime":"2021-12-14 22:31","market":"us","language":"en","title":"U.S.Stocks open lower after PPI reading as investors await Fed","url":"https://stock-news.laohu8.com/highlight/detail?id=1179453620","media":"Tiger Newspress","summary":"U.S.Stocks open lower after PPI reading as investors await Fed,Nasdaq Composite down 1.2% at 15,229.","content":"<p>U.S.Stocks open lower after PPI reading as investors await Fed,Nasdaq Composite down 1.2% at 15,229.96,S&amp;P 500 down 0.7% at 4,635.65,Dow industrials down 98 points, or 0.3%.</p>\n<p>Tesla&nbsp;shares were among the biggest early droppers on the S&amp;P 500, falling 2.1% premarket after CEO Elon Musk announced that that he has sold another $906.5 million in shares.</p>\n<p>Fellow automaker&nbsp;Ford&nbsp;also fell, down 1.7% following news that by 2030Toyotawould beinvesting $35 billion into battery-powered electronic vehicles, a space where Ford has sought to establish itself as a leader.</p>\n<p>Pfizer&nbsp;shares rose nearly 1% after final results of tests on its Covid drug showed it reduced hospitalizations and deaths by 89% in high-risk patients.</p>\n<p>Research from Goldman Sachs showed&nbsp;the S&amp;P 500 is powered by five stocks&nbsp;that have accounted for 51% of its return since the end of April. Microsoft, Google, Apple, Nvidia and Tesla account for more than one-third of the S&amp;P 500's 26% return this year, according to Goldman.</p>\n<p>Traders are awaiting a decision from the Fed on&nbsp;how quickly the central bank will tighten monetary policy&nbsp;amid a backdrop of fresh inflation numbers that reflected the fastest annual increase in nearly four decades. The Labor Department's Consumer Price Index (CPI) soared 6.8% in November compared to last year, according to figures published last week.</p>\n<p>The Federal Open Market Committee (FOMC) is scheduled to hold its two-day policy-setting meeting starting on Tuesday, followed by the release of the monetary policy statement and remarks from Federal Reserve Chair Jerome Powell Wednesday. An updated Summary of Economic Projections outlining individual members' outlooks for economic conditions and interest rates is set to accompany the statement.</p>\n<p>The Fed has been under pressure to control rising inflation levels, as investors watch for clues of a faster taper that could set the stage for earlier rate hikes.</p>\n<p>“Because inflation expectations do appear to be adaptive, our view is that the longer inflation stays elevated, the greater the risk that consumers adjust their behaviors in a way that contributes to persistently elevated inflation” wrote PIMCO economist Tiffany Wilding in a&nbsp;recent note to clients.</p>\n<p>“We believe the Fed will want to manage this risk by shortening the time over which it winds down its purchases of U.S. Treasuries and agency mortgage-backed securities (MBS), aiming to end the program in March 2022, while also signaling a June rate hike is likely,” said Wilding.</p>\n<p>PIMCO managing director and portfolio manager Sonali Pier also separately&nbsp;told Yahoo Finance Live&nbsp;that the firm expects to see two hikes in 2022, three hikes in 2023, and potentially four in 2024, with the Fed trying to bring the policy rate to neutral.</p>\n<p>“Amid proliferating signs of solid growth and a robust job market, various measures depict a deeply troubled economy,” wrote&nbsp;Oxford Economics senior economist Bob Schwartzin a new report. \"Households are downbeat, according to sentiment surveys, and the so-called 'misery index' that adds together inflation and unemployment hovers around recession levels.\"</p>\n<p>Markets&nbsp;await a trove of fresh economic data this week. November retail sales, out on Wednesday, are expected to rise by 0.8%, according to Bloomberg consensus estimates. And November housing starts are forecasted to see a month-over-month increase of 3.3%.</p>\n<p>Meanwhile, Morgan Stanley projects the U.S. unemployment rate will drop to 3% in 2022.</p>\n<p>\"It's stunning to see how much the rate has fallen in the last five months,” Morgan chief U.S. economist&nbsp;Michael Feroli told Yahoo Finance Live. “We expect that pace of decline to slow, but it doesn't take much to get below 4%, even with a tick up in the labor participation rate which has been depressed over the last year and a half.\"</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S.Stocks open lower after PPI reading as investors await Fed</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S.Stocks open lower after PPI reading as investors await Fed\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-14 22:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S.Stocks open lower after PPI reading as investors await Fed,Nasdaq Composite down 1.2% at 15,229.96,S&amp;P 500 down 0.7% at 4,635.65,Dow industrials down 98 points, or 0.3%.</p>\n<p>Tesla&nbsp;shares were among the biggest early droppers on the S&amp;P 500, falling 2.1% premarket after CEO Elon Musk announced that that he has sold another $906.5 million in shares.</p>\n<p>Fellow automaker&nbsp;Ford&nbsp;also fell, down 1.7% following news that by 2030Toyotawould beinvesting $35 billion into battery-powered electronic vehicles, a space where Ford has sought to establish itself as a leader.</p>\n<p>Pfizer&nbsp;shares rose nearly 1% after final results of tests on its Covid drug showed it reduced hospitalizations and deaths by 89% in high-risk patients.</p>\n<p>Research from Goldman Sachs showed&nbsp;the S&amp;P 500 is powered by five stocks&nbsp;that have accounted for 51% of its return since the end of April. Microsoft, Google, Apple, Nvidia and Tesla account for more than one-third of the S&amp;P 500's 26% return this year, according to Goldman.</p>\n<p>Traders are awaiting a decision from the Fed on&nbsp;how quickly the central bank will tighten monetary policy&nbsp;amid a backdrop of fresh inflation numbers that reflected the fastest annual increase in nearly four decades. The Labor Department's Consumer Price Index (CPI) soared 6.8% in November compared to last year, according to figures published last week.</p>\n<p>The Federal Open Market Committee (FOMC) is scheduled to hold its two-day policy-setting meeting starting on Tuesday, followed by the release of the monetary policy statement and remarks from Federal Reserve Chair Jerome Powell Wednesday. An updated Summary of Economic Projections outlining individual members' outlooks for economic conditions and interest rates is set to accompany the statement.</p>\n<p>The Fed has been under pressure to control rising inflation levels, as investors watch for clues of a faster taper that could set the stage for earlier rate hikes.</p>\n<p>“Because inflation expectations do appear to be adaptive, our view is that the longer inflation stays elevated, the greater the risk that consumers adjust their behaviors in a way that contributes to persistently elevated inflation” wrote PIMCO economist Tiffany Wilding in a&nbsp;recent note to clients.</p>\n<p>“We believe the Fed will want to manage this risk by shortening the time over which it winds down its purchases of U.S. Treasuries and agency mortgage-backed securities (MBS), aiming to end the program in March 2022, while also signaling a June rate hike is likely,” said Wilding.</p>\n<p>PIMCO managing director and portfolio manager Sonali Pier also separately&nbsp;told Yahoo Finance Live&nbsp;that the firm expects to see two hikes in 2022, three hikes in 2023, and potentially four in 2024, with the Fed trying to bring the policy rate to neutral.</p>\n<p>“Amid proliferating signs of solid growth and a robust job market, various measures depict a deeply troubled economy,” wrote&nbsp;Oxford Economics senior economist Bob Schwartzin a new report. \"Households are downbeat, according to sentiment surveys, and the so-called 'misery index' that adds together inflation and unemployment hovers around recession levels.\"</p>\n<p>Markets&nbsp;await a trove of fresh economic data this week. November retail sales, out on Wednesday, are expected to rise by 0.8%, according to Bloomberg consensus estimates. And November housing starts are forecasted to see a month-over-month increase of 3.3%.</p>\n<p>Meanwhile, Morgan Stanley projects the U.S. unemployment rate will drop to 3% in 2022.</p>\n<p>\"It's stunning to see how much the rate has fallen in the last five months,” Morgan chief U.S. economist&nbsp;Michael Feroli told Yahoo Finance Live. “We expect that pace of decline to slow, but it doesn't take much to get below 4%, even with a tick up in the labor participation rate which has been depressed over the last year and a half.\"</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1179453620","content_text":"U.S.Stocks open lower after PPI reading as investors await Fed,Nasdaq Composite down 1.2% at 15,229.96,S&P 500 down 0.7% at 4,635.65,Dow industrials down 98 points, or 0.3%.\nTesla shares were among the biggest early droppers on the S&P 500, falling 2.1% premarket after CEO Elon Musk announced that that he has sold another $906.5 million in shares.\nFellow automaker Ford also fell, down 1.7% following news that by 2030Toyotawould beinvesting $35 billion into battery-powered electronic vehicles, a space where Ford has sought to establish itself as a leader.\nPfizer shares rose nearly 1% after final results of tests on its Covid drug showed it reduced hospitalizations and deaths by 89% in high-risk patients.\nResearch from Goldman Sachs showed the S&P 500 is powered by five stocks that have accounted for 51% of its return since the end of April. Microsoft, Google, Apple, Nvidia and Tesla account for more than one-third of the S&P 500's 26% return this year, according to Goldman.\nTraders are awaiting a decision from the Fed on how quickly the central bank will tighten monetary policy amid a backdrop of fresh inflation numbers that reflected the fastest annual increase in nearly four decades. The Labor Department's Consumer Price Index (CPI) soared 6.8% in November compared to last year, according to figures published last week.\nThe Federal Open Market Committee (FOMC) is scheduled to hold its two-day policy-setting meeting starting on Tuesday, followed by the release of the monetary policy statement and remarks from Federal Reserve Chair Jerome Powell Wednesday. An updated Summary of Economic Projections outlining individual members' outlooks for economic conditions and interest rates is set to accompany the statement.\nThe Fed has been under pressure to control rising inflation levels, as investors watch for clues of a faster taper that could set the stage for earlier rate hikes.\n“Because inflation expectations do appear to be adaptive, our view is that the longer inflation stays elevated, the greater the risk that consumers adjust their behaviors in a way that contributes to persistently elevated inflation” wrote PIMCO economist Tiffany Wilding in a recent note to clients.\n“We believe the Fed will want to manage this risk by shortening the time over which it winds down its purchases of U.S. Treasuries and agency mortgage-backed securities (MBS), aiming to end the program in March 2022, while also signaling a June rate hike is likely,” said Wilding.\nPIMCO managing director and portfolio manager Sonali Pier also separately told Yahoo Finance Live that the firm expects to see two hikes in 2022, three hikes in 2023, and potentially four in 2024, with the Fed trying to bring the policy rate to neutral.\n“Amid proliferating signs of solid growth and a robust job market, various measures depict a deeply troubled economy,” wrote Oxford Economics senior economist Bob Schwartzin a new report. \"Households are downbeat, according to sentiment surveys, and the so-called 'misery index' that adds together inflation and unemployment hovers around recession levels.\"\nMarkets await a trove of fresh economic data this week. November retail sales, out on Wednesday, are expected to rise by 0.8%, according to Bloomberg consensus estimates. And November housing starts are forecasted to see a month-over-month increase of 3.3%.\nMeanwhile, Morgan Stanley projects the U.S. unemployment rate will drop to 3% in 2022.\n\"It's stunning to see how much the rate has fallen in the last five months,” Morgan chief U.S. economist Michael Feroli told Yahoo Finance Live. “We expect that pace of decline to slow, but it doesn't take much to get below 4%, even with a tick up in the labor participation rate which has been depressed over the last year and a half.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":169,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604241542,"gmtCreate":1639406872506,"gmtModify":1639406874558,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604241542","repostId":"1167465214","repostType":4,"isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604908371,"gmtCreate":1639294634823,"gmtModify":1639294635087,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/604908371","repostId":"2190679207","repostType":4,"repost":{"id":"2190679207","pubTimestamp":1639281804,"share":"https://www.laohu8.com/m/news/2190679207?lang=&edition=full","pubTime":"2021-12-12 12:03","market":"us","language":"en","title":"Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035","url":"https://stock-news.laohu8.com/highlight/detail?id=2190679207","media":"Motley Fool","summary":"These two stocks could change your retirement.","content":"<p>Over the past 15 years, the <b>S&amp;P 500</b> has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.</p>\n<p>While this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think <b>Latch</b> (NASDAQ:LTCH) and <b>Lemonade</b> (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.</p>\n<h2>1. Latch: Smart security</h2>\n<p>This smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on <a href=\"https://laohu8.com/S/AONE.U\">one</a> platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.</p>\n<p>Nearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.</p>\n<p>Latch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.</p>\n<p>Latch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like <b>Brookfield</b> (NYSE:BAM) and <b>Avalon Bay</b> (NYSE:AVB).</p>\n<p>This company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>Q3 2020</th>\n   <th>Q3 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$15.9 million</td>\n   <td>$34.2 million</td>\n   <td>115%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>311.5%</td>\n   <td>305.7%</td>\n   <td>N/A</td>\n  </tr>\n </tbody>\n</table>\n<p>The company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.</p>\n<p>Also, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.</p>\n<h2>2. Lemonade: An insurance provider anyone can love</h2>\n<p>Lemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.</p>\n<p>Lemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.</p>\n<p>The company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.</p>\n<table border=\"1\">\n <tbody>\n  <tr>\n   <th>Metric</th>\n   <th>First Nine Months of 2020</th>\n   <th>First Nine Months of 2021</th>\n   <th>Change</th>\n  </tr>\n  <tr>\n   <td>Net loss</td>\n   <td>$88.4 million</td>\n   <td>$171.0 million</td>\n   <td>93.4%</td>\n  </tr>\n  <tr>\n   <td>Net loss as a percentage of revenue</td>\n   <td>119.6%</td>\n   <td>195.6%</td>\n   <td><p>N/A</p></td>\n  </tr>\n </tbody>\n</table>\n<p>This major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.</p>\n<p>Lemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.</p>\n<p>Both of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Want $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWant $1 Million in Retirement? Invest $100,000 in These 2 Stocks and Hold Until 2035\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-12 12:03 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4135":"资产管理与托管银行","BK4023":"应用软件","BK4528":"SaaS概念","LTCH":"Latch, Inc.","BAM":"布鲁克菲尔德资产管理","BK4549":"软银资本持仓","AVB":"阿湾物产","ESG":"FlexShares STOXX US ESG Select Index Fund","BK4215":"住宅房地产投资信托","BK4548":"巴美列捷福持仓","BK4535":"淡马锡持仓","BK4551":"寇图资本持仓","BK4543":"AI","LMND":"Lemonade, Inc.","BK4107":"财产与意外伤害保险","AI":"C3.ai, Inc."},"source_url":"https://www.fool.com/investing/2021/12/11/want-1-million-in-retirement-invest-100000-in-thes/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2190679207","content_text":"Over the past 15 years, the S&P 500 has risen in price 232%, which results in a 9.8% compound annual growth rate without inflation. If this continued for the next 15 years, you would have over $300,000 in savings to retire on if you invested $100,000, which is bigger than the average 60-year-old American's 401(k) balance.\nWhile this strategy could produce solid returns, there are two stocks that could crush that average by 2035. Here's why I think Latch (NASDAQ:LTCH) and Lemonade (NYSE:LMND) have the potential to provide high-quality returns so that you can retire right.\n1. Latch: Smart security\nThis smart lock manufacturer is taking the industry by storm with its software. With LatchOS, apartment managers can get a birds-eye view of all their apartments on one platform, making sure all of their tenants are safe and secure. Moreover, managers can let in workers or delivery people from that platform. Latch is the only company that can offer a combination of smart, keyless locks and innovative software, so it's no wonder it is rapidly being adopted by apartment buildings across America.\nNearly a third of new apartment buildings are being built today with Latch installed in them, and once Latch's locks are in, it can be incredibly hard to replace them with a competitor. Additionally, when customers agree to use Latch, they sign six- to 10-year contracts to use LatchOS. These two factors provide amazingly high switching costs, so once Latch is installed, it's likely that its users will stay Latch users for a long time. Latch has experienced zero turnovers since it started operations in 2017, and that will probably continue to be the case.\nLatch's market is massive, and the high switching costs and first-mover advantage will likely allow the company to capitalize on it. Latch sees a market opportunity of $54 billion in the U.S. alone, and if the company is able to expand internationally in a few years, that adds another $90 billion.\nLatch's partnerships will be another integral part of the company's success. Since Latch customers sign agreements with Latch to use its products before the apartments are even built, it is crucial that Latch is in talks with apartment managers before the construction team breaks ground. That is why Latch has partnered with some of the largest apartment builders in the U.S., like Brookfield (NYSE:BAM) and Avalon Bay (NYSE:AVB).\nThis company has only been operational since 2017, so there are plenty of risks with this business. The primary risk is that it is losing lots of cash.\n\n\n\nMetric\nQ3 2020\nQ3 2021\nChange\n\n\nNet loss\n$15.9 million\n$34.2 million\n115%\n\n\nNet loss as a percentage of revenue\n311.5%\n305.7%\nN/A\n\n\n\nThe company is making most of its money today on its locks, which it sells at a loss. These losses are bad today, but Latch's profitability can improve. Latch has noted that the timeframe it takes from construction to a builder beginning their subscription services is 24 months. The contracts the company has seen could finally turn into reportable revenue within the next couple of years. Analysts see the potential as well with growth forecasts of nearly 50% for the next five years.\nAlso, as its customers stay with the company longer and pay more in its subscription fees for the software -- which has gross margins of 90% -- the company's losses will likely improve to provide a pathway to profitability. This could be a multi-year effort, but if it can use its differentiated product and strong partnerships to attract customers and its high switching costs to retain them, Latch could give investors immense returns by 2035.\n2. Lemonade: An insurance provider anyone can love\nLemonade is making insurance enjoyable. Whether applying for insurance or getting a claim, Lemonade's process is easy and hassle-free with its artificial intelligence (AI)-based bots that can approve applicants and claims in seconds. The company is also aligning its interest with its consumers: Lemonade charges a flat fee, and any money from leftover claims that went unpaid goes to charities that Lemonade customers choose. So far in 2021, Lemonade has donated over $2.2 million in unpaid claims on behalf of its customers.\nLemonade's incentive alignment structure can hurt its bottom line, but it has resulted in amazing customer attraction. Lemonade has over 1.3 million customers, and it has been one of the fastest-growing insurance stocks ever.\nThe company started in renters insurance, targeting young renters. However, just as its customers have moved on in life, Lemonade has expanded. Now it offers homeowners, pet, life, and even car insurance. Lemonade hopes to attract young customers with small offerings like renters and car insurance, then integrate them deeper into the ecosystem with its fast and delightful service.\n\n\n\nMetric\nFirst Nine Months of 2020\nFirst Nine Months of 2021\nChange\n\n\nNet loss\n$88.4 million\n$171.0 million\n93.4%\n\n\nNet loss as a percentage of revenue\n119.6%\n195.6%\nN/A\n\n\n\nThis major uptick in net losses has primarily been because of the company's loss ratio. Lemonade's net loss ratio -- which represents the amount of premium paid out on claims -- was 77% in the third quarter. A ratio of 75% or below is the long-term goal that management is targeting, but it has been consistently higher in 2021 because of the new products that Lemonade has launched this year and in 2020.\nLemonade's AI can often take time to learn and collect data about its new markets, resulting in poor short-term performance but long-term opportunities. As its AI obtains more data, it should become more accurate, lowering its loss ratio and its net loss. With the lowered loss ratio, investors could expect the company to generate a profit, which would provide optimism beyond its environmental, social, and governance (ESG) efforts.\nBoth of these companies are incredibly young and are quite risky today, which is clearly noted in the stock decreases of more than 25% for each year-to-date. But in a balanced portfolio, these stocks could define someone's future investing success. If both companies can use their competitive edges to rapidly grow their business over the next 15 years and become profitable, they could reward investors by 2035.","news_type":1},"isVote":1,"tweetType":1,"viewCount":65,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605440004,"gmtCreate":1639230675833,"gmtModify":1639230676064,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605440004","repostId":"1175981162","repostType":4,"repost":{"id":"1175981162","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639128192,"share":"https://www.laohu8.com/m/news/1175981162?lang=&edition=full","pubTime":"2021-12-10 17:23","market":"us","language":"en","title":"TSMC stock rose slightly by 0.5% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1175981162","media":"Tiger Newspress","summary":"TSMC stock rose slightly by 0.5% in premarket trading as its revenue for November increased 18.7% Yo","content":"<p>TSMC stock rose slightly by 0.5% in premarket trading&nbsp;as&nbsp;its&nbsp;revenue for November&nbsp;increased&nbsp;18.7%&nbsp;YoY.</p>\n<p><img src=\"https://static.tigerbbs.com/9b045ceefe3bb6f3b519bc57ed43747b\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p>TSMC&nbsp;today announced its net revenue for November 2021: On a consolidated basis, revenue for November 2021 was approximately NT$148.27 billion, an increase of 10.2 percent from October 2021 and an increase of 18.7percent from November 2020. Revenue for January through November 2021 totaled NT$1,432.03 billion, an increase of 17.2 percent compared to the same period in 2020.</p>\n<p><img src=\"https://static.tigerbbs.com/f1196c50b76a0a7a17776cc05c842e0d\" tg-width=\"679\" tg-height=\"143\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>TSMC stock rose slightly by 0.5% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTSMC stock rose slightly by 0.5% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-10 17:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TSMC stock rose slightly by 0.5% in premarket trading&nbsp;as&nbsp;its&nbsp;revenue for November&nbsp;increased&nbsp;18.7%&nbsp;YoY.</p>\n<p><img src=\"https://static.tigerbbs.com/9b045ceefe3bb6f3b519bc57ed43747b\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p>TSMC&nbsp;today announced its net revenue for November 2021: On a consolidated basis, revenue for November 2021 was approximately NT$148.27 billion, an increase of 10.2 percent from October 2021 and an increase of 18.7percent from November 2020. Revenue for January through November 2021 totaled NT$1,432.03 billion, an increase of 17.2 percent compared to the same period in 2020.</p>\n<p><img src=\"https://static.tigerbbs.com/f1196c50b76a0a7a17776cc05c842e0d\" tg-width=\"679\" tg-height=\"143\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSM":"台积电"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1175981162","content_text":"TSMC stock rose slightly by 0.5% in premarket trading as its revenue for November increased 18.7% YoY.\n\nTSMC today announced its net revenue for November 2021: On a consolidated basis, revenue for November 2021 was approximately NT$148.27 billion, an increase of 10.2 percent from October 2021 and an increase of 18.7percent from November 2020. Revenue for January through November 2021 totaled NT$1,432.03 billion, an increase of 17.2 percent compared to the same period in 2020.","news_type":1},"isVote":1,"tweetType":1,"viewCount":270,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":605693608,"gmtCreate":1639149586328,"gmtModify":1639149586584,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/605693608","repostId":"1122303970","repostType":4,"repost":{"id":"1122303970","pubTimestamp":1639135689,"share":"https://www.laohu8.com/m/news/1122303970?lang=&edition=full","pubTime":"2021-12-10 19:28","market":"us","language":"en","title":"Is It Time to Buy the Dow's 3 Worst Performing Stocks This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=1122303970","media":"Motley Fool","summary":"Take a look to see if these dogs of the Dow are worth buying.","content":"<p>The&nbsp;<b>Dow Jones Industrial Average</b>&nbsp;is an index made up of 30 of the largest and most influential companies on U.S. stock exchanges. The index has historically returned around 7.5% each year, so being up over 15% makes 2021 a year to celebrate.</p>\n<p>Not every stock in the Dow Jones has performed well. The three stocks we'll discuss are all down and have been since the beginning of 2021, despite the index being up so much. We'll look at each one to determine whether they represent an opportunity or are down for a good reason.</p>\n<p><b>1. Amgen</b></p>\n<p>Biotech company&nbsp;<b>Amgen</b>&nbsp;has been down about 7% since the beginning of 2021. The company develops and sells drugs aimed at inflammation, cancer, bone health, heart disease, and more.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/115c1a57215446a5a83d447ffbb995ca\" tg-width=\"2000\" tg-height=\"1333\" width=\"100%\" height=\"auto\"><span>Image source: Getty Images.</span></p>\n<p>When a company invents a successful drug, its formula is patented, protecting it from direct competition for many years. Medications can cost millions of dollars to research and develop but can fail when tested in trials. A successful drug sometimes referred to as a blockbuster, can bring in billions in revenue over the length of its patent.</p>\n<p>Investors can get a feel for the trajectory of a drug company by following when its key products lose their patent protection. Once this happens, generic competitors flood the market at lower prices, significantly reducing the original drug's sales.</p>\n<p>Many of Amgen's primary products could lose sales when their patents expire:</p>\n<ul>\n <li>Enbrel (19% of revenue) expires in the U.S. in 2029.</li>\n <li>Prolia (12% of revenue) expires in the U.S. in 2025.</li>\n <li>Otezla (9% of revenue) expires in the U.S. in 2028.</li>\n <li>Xgeva (8% of revenue) expires in the U.S. in 2025.</li>\n</ul>\n<p>The United States has a more-complicated patent system, where drug companies can extend their patents by making minor changes to them. This, combined with the high drug prices charged in the U.S. market, is why domestic sales account for 68% of Amgen's global revenue. As these patents expire over the next decade, the company will&nbsp;need its pipeline to deliver&nbsp;successful products to replace this lost revenue.</p>\n<p>The stock currently trades at a&nbsp;price-to-earnings ratio&nbsp;(P/E) of 12 using analyst estimates for 2021&nbsp;earnings per share&nbsp;(EPS), far less than its historical average of 17. Analysts are calling for growth of 8% per year over the next three to five years, and pharmaceutical companies face political pressure in the United States due to drug prices. These risks probably justify a discounted valuation, and that's just what the stock offers at these levels.</p>\n<p><b>Verdict: thumbs-up</b></p>\n<p><b>2. Merck</b></p>\n<p>A rival to Amgen,<b>Merck</b>&nbsp;develops drugs for cancer, immunology, and virology, as well as vaccine products, along with a separate business unit that develops drugs for veterinary use. The stock has maintained its 11% decline since the beginning of the year.</p>\n<p>Merck doesn't have a patent cliff that's quite as imminent as Amgen's. Its Januvia/Janumet accounts for about 10% of sales, and its patent expires in 2022, but the patents for the rest of Merck's significant drugs like Keytruda (34% of revenue) and Gardasil (15% of revenue) don't expire until 2028.</p>\n<p>The company also released positive results from its clinical trials on molnupiravir, a pill that, when taken at the early stages of COVID-19 infection, can reduce the risk of serious illness by 30%. Merck has already agreed to sell more than $2.2 billion in treatments, so as the omicron variant continues to spread, it could give a spark to Merck's business. Rival&nbsp;<b>Pfizer</b>&nbsp;is also bringing a similar pill to market, but there could be&nbsp;enough demand for both to succeedhere.</p>\n<p>The stock is trading at a P/E of 11, a significant discount to its historical P/E of 27. Analysts are calling for modest growth of 6% per year over the next three to five years, but that might be conservative due to COVID treatments. Investors might not be factoring in the potential business from the COVID pill, and the valuation markdown could provide a margin of safety.</p>\n<p><b>Verdict: thumbs-up</b></p>\n<p><b>3. Verizon Communications</b></p>\n<p>Down 14% year to date, telecom company&nbsp;<b>Verizon Communications</b>&nbsp;is among a select few companies that control the wireless networks in the United States. The infrastructure that supports our nationwide phone network costs billions of dollars and took years to build out, so there is a minor threat from outside competition, even with fierce competitors like&nbsp;<b>AT&amp;T</b>&nbsp;and&nbsp;<b>T-Mobile</b>.</p>\n<p>The stock trades at a P/E of just over 9 based on 2021 EPS estimates. This is a bargain valuation if we look at its historical average, 14. While many would assume that 5G technology would unlock a lot of growth, Verizon has historically been a slow-growing business even with the emergence of 3G and 4G networks over time.</p>\n<p>Analysts estimate the company's three-to-five-year EPS growth at around 3% annually. Defensive investors who want a solid dividend can benefit here: It pays a dividend that yields 5% and needs just half of its profits to afford that payment. Investors focused on total returns probably won't get excited about Verizon, even at this reduced valuation.</p>\n<p><b>Verdict: thumbs-down</b></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Is It Time to Buy the Dow's 3 Worst Performing Stocks This Year?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nIs It Time to Buy the Dow's 3 Worst Performing Stocks This Year?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-10 19:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/12/10/is-it-time-to-buy-the-dow-jones-3-worst-performing/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Dow Jones Industrial Average is an index made up of 30 of the largest and most influential companies on U.S. stock exchanges. The index has historically returned around 7.5% each year, so being up...</p>\n\n<a href=\"https://www.fool.com/investing/2021/12/10/is-it-time-to-buy-the-dow-jones-3-worst-performing/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AMGN":"安进","VZ":"威瑞森","MRK":"默沙东"},"source_url":"https://www.fool.com/investing/2021/12/10/is-it-time-to-buy-the-dow-jones-3-worst-performing/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122303970","content_text":"The Dow Jones Industrial Average is an index made up of 30 of the largest and most influential companies on U.S. stock exchanges. The index has historically returned around 7.5% each year, so being up over 15% makes 2021 a year to celebrate.\nNot every stock in the Dow Jones has performed well. The three stocks we'll discuss are all down and have been since the beginning of 2021, despite the index being up so much. We'll look at each one to determine whether they represent an opportunity or are down for a good reason.\n1. Amgen\nBiotech company Amgen has been down about 7% since the beginning of 2021. The company develops and sells drugs aimed at inflammation, cancer, bone health, heart disease, and more.\nImage source: Getty Images.\nWhen a company invents a successful drug, its formula is patented, protecting it from direct competition for many years. Medications can cost millions of dollars to research and develop but can fail when tested in trials. A successful drug sometimes referred to as a blockbuster, can bring in billions in revenue over the length of its patent.\nInvestors can get a feel for the trajectory of a drug company by following when its key products lose their patent protection. Once this happens, generic competitors flood the market at lower prices, significantly reducing the original drug's sales.\nMany of Amgen's primary products could lose sales when their patents expire:\n\nEnbrel (19% of revenue) expires in the U.S. in 2029.\nProlia (12% of revenue) expires in the U.S. in 2025.\nOtezla (9% of revenue) expires in the U.S. in 2028.\nXgeva (8% of revenue) expires in the U.S. in 2025.\n\nThe United States has a more-complicated patent system, where drug companies can extend their patents by making minor changes to them. This, combined with the high drug prices charged in the U.S. market, is why domestic sales account for 68% of Amgen's global revenue. As these patents expire over the next decade, the company will need its pipeline to deliver successful products to replace this lost revenue.\nThe stock currently trades at a price-to-earnings ratio (P/E) of 12 using analyst estimates for 2021 earnings per share (EPS), far less than its historical average of 17. Analysts are calling for growth of 8% per year over the next three to five years, and pharmaceutical companies face political pressure in the United States due to drug prices. These risks probably justify a discounted valuation, and that's just what the stock offers at these levels.\nVerdict: thumbs-up\n2. Merck\nA rival to Amgen,Merck develops drugs for cancer, immunology, and virology, as well as vaccine products, along with a separate business unit that develops drugs for veterinary use. The stock has maintained its 11% decline since the beginning of the year.\nMerck doesn't have a patent cliff that's quite as imminent as Amgen's. Its Januvia/Janumet accounts for about 10% of sales, and its patent expires in 2022, but the patents for the rest of Merck's significant drugs like Keytruda (34% of revenue) and Gardasil (15% of revenue) don't expire until 2028.\nThe company also released positive results from its clinical trials on molnupiravir, a pill that, when taken at the early stages of COVID-19 infection, can reduce the risk of serious illness by 30%. Merck has already agreed to sell more than $2.2 billion in treatments, so as the omicron variant continues to spread, it could give a spark to Merck's business. Rival Pfizer is also bringing a similar pill to market, but there could be enough demand for both to succeedhere.\nThe stock is trading at a P/E of 11, a significant discount to its historical P/E of 27. Analysts are calling for modest growth of 6% per year over the next three to five years, but that might be conservative due to COVID treatments. Investors might not be factoring in the potential business from the COVID pill, and the valuation markdown could provide a margin of safety.\nVerdict: thumbs-up\n3. Verizon Communications\nDown 14% year to date, telecom company Verizon Communications is among a select few companies that control the wireless networks in the United States. The infrastructure that supports our nationwide phone network costs billions of dollars and took years to build out, so there is a minor threat from outside competition, even with fierce competitors like AT&T and T-Mobile.\nThe stock trades at a P/E of just over 9 based on 2021 EPS estimates. This is a bargain valuation if we look at its historical average, 14. While many would assume that 5G technology would unlock a lot of growth, Verizon has historically been a slow-growing business even with the emergence of 3G and 4G networks over time.\nAnalysts estimate the company's three-to-five-year EPS growth at around 3% annually. Defensive investors who want a solid dividend can benefit here: It pays a dividend that yields 5% and needs just half of its profits to afford that payment. Investors focused on total returns probably won't get excited about Verizon, even at this reduced valuation.\nVerdict: thumbs-down","news_type":1},"isVote":1,"tweetType":1,"viewCount":222,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":602528599,"gmtCreate":1639044248057,"gmtModify":1639044248295,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/602528599","repostId":"1164348405","repostType":4,"repost":{"id":"1164348405","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639041804,"share":"https://www.laohu8.com/m/news/1164348405?lang=&edition=full","pubTime":"2021-12-09 17:23","market":"us","language":"en","title":"UiPath stock dropped more than 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1164348405","media":"Tiger Newspress","summary":"UiPath stock dropped more than 4% in premarket trading even as the “software robots” provider’s quar","content":"<p>UiPath stock dropped more than&nbsp;4% in premarket trading&nbsp;even as the “software robots” provider’s quarterly results topped Wall Street expectations.</p>\n<p><img src=\"https://static.tigerbbs.com/b9992942633cc9d47991590204e34ec3\" tg-width=\"851\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p>\n<p>The company reported a third-quarter loss of $122.8 million, or 23 cents a share, compared with a loss of $70.8 million, or 41 cents a share, in the year-ago period. Adjusted earnings, which exclude stock-based compensation expenses and other items, were break-even a share, compared with a loss of 4 cents a share in the year-ago period.</p>\n<p>Revenue rose to $220.8 million from $147.3 million in the year-ago quarter. The company’s annualized renewal run rate, or ARR, rose 58% to $818.4 million from a year ago. ARR is a metric often used by software-as-a-service companies to show how much revenue the company can expect based on subscriptions.</p>\n<p>Analysts surveyed by FactSet had forecast a loss of 4 cents a share on revenue of $208.3 million and an ARR of $797.9 million, based on UiPath’s forecast revenue of $207 million to $209 million and ARR of $796 million to $798 million for the third quarter.</p>\n<p>UiPath forecast revenue of $281 million to $283 million and ARR of $901 million to $903 million for the fourth quarter, while analysts expect revenue of $281.5 million and ARR of $880.3 million.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>UiPath stock dropped more than 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUiPath stock dropped more than 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-09 17:23</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>UiPath stock dropped more than&nbsp;4% in premarket trading&nbsp;even as the “software robots” provider’s quarterly results topped Wall Street expectations.</p>\n<p><img src=\"https://static.tigerbbs.com/b9992942633cc9d47991590204e34ec3\" tg-width=\"851\" tg-height=\"617\" width=\"100%\" height=\"auto\"></p>\n<p>The company reported a third-quarter loss of $122.8 million, or 23 cents a share, compared with a loss of $70.8 million, or 41 cents a share, in the year-ago period. Adjusted earnings, which exclude stock-based compensation expenses and other items, were break-even a share, compared with a loss of 4 cents a share in the year-ago period.</p>\n<p>Revenue rose to $220.8 million from $147.3 million in the year-ago quarter. The company’s annualized renewal run rate, or ARR, rose 58% to $818.4 million from a year ago. ARR is a metric often used by software-as-a-service companies to show how much revenue the company can expect based on subscriptions.</p>\n<p>Analysts surveyed by FactSet had forecast a loss of 4 cents a share on revenue of $208.3 million and an ARR of $797.9 million, based on UiPath’s forecast revenue of $207 million to $209 million and ARR of $796 million to $798 million for the third quarter.</p>\n<p>UiPath forecast revenue of $281 million to $283 million and ARR of $901 million to $903 million for the fourth quarter, while analysts expect revenue of $281.5 million and ARR of $880.3 million.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PATH":"UiPath"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164348405","content_text":"UiPath stock dropped more than 4% in premarket trading even as the “software robots” provider’s quarterly results topped Wall Street expectations.\n\nThe company reported a third-quarter loss of $122.8 million, or 23 cents a share, compared with a loss of $70.8 million, or 41 cents a share, in the year-ago period. Adjusted earnings, which exclude stock-based compensation expenses and other items, were break-even a share, compared with a loss of 4 cents a share in the year-ago period.\nRevenue rose to $220.8 million from $147.3 million in the year-ago quarter. The company’s annualized renewal run rate, or ARR, rose 58% to $818.4 million from a year ago. ARR is a metric often used by software-as-a-service companies to show how much revenue the company can expect based on subscriptions.\nAnalysts surveyed by FactSet had forecast a loss of 4 cents a share on revenue of $208.3 million and an ARR of $797.9 million, based on UiPath’s forecast revenue of $207 million to $209 million and ARR of $796 million to $798 million for the third quarter.\nUiPath forecast revenue of $281 million to $283 million and ARR of $901 million to $903 million for the fourth quarter, while analysts expect revenue of $281.5 million and ARR of $880.3 million.","news_type":1},"isVote":1,"tweetType":1,"viewCount":510,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":692186412,"gmtCreate":1640875462759,"gmtModify":1640875463023,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":3,"repostSize":0,"link":"https://laohu8.com/post/692186412","repostId":"1132789312","repostType":4,"repost":{"id":"1132789312","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640875231,"share":"https://www.laohu8.com/m/news/1132789312?lang=&edition=full","pubTime":"2021-12-30 22:40","market":"us","language":"en","title":"EV Stocks Rallied in Morning Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1132789312","media":"Tiger Newspress","summary":"EV stocks rallied in morning trading.Lucid, Nio, Xpeng Motors, Li Auto, Fisker, Nikola, Canoo, Farad","content":"<html><head></head><body><p>EV stocks rallied in morning trading.Lucid, Nio, Xpeng Motors, Li Auto, Fisker, Nikola, Canoo, Faraday Future, Workhorse and Lordstown climbed between 1% and 4%.While Tesla fell more than 2% after the company filed a recall of over 475,000 vehicles..</p><p><img src=\"https://static.tigerbbs.com/c5dbbcef1922d3641650b829b9b76c56\" tg-width=\"415\" tg-height=\"718\" referrerpolicy=\"no-referrer\"/><img src=\"https://static.tigerbbs.com/694f72dfeead61c37c1d280c0e9f4433\" tg-width=\"421\" tg-height=\"246\" width=\"100%\" height=\"auto\"/></p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EV Stocks Rallied in Morning Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEV Stocks Rallied in Morning Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-30 22:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>EV stocks rallied in morning trading.Lucid, Nio, Xpeng Motors, Li Auto, Fisker, Nikola, Canoo, Faraday Future, Workhorse and Lordstown climbed between 1% and 4%.While Tesla fell more than 2% after the company filed a recall of over 475,000 vehicles..</p><p><img src=\"https://static.tigerbbs.com/c5dbbcef1922d3641650b829b9b76c56\" tg-width=\"415\" tg-height=\"718\" referrerpolicy=\"no-referrer\"/><img src=\"https://static.tigerbbs.com/694f72dfeead61c37c1d280c0e9f4433\" tg-width=\"421\" tg-height=\"246\" width=\"100%\" height=\"auto\"/></p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NKLA":"Nikola Corporation","LCID":"Lucid Group Inc","FFIE":"Faraday Future","TSLA":"特斯拉","XPEV":"小鹏汽车","LI":"理想汽车","NIO":"蔚来","GOEV":"Canoo Inc.","WKHS":"Workhorse Group, Inc.","NIU":"小牛电动","RIVN":"Rivian Automotive, Inc.","FSR":"菲斯克"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1132789312","content_text":"EV stocks rallied in morning trading.Lucid, Nio, Xpeng Motors, Li Auto, Fisker, Nikola, Canoo, Faraday Future, Workhorse and Lordstown climbed between 1% and 4%.While Tesla fell more than 2% after the company filed a recall of over 475,000 vehicles..","news_type":1},"isVote":1,"tweetType":1,"viewCount":429,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":821513975,"gmtCreate":1633758554517,"gmtModify":1633758554869,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":9,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/821513975","repostId":"1167388174","repostType":4,"repost":{"id":"1167388174","pubTimestamp":1633742914,"share":"https://www.laohu8.com/m/news/1167388174?lang=&edition=full","pubTime":"2021-10-09 09:28","market":"us","language":"en","title":"US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week","url":"https://stock-news.laohu8.com/highlight/detail?id=1167388174","media":"renaissancecap...","summary":"The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the w","content":"<p>The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.</p>\n<p>Software development platform&nbsp;<b>GitLab</b>(GTLB) plans to raise $598 million at a $9.4 billion market cap. This founder-led company provides an end-to-end DevOps platform to accelerate the software development cycle from weeks to minutes and enable rapid, continuous updates. Although it competes with large players, Gitlab has delivered strong revenue growth and net retention.</p>\n<p>B2B payments platform&nbsp;<b>AvidXchange</b>(AVDX) plans to raise $528 million at a $4.7 billion market cap. This SaaS provides an end-to-end billing and payment software platform to over 7,000 mid-market businesses. Avidxchange is growing but highly unprofitable with negative cash flow.</p>\n<p><b>IHS Holding</b>(IHS) plans to raise $506 million at a $7.6 billion market cap. This telecom giant is Africa’s largest independent operator and developer of shared telecom infrastructure, operating over 30,000 towers across five countries in Africa. Growing and profitable, IHS is the largest tower operator in six of the nine markets in which it operates.</p>\n<p>Orthopedic medical device company&nbsp;<b>Paragon 28</b>(FNA) plans to raise $125 million at a $1.3 billion market cap. This medical device company is developing orthopedic implants and related medical devices for foot and ankle ailments. Growing and profitable, Paragon 28 offers a suite of surgical solutions with over 7 product systems and approximately 8,700 SKUs.</p>\n<p>Medical diagnostics company&nbsp;<b>Lucid Diagnostics</b>(LUCD) plans to raise $75 million at a $575 million market cap. This company makes diagnostic tests for esophageal precancer and cancer in gastroesophageal reflux disease (GERD) patients. Lucid Diagnostic states that its lead product is the first and only commercially available screening tool to prevent esophageal adenocarcinoma through early detection.</p>\n<p>ADHD drug developer&nbsp;<b>Cingulate</b>(CING) plans to raise $50 million at a $225 million market cap. Its two candidates, CTx-1301 and CTx-1302, are being developed for the treatment of ADHD. The company announced positive results from a Phase 1/2 study of CTx-1301 in October 2020, and plans to initiate Phase 3 trials in the 4Q21 with results expected in late 2022.</p>\n<p>Managed health plan provider&nbsp;<b>Marpai</b>(MRAI) plans to raise $25 million at a $142 million market cap. Marpai provides and manages a health plan platform for self-insured employers that pay for their employees’ healthcare benefits. Growing but highly unprofitable, this health plan platform uses AI to predict costly events to optimize employee care and employer savings.</p>\n<p>Dermatological drug spinoff&nbsp;<b>Biofrontera</b>(BFRI) plans to raise $18 million at a $66 million market cap. This pharmaceutical company commercializes dermatological drugs, specifically ones used to treat diseases caused by sunlight exposure that results in skin damage. Biofrontera’s principal product, Ameluz, is currently approved by the FDA for use in treating actinic keratosis.</p>","source":"lsy1625129603274","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>US IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nUS IPO Week Ahead: Software, payments, telecom towers, and more in an 8 IPO week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-09 09:28 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee><strong>renaissancecap...</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.\nSoftware development platform GitLab(GTLB) plans to raise $598 million at a $9.4 billion ...</p>\n\n<a href=\"https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AVDX":"AvidXchange Holdings, Inc","LUCD":"LUCID DIAGNOSTICS INC.","IHS":"IHS Holding Ltd","GTLB":"GitLab, Inc."},"source_url":"https://www.renaissancecapital.com/IPO-Center/News/87028/US-IPO-Week-Ahead-Software-payments-telecom-towers-and-more-in-an-8-IPO-wee","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167388174","content_text":"The Fall IPO market is expected to stay busy with eight IPOs schedule to raise $1.9 billion in the week ahead.\nSoftware development platform GitLab(GTLB) plans to raise $598 million at a $9.4 billion market cap. This founder-led company provides an end-to-end DevOps platform to accelerate the software development cycle from weeks to minutes and enable rapid, continuous updates. Although it competes with large players, Gitlab has delivered strong revenue growth and net retention.\nB2B payments platform AvidXchange(AVDX) plans to raise $528 million at a $4.7 billion market cap. This SaaS provides an end-to-end billing and payment software platform to over 7,000 mid-market businesses. Avidxchange is growing but highly unprofitable with negative cash flow.\nIHS Holding(IHS) plans to raise $506 million at a $7.6 billion market cap. This telecom giant is Africa’s largest independent operator and developer of shared telecom infrastructure, operating over 30,000 towers across five countries in Africa. Growing and profitable, IHS is the largest tower operator in six of the nine markets in which it operates.\nOrthopedic medical device company Paragon 28(FNA) plans to raise $125 million at a $1.3 billion market cap. This medical device company is developing orthopedic implants and related medical devices for foot and ankle ailments. Growing and profitable, Paragon 28 offers a suite of surgical solutions with over 7 product systems and approximately 8,700 SKUs.\nMedical diagnostics company Lucid Diagnostics(LUCD) plans to raise $75 million at a $575 million market cap. This company makes diagnostic tests for esophageal precancer and cancer in gastroesophageal reflux disease (GERD) patients. Lucid Diagnostic states that its lead product is the first and only commercially available screening tool to prevent esophageal adenocarcinoma through early detection.\nADHD drug developer Cingulate(CING) plans to raise $50 million at a $225 million market cap. Its two candidates, CTx-1301 and CTx-1302, are being developed for the treatment of ADHD. The company announced positive results from a Phase 1/2 study of CTx-1301 in October 2020, and plans to initiate Phase 3 trials in the 4Q21 with results expected in late 2022.\nManaged health plan provider Marpai(MRAI) plans to raise $25 million at a $142 million market cap. Marpai provides and manages a health plan platform for self-insured employers that pay for their employees’ healthcare benefits. Growing but highly unprofitable, this health plan platform uses AI to predict costly events to optimize employee care and employer savings.\nDermatological drug spinoff Biofrontera(BFRI) plans to raise $18 million at a $66 million market cap. This pharmaceutical company commercializes dermatological drugs, specifically ones used to treat diseases caused by sunlight exposure that results in skin damage. Biofrontera’s principal product, Ameluz, is currently approved by the FDA for use in treating actinic keratosis.","news_type":1},"isVote":1,"tweetType":1,"viewCount":8,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":850002353,"gmtCreate":1634530358932,"gmtModify":1634530359259,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/850002353","repostId":"1185155570","repostType":4,"repost":{"id":"1185155570","pubTimestamp":1634511079,"share":"https://www.laohu8.com/m/news/1185155570?lang=&edition=full","pubTime":"2021-10-18 06:51","market":"us","language":"en","title":"Tesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=1185155570","media":"Barrons","summary":"Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. ","content":"<p>Seventy-two&nbsp;S&amp;P 500&nbsp;companies report earnings this week,&nbsp;as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights&nbsp;will include&nbsp;results from notable companies in telecom, consumer staples, energy, technology, health care, and the airline industry.</p>\n<p><img src=\"https://static.tigerbbs.com/685ba1e7f4763c12a3c0159fc2469ded\" tg-width=\"1878\" tg-height=\"2461\" width=\"100%\" height=\"auto\"></p>\n<p>Albertsons and&nbsp;State Street&nbsp;get the ball rolling on Monday.Procter &amp; Gamble,Halliburton,and&nbsp;Johnson &amp; Johnson&nbsp;are Tuesday morning’s highlights, followed by&nbsp;Netflix&nbsp;and&nbsp;United Airlines Holdings&nbsp;after the market closes.</p>\n<p>On Wednesday,Verizon Communications,IBM,and Tesla will get the most attention.AT&amp;T, American Airlines Group,Southwest Airlines,and&nbsp;Chipotle Mexican Grill&nbsp;report on Thursday, then&nbsp;American Express,Schlumberger,and&nbsp;Honeywell International&nbsp;close the week on Friday.</p>\n<p>Economic data highlights this week include the Conference Board’s Leading Economic Index for September on Thursday and&nbsp;IHS Markit’s&nbsp;Manufacturing and Services Purchasing Managers’ indexes for October on Friday. All are seen easing back from their prior months’ levels.</p>\n<p>Other releases this week include the Federal Reserve’s most recent Beige Book, describing economic conditions across the U.S., and a pair of September housing-market indicators: The Census Bureau reports new residential construction data on Tuesday and the National Association of Realtors reports existing-home sales on Thursday.</p>\n<p><b>Monday 10/18</b></p>\n<p><b>The Federal Reserve</b>&nbsp;releases industrial production data for September. Economists are looking for a 0.20% rise after a 0.4% increase in August. Capacity utilization is expected at 76.5% for September, roughly in line with August’s 76.4%.</p>\n<p>Albertsons, Philips, Steel Dynamics, and State Street are among companies releasing quarterly financial results.</p>\n<p><b>Tuesday 10/19</b></p>\n<p><b>The Census Bureau</b> reports new residential construction data for September. Economists forecast a seasonally adjusted annual rate of 1.623 million housing starts, compared with 1.615 million in August.</p>\n<p>Halliburton, Procter &amp; Gamble, Johnson &amp; Johnson, Synchrony, Travelers, Philip Morris International, Kansas City Southern, WD-40, Interactive Brokers Group, Netflix, ManpowerGroup, Dover, and Canadian National Railway are among companies hosting earnings conference calls.</p>\n<p><b>Wednesday 10/20</b></p>\n<p><b>The Federal Reserve</b> releases its beige book about current economic conditions across the central bank’s 12 districts.</p>\n<p>Abbott Laboratories, Biogen, NextEra Energy, ASML Holding, Nasdaq, Canadian Pacific Railway, Verizon Communications, CSX, Lam Research, Tesla, IBM, and Anthem discuss quarterly financial results.</p>\n<p><b>Thursday 10/21</b></p>\n<p><b>The National Association</b> of Realtors reports existing-home sales for September. Economists forecast a seasonally adjusted annual rate of 6.10 million homes sold, compared with 5.88 million homes in August.</p>\n<p>Dow, Freeport-McMoRan, Genuine Parts, Southwest Airlines, Valero Energy, Blackstone, Quest Diagnostics, Snap-on, Tractor Supply, Barclays, Danaher, AT&amp;T, Nucor, American Airlines Group, AutoNation, Valero Energy, SL Green Realty, Intel, Snap, Boston Beer, Mattel, and Chipotle Mexican Grill host earnings conference calls to discuss quarterly results.</p>\n<p><b>The Philadelphia Fed</b>&nbsp;diffusion index, a measure of overall manufacturing activity, is expected to fall to 24 in October from September’s 30.7 reading.</p>\n<p><b>The Conference Board</b>&nbsp;releases its Leading Economic Index for September. Expectations are for a 0.50% rise, after August’s 0.90% gain.</p>\n<p><b>Friday 10/22</b></p>\n<p><b>IHS Markit releases</b>&nbsp;the Manufacturing and Services Purchasing Managers’ indexes for October. Consensus estimate for the Manufacturing PMI is 60.3, while the Services PMI is expected to be 54.7, compared with 60.7 and 54.9, respectively, in September.</p>\n<p>Whirlpool, Honeywell, Cleveland-Cliffs, Celanese, HCA Healthcare, Schlumberger, Seagate Technology Holdings, VF Corp., and American Express host investor conference calls.</p>","source":"lsy1601382232898","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla, AT&T, Netflix, ASML, Snap and Other Stocks for Investors to Watch This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-18 06:51 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST><strong>Barrons</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights ...</p>\n\n<a href=\"https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index","HAL":"哈里伯顿","TSLA":"特斯拉","JNJ":"强生","IBM":"IBM","NFLX":"奈飞","AXP":"美国运通","LUV":"西南航空","CMG":"墨式烧烤","T":"美国电话电报","AAL":"美国航空","INTC":"英特尔",".DJI":"道琼斯","UAL":"联合大陆航空"},"source_url":"https://www.barrons.com/articles/tesla-at-t-netflix-chipotle-and-other-stocks-for-investors-to-watch-this-week-51634497206?mod=hp_LATEST","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1185155570","content_text":"Seventy-two S&P 500 companies report earnings this week, as third-quarter earnings season ramps up. Several big U.S. banks got things off to a strong start last week. This week’s earnings highlights will include results from notable companies in telecom, consumer staples, energy, technology, health care, and the airline industry.\n\nAlbertsons and State Street get the ball rolling on Monday.Procter & Gamble,Halliburton,and Johnson & Johnson are Tuesday morning’s highlights, followed by Netflix and United Airlines Holdings after the market closes.\nOn Wednesday,Verizon Communications,IBM,and Tesla will get the most attention.AT&T, American Airlines Group,Southwest Airlines,and Chipotle Mexican Grill report on Thursday, then American Express,Schlumberger,and Honeywell International close the week on Friday.\nEconomic data highlights this week include the Conference Board’s Leading Economic Index for September on Thursday and IHS Markit’s Manufacturing and Services Purchasing Managers’ indexes for October on Friday. All are seen easing back from their prior months’ levels.\nOther releases this week include the Federal Reserve’s most recent Beige Book, describing economic conditions across the U.S., and a pair of September housing-market indicators: The Census Bureau reports new residential construction data on Tuesday and the National Association of Realtors reports existing-home sales on Thursday.\nMonday 10/18\nThe Federal Reserve releases industrial production data for September. Economists are looking for a 0.20% rise after a 0.4% increase in August. Capacity utilization is expected at 76.5% for September, roughly in line with August’s 76.4%.\nAlbertsons, Philips, Steel Dynamics, and State Street are among companies releasing quarterly financial results.\nTuesday 10/19\nThe Census Bureau reports new residential construction data for September. Economists forecast a seasonally adjusted annual rate of 1.623 million housing starts, compared with 1.615 million in August.\nHalliburton, Procter & Gamble, Johnson & Johnson, Synchrony, Travelers, Philip Morris International, Kansas City Southern, WD-40, Interactive Brokers Group, Netflix, ManpowerGroup, Dover, and Canadian National Railway are among companies hosting earnings conference calls.\nWednesday 10/20\nThe Federal Reserve releases its beige book about current economic conditions across the central bank’s 12 districts.\nAbbott Laboratories, Biogen, NextEra Energy, ASML Holding, Nasdaq, Canadian Pacific Railway, Verizon Communications, CSX, Lam Research, Tesla, IBM, and Anthem discuss quarterly financial results.\nThursday 10/21\nThe National Association of Realtors reports existing-home sales for September. Economists forecast a seasonally adjusted annual rate of 6.10 million homes sold, compared with 5.88 million homes in August.\nDow, Freeport-McMoRan, Genuine Parts, Southwest Airlines, Valero Energy, Blackstone, Quest Diagnostics, Snap-on, Tractor Supply, Barclays, Danaher, AT&T, Nucor, American Airlines Group, AutoNation, Valero Energy, SL Green Realty, Intel, Snap, Boston Beer, Mattel, and Chipotle Mexican Grill host earnings conference calls to discuss quarterly results.\nThe Philadelphia Fed diffusion index, a measure of overall manufacturing activity, is expected to fall to 24 in October from September’s 30.7 reading.\nThe Conference Board releases its Leading Economic Index for September. Expectations are for a 0.50% rise, after August’s 0.90% gain.\nFriday 10/22\nIHS Markit releases the Manufacturing and Services Purchasing Managers’ indexes for October. Consensus estimate for the Manufacturing PMI is 60.3, while the Services PMI is expected to be 54.7, compared with 60.7 and 54.9, respectively, in September.\nWhirlpool, Honeywell, Cleveland-Cliffs, Celanese, HCA Healthcare, Schlumberger, Seagate Technology Holdings, VF Corp., and American Express host investor conference calls.","news_type":1},"isVote":1,"tweetType":1,"viewCount":16,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":846072589,"gmtCreate":1636037443783,"gmtModify":1636037444129,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/846072589","repostId":"1122426929","repostType":4,"repost":{"id":"1122426929","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636036255,"share":"https://www.laohu8.com/m/news/1122426929?lang=&edition=full","pubTime":"2021-11-04 22:30","market":"us","language":"en","title":"Videogame stocks rallied in morning trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1122426929","media":"Tiger Newspress","summary":"Videogame stocks rallied in morning trading.Electronic Arts,Activision Blizzard,Take-Two Interactive","content":"<p>Videogame stocks rallied in morning trading.Electronic Arts,Activision Blizzard,Take-Two Interactive Software,Unity Software&nbsp;and&nbsp;Roblox&nbsp;climbed between 1% and 4%&nbsp;while&nbsp;Playtika&nbsp;continued to fall&nbsp;5%.</p>\n<p><img src=\"https://static.tigerbbs.com/5dd591da272c86872086088d9d4468f1\" tg-width=\"397\" tg-height=\"419\" referrerpolicy=\"no-referrer\"></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Videogame stocks rallied in morning trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVideogame stocks rallied in morning trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-04 22:30</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Videogame stocks rallied in morning trading.Electronic Arts,Activision Blizzard,Take-Two Interactive Software,Unity Software&nbsp;and&nbsp;Roblox&nbsp;climbed between 1% and 4%&nbsp;while&nbsp;Playtika&nbsp;continued to fall&nbsp;5%.</p>\n<p><img src=\"https://static.tigerbbs.com/5dd591da272c86872086088d9d4468f1\" tg-width=\"397\" tg-height=\"419\" referrerpolicy=\"no-referrer\"></p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"APP":"AppLovin Corporation","U":"Unity Software Inc.","EA":"艺电","TTWO":"Take-Two Interactive Software","ATVI":"动视暴雪","RBLX":"Roblox Corporation","PLTK":"Playtika Holding Corp."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1122426929","content_text":"Videogame stocks rallied in morning trading.Electronic Arts,Activision Blizzard,Take-Two Interactive Software,Unity Software and Roblox climbed between 1% and 4% while Playtika continued to fall 5%.","news_type":1},"isVote":1,"tweetType":1,"viewCount":32,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":853803349,"gmtCreate":1634784345816,"gmtModify":1634784346229,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/853803349","repostId":"2177314294","repostType":4,"repost":{"id":"2177314294","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1634770539,"share":"https://www.laohu8.com/m/news/2177314294?lang=&edition=full","pubTime":"2021-10-21 06:55","market":"us","language":"en","title":"Wall Street closes higher as earnings reports soothe investor fears","url":"https://stock-news.laohu8.com/highlight/detail?id=2177314294","media":"Reuters","summary":"* Healthcare sector gains with earnings boost from Anthem, Abbott\n* Verizon up on customer growth,\n*","content":"<p>* Healthcare sector gains with earnings boost from Anthem, Abbott</p>\n<p>* Verizon up on customer growth,</p>\n<p>* <a href=\"https://laohu8.com/S/IBM\">IBM</a> falls sharply in late trade after revenue miss</p>\n<p>* Dow up 0.43%, S&amp;P up 0.37%, Nasdaq down 0.05%</p>\n<p>Oct 20 (Reuters) - The S&amp;P 500 and the Dow climbed on Wednesday with the Dow hitting an intraday record high as investors eyed better than expected third-quarter earnings from U.S. companies.</p>\n<p>While the Nasdaq lagged as technology stocks took a breather, the Dow Jones Industrials Average surpassed its previous record reached in mid-August before paring gains during the session. The benchmark S&amp;P 500 index came within five points of its early September record at its peak for the day.</p>\n<p>The S&amp;P's healthcare index rallied for a second day in a row with help from Anthem and Abbott, which both gained ground on impressive financial forecasts.</p>\n<p>The S&amp;P had fallen almost 6% below its record by Oct. 4 as investors worried about supply chain problems, profit margin pressures, higher wages and increasing input costs ahead of the earnings season, which kicked off last week.</p>\n<p>And while U.S. companies have been citing supply chain problems and higher costs during their earnings calls, investors have been relieved so far that they seem to be able to maintain profit margins by passing on costs to customers, according to Jack Janasiewicz, strategist and portfolio manager at Natixis Investment Managers Solutions.</p>\n<p>\"Earnings are what matter and thus far what we've seen have actually been better than expected. Margins are actually holding up, said Janasiewicz.</p>\n<p>\"The bar was set pretty low coming into (earnings season) so that makes things a little easier ... Things are coming out, so far, better than expected. That's putting upward pressure on stocks.\"</p>\n<p>With just about 14% of S&amp;P 500 third-quarter reports in, analysts were expecting earnings for the benchmark index to rise 33% from the year-ago quarter. More than 85% of earnings beat expectations, according to the latest Refinitiv data.</p>\n<p>The Dow Jones Industrial Average rose 152.03 points, or 0.43%, to 35,609.34, the S&amp;P 500 gained 16.56 points, or 0.37%, to 4,536.19 and the Nasdaq Composite dropped 7.41 points, or 0.05%, to 15,121.68.</p>\n<p>The CBOE volatility index, also known as Wall Street's fear gauge, closed at 15.49 after earlier hitting 15.29, its lowest level since Aug. 13.</p>\n<p>Eight of the S&amp;P's eleven major industry sectors indexes were advanced, led by utilities and real estate , both finishing up about 1.6% higher, and healthcare stocks, which closed up 1.5%.</p>\n<p>The technology sector was the S&amp;P's biggest laggard, down 0.3%, as it snapped a five-day rally.</p>\n<p>The S&amp;P 500 Value index, which houses economically-sensitive stocks like energy and industrials, closed up 0.9% after hitting a fresh record high.</p>\n<p>Pinterest&nbsp;stock&nbsp;surged 12.8%.Paypal in talks to buy Pinterest - Person familiar with matter.</p>\n<p>However, shares in IBM were down around 5% in after the bell trading on Wednesday after it missed market estimates for third-quarter revenue due to a decline in orders at its managed infrastructure unit ahead of a spinoff.</p>\n<p>Shares in Tesla Inc dipped slightly in late trade even after it beat Wall Street expectations for third-quarter revenue on the back of record deliveries, as the electric carmaker navigates through a prolonged global shortage of chips and raw materials.</p>\n<p>Abbott Laboratories had finished the regular trading session up 3.3% after raising its full-year profit forecast on a rebound in COVID-19 test sales.</p>\n<p><a href=\"https://laohu8.com/S/ANTM\">Anthem Inc</a> soared 7.7% after raising its full-year earnings forecasts. However, Biogen Inc shares closed down 0.6% as it reported a much smaller-than-expected quarterly sales of its Alzheimer's drug while it raised its full year earnings forecast.</p>\n<p>Verizon Communications Inc gained 2.4% after it added more postpaid phone subscribers than expected in the third quarter.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.29-to-1 ratio; on Nasdaq, a 1.37-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 63 new 52-week highs and no new lows; the Nasdaq Composite recorded 106 new highs and 41 new lows.</p>\n<p>On U.S. exchanges 9.29 billion shares changed hands compared with the 10.26 billion average for the last 20 sessions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Wall Street closes higher as earnings reports soothe investor fears</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWall Street closes higher as earnings reports soothe investor fears\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-10-21 06:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>* Healthcare sector gains with earnings boost from Anthem, Abbott</p>\n<p>* Verizon up on customer growth,</p>\n<p>* <a href=\"https://laohu8.com/S/IBM\">IBM</a> falls sharply in late trade after revenue miss</p>\n<p>* Dow up 0.43%, S&amp;P up 0.37%, Nasdaq down 0.05%</p>\n<p>Oct 20 (Reuters) - The S&amp;P 500 and the Dow climbed on Wednesday with the Dow hitting an intraday record high as investors eyed better than expected third-quarter earnings from U.S. companies.</p>\n<p>While the Nasdaq lagged as technology stocks took a breather, the Dow Jones Industrials Average surpassed its previous record reached in mid-August before paring gains during the session. The benchmark S&amp;P 500 index came within five points of its early September record at its peak for the day.</p>\n<p>The S&amp;P's healthcare index rallied for a second day in a row with help from Anthem and Abbott, which both gained ground on impressive financial forecasts.</p>\n<p>The S&amp;P had fallen almost 6% below its record by Oct. 4 as investors worried about supply chain problems, profit margin pressures, higher wages and increasing input costs ahead of the earnings season, which kicked off last week.</p>\n<p>And while U.S. companies have been citing supply chain problems and higher costs during their earnings calls, investors have been relieved so far that they seem to be able to maintain profit margins by passing on costs to customers, according to Jack Janasiewicz, strategist and portfolio manager at Natixis Investment Managers Solutions.</p>\n<p>\"Earnings are what matter and thus far what we've seen have actually been better than expected. Margins are actually holding up, said Janasiewicz.</p>\n<p>\"The bar was set pretty low coming into (earnings season) so that makes things a little easier ... Things are coming out, so far, better than expected. That's putting upward pressure on stocks.\"</p>\n<p>With just about 14% of S&amp;P 500 third-quarter reports in, analysts were expecting earnings for the benchmark index to rise 33% from the year-ago quarter. More than 85% of earnings beat expectations, according to the latest Refinitiv data.</p>\n<p>The Dow Jones Industrial Average rose 152.03 points, or 0.43%, to 35,609.34, the S&amp;P 500 gained 16.56 points, or 0.37%, to 4,536.19 and the Nasdaq Composite dropped 7.41 points, or 0.05%, to 15,121.68.</p>\n<p>The CBOE volatility index, also known as Wall Street's fear gauge, closed at 15.49 after earlier hitting 15.29, its lowest level since Aug. 13.</p>\n<p>Eight of the S&amp;P's eleven major industry sectors indexes were advanced, led by utilities and real estate , both finishing up about 1.6% higher, and healthcare stocks, which closed up 1.5%.</p>\n<p>The technology sector was the S&amp;P's biggest laggard, down 0.3%, as it snapped a five-day rally.</p>\n<p>The S&amp;P 500 Value index, which houses economically-sensitive stocks like energy and industrials, closed up 0.9% after hitting a fresh record high.</p>\n<p>Pinterest&nbsp;stock&nbsp;surged 12.8%.Paypal in talks to buy Pinterest - Person familiar with matter.</p>\n<p>However, shares in IBM were down around 5% in after the bell trading on Wednesday after it missed market estimates for third-quarter revenue due to a decline in orders at its managed infrastructure unit ahead of a spinoff.</p>\n<p>Shares in Tesla Inc dipped slightly in late trade even after it beat Wall Street expectations for third-quarter revenue on the back of record deliveries, as the electric carmaker navigates through a prolonged global shortage of chips and raw materials.</p>\n<p>Abbott Laboratories had finished the regular trading session up 3.3% after raising its full-year profit forecast on a rebound in COVID-19 test sales.</p>\n<p><a href=\"https://laohu8.com/S/ANTM\">Anthem Inc</a> soared 7.7% after raising its full-year earnings forecasts. However, Biogen Inc shares closed down 0.6% as it reported a much smaller-than-expected quarterly sales of its Alzheimer's drug while it raised its full year earnings forecast.</p>\n<p>Verizon Communications Inc gained 2.4% after it added more postpaid phone subscribers than expected in the third quarter.</p>\n<p>Advancing issues outnumbered declining ones on the NYSE by a 2.29-to-1 ratio; on Nasdaq, a 1.37-to-1 ratio favored advancers.</p>\n<p>The S&amp;P 500 posted 63 new 52-week highs and no new lows; the Nasdaq Composite recorded 106 new highs and 41 new lows.</p>\n<p>On U.S. exchanges 9.29 billion shares changed hands compared with the 10.26 billion average for the last 20 sessions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"IBM":"IBM","ABT":"雅培","PINS":"Pinterest, Inc.","SQ":"Block","COMP":"Compass, Inc.",".DJI":"道琼斯","VZ":"威瑞森",".IXIC":"NASDAQ Composite","PYPL":"PayPal",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2177314294","content_text":"* Healthcare sector gains with earnings boost from Anthem, Abbott\n* Verizon up on customer growth,\n* IBM falls sharply in late trade after revenue miss\n* Dow up 0.43%, S&P up 0.37%, Nasdaq down 0.05%\nOct 20 (Reuters) - The S&P 500 and the Dow climbed on Wednesday with the Dow hitting an intraday record high as investors eyed better than expected third-quarter earnings from U.S. companies.\nWhile the Nasdaq lagged as technology stocks took a breather, the Dow Jones Industrials Average surpassed its previous record reached in mid-August before paring gains during the session. The benchmark S&P 500 index came within five points of its early September record at its peak for the day.\nThe S&P's healthcare index rallied for a second day in a row with help from Anthem and Abbott, which both gained ground on impressive financial forecasts.\nThe S&P had fallen almost 6% below its record by Oct. 4 as investors worried about supply chain problems, profit margin pressures, higher wages and increasing input costs ahead of the earnings season, which kicked off last week.\nAnd while U.S. companies have been citing supply chain problems and higher costs during their earnings calls, investors have been relieved so far that they seem to be able to maintain profit margins by passing on costs to customers, according to Jack Janasiewicz, strategist and portfolio manager at Natixis Investment Managers Solutions.\n\"Earnings are what matter and thus far what we've seen have actually been better than expected. Margins are actually holding up, said Janasiewicz.\n\"The bar was set pretty low coming into (earnings season) so that makes things a little easier ... Things are coming out, so far, better than expected. That's putting upward pressure on stocks.\"\nWith just about 14% of S&P 500 third-quarter reports in, analysts were expecting earnings for the benchmark index to rise 33% from the year-ago quarter. More than 85% of earnings beat expectations, according to the latest Refinitiv data.\nThe Dow Jones Industrial Average rose 152.03 points, or 0.43%, to 35,609.34, the S&P 500 gained 16.56 points, or 0.37%, to 4,536.19 and the Nasdaq Composite dropped 7.41 points, or 0.05%, to 15,121.68.\nThe CBOE volatility index, also known as Wall Street's fear gauge, closed at 15.49 after earlier hitting 15.29, its lowest level since Aug. 13.\nEight of the S&P's eleven major industry sectors indexes were advanced, led by utilities and real estate , both finishing up about 1.6% higher, and healthcare stocks, which closed up 1.5%.\nThe technology sector was the S&P's biggest laggard, down 0.3%, as it snapped a five-day rally.\nThe S&P 500 Value index, which houses economically-sensitive stocks like energy and industrials, closed up 0.9% after hitting a fresh record high.\nPinterest stock surged 12.8%.Paypal in talks to buy Pinterest - Person familiar with matter.\nHowever, shares in IBM were down around 5% in after the bell trading on Wednesday after it missed market estimates for third-quarter revenue due to a decline in orders at its managed infrastructure unit ahead of a spinoff.\nShares in Tesla Inc dipped slightly in late trade even after it beat Wall Street expectations for third-quarter revenue on the back of record deliveries, as the electric carmaker navigates through a prolonged global shortage of chips and raw materials.\nAbbott Laboratories had finished the regular trading session up 3.3% after raising its full-year profit forecast on a rebound in COVID-19 test sales.\nAnthem Inc soared 7.7% after raising its full-year earnings forecasts. However, Biogen Inc shares closed down 0.6% as it reported a much smaller-than-expected quarterly sales of its Alzheimer's drug while it raised its full year earnings forecast.\nVerizon Communications Inc gained 2.4% after it added more postpaid phone subscribers than expected in the third quarter.\nAdvancing issues outnumbered declining ones on the NYSE by a 2.29-to-1 ratio; on Nasdaq, a 1.37-to-1 ratio favored advancers.\nThe S&P 500 posted 63 new 52-week highs and no new lows; the Nasdaq Composite recorded 106 new highs and 41 new lows.\nOn U.S. exchanges 9.29 billion shares changed hands compared with the 10.26 billion average for the last 20 sessions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690654737,"gmtCreate":1639665982473,"gmtModify":1639666001035,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690654737","repostId":"1103611253","repostType":4,"repost":{"id":"1103611253","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639665157,"share":"https://www.laohu8.com/m/news/1103611253?lang=&edition=full","pubTime":"2021-12-16 22:32","market":"us","language":"en","title":"U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1103611253","media":"Tiger Newspress","summary":"U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%","content":"<p>U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%,Dow climbs 0.5%; S&amp;P 500 advances 0.4%,S&amp;P 500 trades in record-close territory early Thursday.</p>\n<p>Shares of companies that&nbsp;have done well in previous rate-hiking cycles&nbsp;led premarket gainers. Materials stocks FMC Corp. and Freeport-McMoRan both rose more than 3% ahead of the opening bell. Bank stocks also rose across the board, with&nbsp;JPMorgan Chase,Citigroup&nbsp;and&nbsp;Bank of America&nbsp;all up about 0.6%.</p>\n<p>In transportation news,Delta Air Lines&nbsp;reported that it now expects to see a&nbsp;profit of $200 million in the fourth quarter, after previously projecting a loss. Shares rose 2.2% on the news.</p>\n<p>In other central banking news, the Bank of England announced it is hiking its key policy rate by 15 basis points to 0.25%. Markets were awaiting a separate policy decision from the European Central Bank. There also is more economic news on tap, with weekly jobless claims and housing starts out at 8:30 a.m. ET.</p>\n<p>Following the Fed news, traders accelerated their own expectations for interest rate increases. Fed funds futures trading now points to a 63% chance of the first quarter-percentage-point increase coming in May 2022, with chances also rising to about 44% that the central bank could make its first move as soon as March, according to the CME FedWatch Tool.</p>\n<p>Stocks traded in negative territory throughout the regular session Wednesday and turned higher ahead of Fed Chairman Jerome Powell’s press conference in the afternoon at the conclusion of the two-day Federal Open Market Committee meeting. The Dow added 383 points, or 1.08%. The S&amp;P 500 rose 1.63% and the tech-heavy Nasdaq Composite jumped 2.15%.</p>\n<p>“The fact that the FOMC acknowledged new COVID variants as a threat to the economic recovery that could alter policy going forward, as well as the generally optimistic tone from Powell in the presser, helped spark a relief rally as the Fed meeting was viewed as being not-as-hawkish-as-feared,” Tom Essaye of the Sevens Report said in a note on Thursday.</p>\n<p>The Fed will begin reducing the pace of its asset purchases in January and buy just $60 billion of bonds each month going forward, compared to $90 billion in the month of December. That decision follows recent inflation data showing a 6.8% surge in November, which is&nbsp;higher than expected and the fastest rate since 1982.</p>\n<p>“The notion that elevated inflation levels would be transitory has finally been thrown out the window by the Fed and the latest policy adjustments are reflective of a committee that doesn’t want to miss the next train leaving the station,” said Charlie Ripley, senior investment strategist for Allianz Investment Management.</p>\n<p>Corporate earnings looked to be a weak spot for the market on Thursday, with shares of Adobe and Lennar falling in premarket trading after underwhelming quarterly reports.</p>\n<p>On the economic data front, weekly jobless claims came in slightly higher than expected, while housing starts for November were much stronger than economists projected after declining in the prior month.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-16 22:32</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%,Dow climbs 0.5%; S&amp;P 500 advances 0.4%,S&amp;P 500 trades in record-close territory early Thursday.</p>\n<p>Shares of companies that&nbsp;have done well in previous rate-hiking cycles&nbsp;led premarket gainers. Materials stocks FMC Corp. and Freeport-McMoRan both rose more than 3% ahead of the opening bell. Bank stocks also rose across the board, with&nbsp;JPMorgan Chase,Citigroup&nbsp;and&nbsp;Bank of America&nbsp;all up about 0.6%.</p>\n<p>In transportation news,Delta Air Lines&nbsp;reported that it now expects to see a&nbsp;profit of $200 million in the fourth quarter, after previously projecting a loss. Shares rose 2.2% on the news.</p>\n<p>In other central banking news, the Bank of England announced it is hiking its key policy rate by 15 basis points to 0.25%. Markets were awaiting a separate policy decision from the European Central Bank. There also is more economic news on tap, with weekly jobless claims and housing starts out at 8:30 a.m. ET.</p>\n<p>Following the Fed news, traders accelerated their own expectations for interest rate increases. Fed funds futures trading now points to a 63% chance of the first quarter-percentage-point increase coming in May 2022, with chances also rising to about 44% that the central bank could make its first move as soon as March, according to the CME FedWatch Tool.</p>\n<p>Stocks traded in negative territory throughout the regular session Wednesday and turned higher ahead of Fed Chairman Jerome Powell’s press conference in the afternoon at the conclusion of the two-day Federal Open Market Committee meeting. The Dow added 383 points, or 1.08%. The S&amp;P 500 rose 1.63% and the tech-heavy Nasdaq Composite jumped 2.15%.</p>\n<p>“The fact that the FOMC acknowledged new COVID variants as a threat to the economic recovery that could alter policy going forward, as well as the generally optimistic tone from Powell in the presser, helped spark a relief rally as the Fed meeting was viewed as being not-as-hawkish-as-feared,” Tom Essaye of the Sevens Report said in a note on Thursday.</p>\n<p>The Fed will begin reducing the pace of its asset purchases in January and buy just $60 billion of bonds each month going forward, compared to $90 billion in the month of December. That decision follows recent inflation data showing a 6.8% surge in November, which is&nbsp;higher than expected and the fastest rate since 1982.</p>\n<p>“The notion that elevated inflation levels would be transitory has finally been thrown out the window by the Fed and the latest policy adjustments are reflective of a committee that doesn’t want to miss the next train leaving the station,” said Charlie Ripley, senior investment strategist for Allianz Investment Management.</p>\n<p>Corporate earnings looked to be a weak spot for the market on Thursday, with shares of Adobe and Lennar falling in premarket trading after underwhelming quarterly reports.</p>\n<p>On the economic data front, weekly jobless claims came in slightly higher than expected, while housing starts for November were much stronger than economists projected after declining in the prior month.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1103611253","content_text":"U.S. stock market opens higher Thursday after Wednesday's Fed-day rally,Nasdaq Composite climbs 0.4%,Dow climbs 0.5%; S&P 500 advances 0.4%,S&P 500 trades in record-close territory early Thursday.\nShares of companies that have done well in previous rate-hiking cycles led premarket gainers. Materials stocks FMC Corp. and Freeport-McMoRan both rose more than 3% ahead of the opening bell. Bank stocks also rose across the board, with JPMorgan Chase,Citigroup and Bank of America all up about 0.6%.\nIn transportation news,Delta Air Lines reported that it now expects to see a profit of $200 million in the fourth quarter, after previously projecting a loss. Shares rose 2.2% on the news.\nIn other central banking news, the Bank of England announced it is hiking its key policy rate by 15 basis points to 0.25%. Markets were awaiting a separate policy decision from the European Central Bank. There also is more economic news on tap, with weekly jobless claims and housing starts out at 8:30 a.m. ET.\nFollowing the Fed news, traders accelerated their own expectations for interest rate increases. Fed funds futures trading now points to a 63% chance of the first quarter-percentage-point increase coming in May 2022, with chances also rising to about 44% that the central bank could make its first move as soon as March, according to the CME FedWatch Tool.\nStocks traded in negative territory throughout the regular session Wednesday and turned higher ahead of Fed Chairman Jerome Powell’s press conference in the afternoon at the conclusion of the two-day Federal Open Market Committee meeting. The Dow added 383 points, or 1.08%. The S&P 500 rose 1.63% and the tech-heavy Nasdaq Composite jumped 2.15%.\n“The fact that the FOMC acknowledged new COVID variants as a threat to the economic recovery that could alter policy going forward, as well as the generally optimistic tone from Powell in the presser, helped spark a relief rally as the Fed meeting was viewed as being not-as-hawkish-as-feared,” Tom Essaye of the Sevens Report said in a note on Thursday.\nThe Fed will begin reducing the pace of its asset purchases in January and buy just $60 billion of bonds each month going forward, compared to $90 billion in the month of December. That decision follows recent inflation data showing a 6.8% surge in November, which is higher than expected and the fastest rate since 1982.\n“The notion that elevated inflation levels would be transitory has finally been thrown out the window by the Fed and the latest policy adjustments are reflective of a committee that doesn’t want to miss the next train leaving the station,” said Charlie Ripley, senior investment strategist for Allianz Investment Management.\nCorporate earnings looked to be a weak spot for the market on Thursday, with shares of Adobe and Lennar falling in premarket trading after underwhelming quarterly reports.\nOn the economic data front, weekly jobless claims came in slightly higher than expected, while housing starts for November were much stronger than economists projected after declining in the prior month.","news_type":1},"isVote":1,"tweetType":1,"viewCount":113,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":607440513,"gmtCreate":1639581173341,"gmtModify":1639581199423,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":2,"repostSize":0,"link":"https://laohu8.com/post/607440513","repostId":"1149717556","repostType":4,"repost":{"id":"1149717556","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639579526,"share":"https://www.laohu8.com/m/news/1149717556?lang=&edition=full","pubTime":"2021-12-15 22:45","market":"us","language":"en","title":"Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1149717556","media":"Tiger Newspress","summary":"Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax risi","content":"<p>Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%.<img src=\"https://static.tigerbbs.com/9fe6a9d4d67542197b8f5233dddb808c\" tg-width=\"287\" tg-height=\"246\" width=\"100%\" height=\"auto\">Vir Biotechnology (VIR) unveiled late Tuesday new preclinical data that demonstrates the impact of the \"significant antigenic shift\" of the new SARS-CoV-2 Omicron variant on neutralizing activity of monoclonal antibodies.</p>\n<p>The company said a \"significant\" reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nVaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-15 22:45</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%.<img src=\"https://static.tigerbbs.com/9fe6a9d4d67542197b8f5233dddb808c\" tg-width=\"287\" tg-height=\"246\" width=\"100%\" height=\"auto\">Vir Biotechnology (VIR) unveiled late Tuesday new preclinical data that demonstrates the impact of the \"significant antigenic shift\" of the new SARS-CoV-2 Omicron variant on neutralizing activity of monoclonal antibodies.</p>\n<p>The company said a \"significant\" reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药","VIR":"Vir Biotechnology, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1149717556","content_text":"Vaccine stocks rose sharply in morning trading, with Vir technology rising over 15% and Novavax rising over 4%.Vir Biotechnology (VIR) unveiled late Tuesday new preclinical data that demonstrates the impact of the \"significant antigenic shift\" of the new SARS-CoV-2 Omicron variant on neutralizing activity of monoclonal antibodies.\nThe company said a \"significant\" reduction in plasma neutralizing activity was observed against omicron in sera from vaccinated and convalescent individuals.","news_type":1},"isVote":1,"tweetType":1,"viewCount":179,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":604241542,"gmtCreate":1639406872506,"gmtModify":1639406874558,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/604241542","repostId":"1167465214","repostType":4,"repost":{"id":"1167465214","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639406352,"share":"https://www.laohu8.com/m/news/1167465214?lang=&edition=full","pubTime":"2021-12-13 22:39","market":"us","language":"en","title":"Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share","url":"https://stock-news.laohu8.com/highlight/detail?id=1167465214","media":"Tiger Newspress","summary":"Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share.Pfi","content":"<p>Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share.<img src=\"https://static.tigerbbs.com/baca4cde05c414b1c77aa618108489b1\" tg-width=\"774\" tg-height=\"568\" width=\"100%\" height=\"auto\">Pfizer Inc has agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal to expand its cancer and inflammatory disease treatment pipeline, the companies said on Monday.</p>\n<p>Pfizer will take over all outstanding shares of Arena for $100 per share, representing a 100.2% premium to Arena's last closing price.</p>\n<p>Arena is developing several treatments for gastroenterology, dermatology, and cardiology. The drug developer's ulcerative colitis treatment candidate, etrasimod, is in a late-stage study.</p>\n<p>Pfizer said it expects to finance the transaction with cash on hand.</p>\n<p>Pfizer’s financial advisers for the transaction are BofA Securities and Centerview Partners LLC, while Guggenheim Securities LLC and Evercore Group LLC advised Arena.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nArena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-13 22:39</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share.<img src=\"https://static.tigerbbs.com/baca4cde05c414b1c77aa618108489b1\" tg-width=\"774\" tg-height=\"568\" width=\"100%\" height=\"auto\">Pfizer Inc has agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal to expand its cancer and inflammatory disease treatment pipeline, the companies said on Monday.</p>\n<p>Pfizer will take over all outstanding shares of Arena for $100 per share, representing a 100.2% premium to Arena's last closing price.</p>\n<p>Arena is developing several treatments for gastroenterology, dermatology, and cardiology. The drug developer's ulcerative colitis treatment candidate, etrasimod, is in a late-stage study.</p>\n<p>Pfizer said it expects to finance the transaction with cash on hand.</p>\n<p>Pfizer’s financial advisers for the transaction are BofA Securities and Centerview Partners LLC, while Guggenheim Securities LLC and Evercore Group LLC advised Arena.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PFE":"辉瑞","ARNA":"阿里那"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1167465214","content_text":"Arena Pharmaceuticals jumped over 80% in morning trading as Pfizer acquired it for US $100/share.Pfizer Inc has agreed to acquire Arena Pharmaceuticals in a $6.7 billion all-cash deal to expand its cancer and inflammatory disease treatment pipeline, the companies said on Monday.\nPfizer will take over all outstanding shares of Arena for $100 per share, representing a 100.2% premium to Arena's last closing price.\nArena is developing several treatments for gastroenterology, dermatology, and cardiology. The drug developer's ulcerative colitis treatment candidate, etrasimod, is in a late-stage study.\nPfizer said it expects to finance the transaction with cash on hand.\nPfizer’s financial advisers for the transaction are BofA Securities and Centerview Partners LLC, while Guggenheim Securities LLC and Evercore Group LLC advised Arena.","news_type":1},"isVote":1,"tweetType":1,"viewCount":175,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875574555,"gmtCreate":1637676152851,"gmtModify":1637676152972,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/875574555","repostId":"1170324350","repostType":4,"repost":{"id":"1170324350","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637672596,"share":"https://www.laohu8.com/m/news/1170324350?lang=&edition=full","pubTime":"2021-11-23 21:03","market":"us","language":"en","title":"Toplines Before US Market Open on Tuesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1170324350","media":"Tiger Newspress","summary":"Stock futures traded mixed Tuesday morning as technology stocks came under further pressure, as inve","content":"<p>Stock futures traded mixed Tuesday morning as technology stocks came under further pressure, as investors further mulled the market implications of Federal Reserve Jerome Powell’s renomination to lead the central bank.</p>\n<p>At 8:00 a.m. ET, Dow E-minis were up 12 points, or 0.03%, S&amp;P 500 E-minis were down 2.5 points, or 0.05% and Nasdaq 100 E-minis were down 36.5 points, or 0.22%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8b4950d358bb214cef521ade4b01e7cc\" tg-width=\"669\" tg-height=\"220\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p>\n<p>Bank stocks rose in premarket trade, tracking gains in yields after Jerome Powell's reappointment as Fed Chair raised market expectations for an interest rate hike by as soon as June 2022.</p>\n<p>Wall Street's biggest lenders rose between 0.2% and 0.8%, with Citigroup Inc&nbsp;leading gains.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><a href=\"https://laohu8.com/S/BBY\">Best Buy</a> (BBY) – The electronics retailer’s shares tumbled 10.4% in the premarket, after it forecast holiday season comparable sales largely below Wall Street forecasts as it faces possible product shortages. Best Buy reported a quarterly beat on the top and bottom lines, however, with a profit of $2.08 per share coming in 17 cents a share above estimates.</p>\n<p><a href=\"https://laohu8.com/S/ZM\">Zoom</a> (ZM) – Zoom beat estimates by 2 cents a share, with quarterly profit of $1.11 per share. Revenue also topped Street forecasts and Zoom raised its full-year guidance. The return of many workers to offices is slowing sales growth, however, and the stock tumbled 9.6% in premarket trading.</p>\n<p><a href=\"https://laohu8.com/S/URBN\">Urban Outfitters</a> (URBN) – Urban Outfitters earned 89 cents per share for its latest quarter, 5 cents a share above estimates. Revenue came in very slightly above analysts’ projections. The apparel retailer’s stock is getting hit hard, however, as a shift to more online sales increases costs for the company, and the stock slumped 11.5% in premarket action.</p>\n<p><a href=\"https://laohu8.com/S/DKS\">Dick's Sporting Goods</a> (DKS) – The sporting goods retailer earned $3.19 per share for the third quarter, well above the $1.97 a share consensus estimate. Revenue also beat forecasts, and a comparable-store sales increase of 12.2% was substantially better than the 1.9% consensus estimate from StreetAccount. The stock added 1% in premarket action.</p>\n<p><a href=\"https://laohu8.com/S/ANF\">Abercrombie &amp; Fitch</a> (ANF) – The apparel retailer beat estimates by 20 cents a share, with adjusted earnings of 86 cents per share. Revenue also topped forecasts. Abercrombie’s profit margin dropped by 30 basis points. Its shares fell 3.8% in the premarket.</p>\n<p><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> (DLTR) – Dollar Tree matched estimates with quarterly profit of 96 cents per share. The discount retailer’s revenue came in slightly above estimates. Dollar Tree’s freight costs during the quarter were significantly higher than expected, and its stock fell 1.4% in premarket trading.</p>\n<p><a href=\"https://laohu8.com/S/MDT\">Medtronic PLC</a> (MDT) – Medtronic reported a mixed quarter, with revenue falling below Street forecasts. The medical device maker’s profit beat forecasts by 3 cents a share, with earnings of $1.32 per share. Medtronic also lowered its full-year outlook, citing the Covid-19 resurgence and health-care staffing challenges.</p>\n<p><a href=\"https://laohu8.com/S/SJM\">Smucker's</a> (SJM) – The food producer reported quarterly earnings of $2.43 per share, beating the $2.05 a share consensus estimate. Revenue also beat forecasts and Smucker raised its full-year forecast amid strong consumer demand for its flagship brand as well as Jif, Folgers and Milk-Bone. Smucker rose 1.2% in the premarket.</p>\n<p><a href=\"https://laohu8.com/S/XPEV\">XPeng Inc.</a> (XPEV) – Xpeng jumped 3% in the premarket after the China-based electric vehicle maker reported a wider-than-expected quarterly loss, but also saw revenue come in well above estimates while issuing an upbeat current-quarter outlook.</p>\n<p><a href=\"https://laohu8.com/S/A\">Agilent</a> (A) – Agilent came in 3 cents a share ahead of Street forecasts, with quarterly earnings of $1.21 per share. The life sciences company’s revenue was in line with estimates. Agilent saw particular strength during the quarter from its diagnostics and genomic unit. The company also issued an outlook that falls partially below analysts’ estimates, however, prompting a 4.2% premarket drop in the shares.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Tuesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Tuesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-23 21:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stock futures traded mixed Tuesday morning as technology stocks came under further pressure, as investors further mulled the market implications of Federal Reserve Jerome Powell’s renomination to lead the central bank.</p>\n<p>At 8:00 a.m. ET, Dow E-minis were up 12 points, or 0.03%, S&amp;P 500 E-minis were down 2.5 points, or 0.05% and Nasdaq 100 E-minis were down 36.5 points, or 0.22%.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/8b4950d358bb214cef521ade4b01e7cc\" tg-width=\"669\" tg-height=\"220\" width=\"100%\" height=\"auto\"><span>*Source From Tiger Trade, EST 08:00</span></p>\n<p>Bank stocks rose in premarket trade, tracking gains in yields after Jerome Powell's reappointment as Fed Chair raised market expectations for an interest rate hike by as soon as June 2022.</p>\n<p>Wall Street's biggest lenders rose between 0.2% and 0.8%, with Citigroup Inc&nbsp;leading gains.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><a href=\"https://laohu8.com/S/BBY\">Best Buy</a> (BBY) – The electronics retailer’s shares tumbled 10.4% in the premarket, after it forecast holiday season comparable sales largely below Wall Street forecasts as it faces possible product shortages. Best Buy reported a quarterly beat on the top and bottom lines, however, with a profit of $2.08 per share coming in 17 cents a share above estimates.</p>\n<p><a href=\"https://laohu8.com/S/ZM\">Zoom</a> (ZM) – Zoom beat estimates by 2 cents a share, with quarterly profit of $1.11 per share. Revenue also topped Street forecasts and Zoom raised its full-year guidance. The return of many workers to offices is slowing sales growth, however, and the stock tumbled 9.6% in premarket trading.</p>\n<p><a href=\"https://laohu8.com/S/URBN\">Urban Outfitters</a> (URBN) – Urban Outfitters earned 89 cents per share for its latest quarter, 5 cents a share above estimates. Revenue came in very slightly above analysts’ projections. The apparel retailer’s stock is getting hit hard, however, as a shift to more online sales increases costs for the company, and the stock slumped 11.5% in premarket action.</p>\n<p><a href=\"https://laohu8.com/S/DKS\">Dick's Sporting Goods</a> (DKS) – The sporting goods retailer earned $3.19 per share for the third quarter, well above the $1.97 a share consensus estimate. Revenue also beat forecasts, and a comparable-store sales increase of 12.2% was substantially better than the 1.9% consensus estimate from StreetAccount. The stock added 1% in premarket action.</p>\n<p><a href=\"https://laohu8.com/S/ANF\">Abercrombie &amp; Fitch</a> (ANF) – The apparel retailer beat estimates by 20 cents a share, with adjusted earnings of 86 cents per share. Revenue also topped forecasts. Abercrombie’s profit margin dropped by 30 basis points. Its shares fell 3.8% in the premarket.</p>\n<p><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> (DLTR) – Dollar Tree matched estimates with quarterly profit of 96 cents per share. The discount retailer’s revenue came in slightly above estimates. Dollar Tree’s freight costs during the quarter were significantly higher than expected, and its stock fell 1.4% in premarket trading.</p>\n<p><a href=\"https://laohu8.com/S/MDT\">Medtronic PLC</a> (MDT) – Medtronic reported a mixed quarter, with revenue falling below Street forecasts. The medical device maker’s profit beat forecasts by 3 cents a share, with earnings of $1.32 per share. Medtronic also lowered its full-year outlook, citing the Covid-19 resurgence and health-care staffing challenges.</p>\n<p><a href=\"https://laohu8.com/S/SJM\">Smucker's</a> (SJM) – The food producer reported quarterly earnings of $2.43 per share, beating the $2.05 a share consensus estimate. Revenue also beat forecasts and Smucker raised its full-year forecast amid strong consumer demand for its flagship brand as well as Jif, Folgers and Milk-Bone. Smucker rose 1.2% in the premarket.</p>\n<p><a href=\"https://laohu8.com/S/XPEV\">XPeng Inc.</a> (XPEV) – Xpeng jumped 3% in the premarket after the China-based electric vehicle maker reported a wider-than-expected quarterly loss, but also saw revenue come in well above estimates while issuing an upbeat current-quarter outlook.</p>\n<p><a href=\"https://laohu8.com/S/A\">Agilent</a> (A) – Agilent came in 3 cents a share ahead of Street forecasts, with quarterly earnings of $1.21 per share. The life sciences company’s revenue was in line with estimates. Agilent saw particular strength during the quarter from its diagnostics and genomic unit. The company also issued an outlook that falls partially below analysts’ estimates, however, prompting a 4.2% premarket drop in the shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".IXIC":"NASDAQ Composite",".DJI":"道琼斯",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1170324350","content_text":"Stock futures traded mixed Tuesday morning as technology stocks came under further pressure, as investors further mulled the market implications of Federal Reserve Jerome Powell’s renomination to lead the central bank.\nAt 8:00 a.m. ET, Dow E-minis were up 12 points, or 0.03%, S&P 500 E-minis were down 2.5 points, or 0.05% and Nasdaq 100 E-minis were down 36.5 points, or 0.22%.\n*Source From Tiger Trade, EST 08:00\nBank stocks rose in premarket trade, tracking gains in yields after Jerome Powell's reappointment as Fed Chair raised market expectations for an interest rate hike by as soon as June 2022.\nWall Street's biggest lenders rose between 0.2% and 0.8%, with Citigroup Inc leading gains.\nStocks making the biggest moves in the premarket:\nBest Buy (BBY) – The electronics retailer’s shares tumbled 10.4% in the premarket, after it forecast holiday season comparable sales largely below Wall Street forecasts as it faces possible product shortages. Best Buy reported a quarterly beat on the top and bottom lines, however, with a profit of $2.08 per share coming in 17 cents a share above estimates.\nZoom (ZM) – Zoom beat estimates by 2 cents a share, with quarterly profit of $1.11 per share. Revenue also topped Street forecasts and Zoom raised its full-year guidance. The return of many workers to offices is slowing sales growth, however, and the stock tumbled 9.6% in premarket trading.\nUrban Outfitters (URBN) – Urban Outfitters earned 89 cents per share for its latest quarter, 5 cents a share above estimates. Revenue came in very slightly above analysts’ projections. The apparel retailer’s stock is getting hit hard, however, as a shift to more online sales increases costs for the company, and the stock slumped 11.5% in premarket action.\nDick's Sporting Goods (DKS) – The sporting goods retailer earned $3.19 per share for the third quarter, well above the $1.97 a share consensus estimate. Revenue also beat forecasts, and a comparable-store sales increase of 12.2% was substantially better than the 1.9% consensus estimate from StreetAccount. The stock added 1% in premarket action.\nAbercrombie & Fitch (ANF) – The apparel retailer beat estimates by 20 cents a share, with adjusted earnings of 86 cents per share. Revenue also topped forecasts. Abercrombie’s profit margin dropped by 30 basis points. Its shares fell 3.8% in the premarket.\nDollar Tree (DLTR) – Dollar Tree matched estimates with quarterly profit of 96 cents per share. The discount retailer’s revenue came in slightly above estimates. Dollar Tree’s freight costs during the quarter were significantly higher than expected, and its stock fell 1.4% in premarket trading.\nMedtronic PLC (MDT) – Medtronic reported a mixed quarter, with revenue falling below Street forecasts. The medical device maker’s profit beat forecasts by 3 cents a share, with earnings of $1.32 per share. Medtronic also lowered its full-year outlook, citing the Covid-19 resurgence and health-care staffing challenges.\nSmucker's (SJM) – The food producer reported quarterly earnings of $2.43 per share, beating the $2.05 a share consensus estimate. Revenue also beat forecasts and Smucker raised its full-year forecast amid strong consumer demand for its flagship brand as well as Jif, Folgers and Milk-Bone. Smucker rose 1.2% in the premarket.\nXPeng Inc. (XPEV) – Xpeng jumped 3% in the premarket after the China-based electric vehicle maker reported a wider-than-expected quarterly loss, but also saw revenue come in well above estimates while issuing an upbeat current-quarter outlook.\nAgilent (A) – Agilent came in 3 cents a share ahead of Street forecasts, with quarterly earnings of $1.21 per share. The life sciences company’s revenue was in line with estimates. Agilent saw particular strength during the quarter from its diagnostics and genomic unit. The company also issued an outlook that falls partially below analysts’ estimates, however, prompting a 4.2% premarket drop in the shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":37,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":696662446,"gmtCreate":1640684786487,"gmtModify":1640685634556,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Oh no","listText":"Oh no","text":"Oh no","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/696662446","repostId":"1138246031","repostType":4,"repost":{"id":"1138246031","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1640683578,"share":"https://www.laohu8.com/m/news/1138246031?lang=&edition=full","pubTime":"2021-12-28 17:26","market":"us","language":"en","title":"Novavax shares dropped another 4% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1138246031","media":"Tiger Newspress","summary":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy ","content":"<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Why Novavax Stock Is Sinking</b></p>\n<p>The company didn't announce any new developments. So what's behind the big decline?</p>\n<p>Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p>\n<p>Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p>\n<p>CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p>\n<p><b>So what</b></p>\n<p>Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p>\n<p>But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p>\n<p><b>Now what</b></p>\n<p>Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Novavax shares dropped another 4% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNovavax shares dropped another 4% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-28 17:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Novavax shares dropped another 4% in premarket trading.The stock plunged&nbsp;nearly 11% yesterday.</p>\n<p><img src=\"https://static.tigerbbs.com/04a11fff9a31214bbcf7595183a5d305\" tg-width=\"843\" tg-height=\"618\" referrerpolicy=\"no-referrer\"></p>\n<p><b>Why Novavax Stock Is Sinking</b></p>\n<p>The company didn't announce any new developments. So what's behind the big decline?</p>\n<p>Other&nbsp;vaccine stocks&nbsp;aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.</p>\n<p>Instead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.</p>\n<p>CEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"</p>\n<p><b>So what</b></p>\n<p>Yet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.</p>\n<p>But it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.</p>\n<p><b>Now what</b></p>\n<p>Investors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"NVAX":"诺瓦瓦克斯医药"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1138246031","content_text":"Novavax shares dropped another 4% in premarket trading.The stock plunged nearly 11% yesterday.\n\nWhy Novavax Stock Is Sinking\nThe company didn't announce any new developments. So what's behind the big decline?\nOther vaccine stocks aren't falling nearly as much. Some were even up a little. That rules out the likelihood that declining concerns about the omicron variant played a major factor behind Novavax's drop.\nInstead, investors are probably growing more anxious about Novavax's planned filing for U.S. Emergency Use Authorization (EUA) of it COVID-19 vaccine NVX-CoV2373. Some investors could also be worried about the quality of Novavax's submission to the Food and Drug Administration (FDA) even if it doesn't experience another delay with the filing.\nCEO Stanley Erck's interview with Yahoo! Finance Live last Thursday likely didn't help reassure investors. When asked about when the FDA filing would be done, Erck replied, \"It's probably going to be next week, but I'm sticking with the claim that we'll be doing this by the end of this year.\"\nSo what\nYet another delay in a U.S. filing for NVX-CoV2373 wouldn't be catastrophic for Novavax as long as the company completes the submission soon in the new year. However, management's credibility would definitely take another big blow.\nBut it's premature at this point to speculate that Novavax won't complete the U.S. EUA filing this week. It's also useless to fret about the quality of the company's FDA package. Novavax recently won European Union authorization for NVX-CoV2373. That shows that the vaccine maker can successfully meet regulators' manufacturing-quality hurdles.\nNow what\nInvestors don't like waiting, but that's exactly what they'll have to do for now with Novavax. The company could complete its EUA filing any day now. It could also pick up new authorizations in other countries where it awaits regulatory decisions.","news_type":1},"isVote":1,"tweetType":1,"viewCount":781,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":698589877,"gmtCreate":1640447629416,"gmtModify":1640447629722,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/698589877","repostId":"2193127176","repostType":4,"repost":{"id":"2193127176","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1640345481,"share":"https://www.laohu8.com/m/news/2193127176?lang=&edition=full","pubTime":"2021-12-24 19:31","market":"us","language":"en","title":"Japan health panel approves Merck's oral COVID-19 treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2193127176","media":"Reuters","summary":"TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COV","content":"<p>TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck &amp; Co Inc , part of plans by Prime Minister Fumio Kishida to roll out new treatments by yearend as concerns rise about the Omicron variant.</p>\n<p>The panel decision sets the stage for shipments of 200,000 doses across the country from this weekend, based on preparations announced earlier by Kishida.</p>\n<p>Japan is betting heavily on oral treatments to keep serious infections and deaths at bay should a feared sixth wave of the pandemic emerge. The government agreed last month to pay Merck and its partner Ridgeback Biotherapeutics about $1.2 billion for 1.6 million courses of their drug molnupiravir.</p>\n<p>In addition, Kishida announced last week a deal to procure 2 million doses of a separate antiviral pill&nbsp;developed by Pfizer Inc. And Japan's Shionogi &amp; Co is expected to soon file for approval of its own treatment&nbsp;supplying another 1 million doses by early next year.</p>\n<p>U.S. regulators on Thursday authorized the Merck pill for certain high-risk adult patients.</p>\n<p>Countries rushed to buy Merck's molnupiravir after very promising initial results, but subsequent company data in late November indicated the drug was markedly less effective than previously thought. France cancelled its order on Wednesday.</p>\n<p>Japan this week confirmed the first known cases of Omicron infections that could not be traced back to overseas travelers. Community transmissions of the variant have now been found in the western cities of Osaka and Kyoto, and a suspected case was announced in Tokyo on Friday.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Japan health panel approves Merck's oral COVID-19 treatment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJapan health panel approves Merck's oral COVID-19 treatment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2021-12-24 19:31</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck &amp; Co Inc , part of plans by Prime Minister Fumio Kishida to roll out new treatments by yearend as concerns rise about the Omicron variant.</p>\n<p>The panel decision sets the stage for shipments of 200,000 doses across the country from this weekend, based on preparations announced earlier by Kishida.</p>\n<p>Japan is betting heavily on oral treatments to keep serious infections and deaths at bay should a feared sixth wave of the pandemic emerge. The government agreed last month to pay Merck and its partner Ridgeback Biotherapeutics about $1.2 billion for 1.6 million courses of their drug molnupiravir.</p>\n<p>In addition, Kishida announced last week a deal to procure 2 million doses of a separate antiviral pill&nbsp;developed by Pfizer Inc. And Japan's Shionogi &amp; Co is expected to soon file for approval of its own treatment&nbsp;supplying another 1 million doses by early next year.</p>\n<p>U.S. regulators on Thursday authorized the Merck pill for certain high-risk adult patients.</p>\n<p>Countries rushed to buy Merck's molnupiravir after very promising initial results, but subsequent company data in late November indicated the drug was markedly less effective than previously thought. France cancelled its order on Wednesday.</p>\n<p>Japan this week confirmed the first known cases of Omicron infections that could not be traced back to overseas travelers. Community transmissions of the variant have now been found in the western cities of Osaka and Kyoto, and a suspected case was announced in Tokyo on Friday.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4550":"红杉资本持仓","BK4516":"特朗普概念","BK4007":"制药","MRK":"默沙东","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4559":"巴菲特持仓","BK4534":"瑞士信贷持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2193127176","content_text":"TOKYO, Dec 24 (Reuters) - A Japanese health ministry panel on Friday recommended approval of the COVID-19 antiviral pill developed by Merck & Co Inc , part of plans by Prime Minister Fumio Kishida to roll out new treatments by yearend as concerns rise about the Omicron variant.\nThe panel decision sets the stage for shipments of 200,000 doses across the country from this weekend, based on preparations announced earlier by Kishida.\nJapan is betting heavily on oral treatments to keep serious infections and deaths at bay should a feared sixth wave of the pandemic emerge. The government agreed last month to pay Merck and its partner Ridgeback Biotherapeutics about $1.2 billion for 1.6 million courses of their drug molnupiravir.\nIn addition, Kishida announced last week a deal to procure 2 million doses of a separate antiviral pill developed by Pfizer Inc. And Japan's Shionogi & Co is expected to soon file for approval of its own treatment supplying another 1 million doses by early next year.\nU.S. regulators on Thursday authorized the Merck pill for certain high-risk adult patients.\nCountries rushed to buy Merck's molnupiravir after very promising initial results, but subsequent company data in late November indicated the drug was markedly less effective than previously thought. France cancelled its order on Wednesday.\nJapan this week confirmed the first known cases of Omicron infections that could not be traced back to overseas travelers. Community transmissions of the variant have now been found in the western cities of Osaka and Kyoto, and a suspected case was announced in Tokyo on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":601212534,"gmtCreate":1638534442823,"gmtModify":1638534442968,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/601212534","repostId":"1144924535","repostType":4,"repost":{"id":"1144924535","weMediaInfo":{"introduction":"为用户提供金融资讯、行情、数据，旨在帮助投资者理解世界，做投资决策。","home_visible":1,"media_name":"老虎资讯综合","id":"102","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1638533072,"share":"https://www.laohu8.com/m/news/1144924535?lang=&edition=full","pubTime":"2021-12-03 20:04","market":"us","language":"en","title":"Moderna stock jumped more than 5% in premarket trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1144924535","media":"老虎资讯综合","summary":"Moderna stock jumped more than 5% in premarket trading because Moderna led with antibody response in","content":"<p>Moderna stock jumped more than 5% in premarket trading&nbsp;because&nbsp;Moderna led with antibody response in COVID-19 booster trial in U.K..</p>\n<p><img src=\"https://static.tigerbbs.com/7b43bf58e1f0e28dcfc0f4c263ef6736\" tg-width=\"853\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p>\n<p>According to a peer-reviewed study published in&nbsp;<i>The Lancet</i>&nbsp;on Thursday, Moderna&nbsp;COVID-19 vaccine has shown the strongest antibody effect in a trial that evaluated the different combinations of COVID-19 vaccines as boosters.</p>\n<p>The Phase 2 \"COV-Boost\" study conducted across 18 different U.K. locations involved nearly 2,900 individuals aged over 30 years. Half in the study had received two doses of Oxford-AstraZeneca&nbsp;vaccine, and the rest had received the Pfizer/BioNTec&nbsp;vaccine.</p>\n<p>The trial was designed to evaluate the safety and efficacy of seven booster vaccines developed by AstraZeneca, Pfizer/ BioNTech, Novavax, Johnson &amp; Johnson, Moderna, Valneva&nbsp;and Curevac.</p>\n<p>While all seven vaccines except Valneva’s (VALN) boosted immunity in those who had received initial doses of Pfizer/ BioNTech, all seven had upped the immunity level when given 10 – 12 weeks after the initial regimen of the AstraZeneca&nbsp;vaccine.</p>\n<p>Notably, Moderna&nbsp;COVID-19 shot had generated the strongest booster effect leading to an over 32-fold rise in antibody level in the AstraZeneca&nbsp;group and over 11-fold increase in the Pfizer/ BioNTech&nbsp;group,&nbsp;<i>The Guardian</i>&nbsp;reported.</p>\n<p>In addition,Britain said on Wednesday it had agreed deals to buy 114 million more Pfizer/BioNTech and Moderna COVID-19 vaccine shots, saying it had sped up signing the new contracts in light of the emergence of the new Omicron variant.</p>\n<p>The deal involves an additional 60 million Moderna&nbsp;shots and 54 million Pfizer&nbsp;doses for next year and 2023, and will also include access to any modified vaccinations if they are needed to combat the Omicron strain or any other variant, the British health ministry said.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Moderna stock jumped more than 5% in premarket trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nModerna stock jumped more than 5% in premarket trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/102\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">老虎资讯综合 </p>\n<p class=\"h-time\">2021-12-03 20:04</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Moderna stock jumped more than 5% in premarket trading&nbsp;because&nbsp;Moderna led with antibody response in COVID-19 booster trial in U.K..</p>\n<p><img src=\"https://static.tigerbbs.com/7b43bf58e1f0e28dcfc0f4c263ef6736\" tg-width=\"853\" tg-height=\"617\" referrerpolicy=\"no-referrer\"></p>\n<p>According to a peer-reviewed study published in&nbsp;<i>The Lancet</i>&nbsp;on Thursday, Moderna&nbsp;COVID-19 vaccine has shown the strongest antibody effect in a trial that evaluated the different combinations of COVID-19 vaccines as boosters.</p>\n<p>The Phase 2 \"COV-Boost\" study conducted across 18 different U.K. locations involved nearly 2,900 individuals aged over 30 years. Half in the study had received two doses of Oxford-AstraZeneca&nbsp;vaccine, and the rest had received the Pfizer/BioNTec&nbsp;vaccine.</p>\n<p>The trial was designed to evaluate the safety and efficacy of seven booster vaccines developed by AstraZeneca, Pfizer/ BioNTech, Novavax, Johnson &amp; Johnson, Moderna, Valneva&nbsp;and Curevac.</p>\n<p>While all seven vaccines except Valneva’s (VALN) boosted immunity in those who had received initial doses of Pfizer/ BioNTech, all seven had upped the immunity level when given 10 – 12 weeks after the initial regimen of the AstraZeneca&nbsp;vaccine.</p>\n<p>Notably, Moderna&nbsp;COVID-19 shot had generated the strongest booster effect leading to an over 32-fold rise in antibody level in the AstraZeneca&nbsp;group and over 11-fold increase in the Pfizer/ BioNTech&nbsp;group,&nbsp;<i>The Guardian</i>&nbsp;reported.</p>\n<p>In addition,Britain said on Wednesday it had agreed deals to buy 114 million more Pfizer/BioNTech and Moderna COVID-19 vaccine shots, saying it had sped up signing the new contracts in light of the emergence of the new Omicron variant.</p>\n<p>The deal involves an additional 60 million Moderna&nbsp;shots and 54 million Pfizer&nbsp;doses for next year and 2023, and will also include access to any modified vaccinations if they are needed to combat the Omicron strain or any other variant, the British health ministry said.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1144924535","content_text":"Moderna stock jumped more than 5% in premarket trading because Moderna led with antibody response in COVID-19 booster trial in U.K..\n\nAccording to a peer-reviewed study published in The Lancet on Thursday, Moderna COVID-19 vaccine has shown the strongest antibody effect in a trial that evaluated the different combinations of COVID-19 vaccines as boosters.\nThe Phase 2 \"COV-Boost\" study conducted across 18 different U.K. locations involved nearly 2,900 individuals aged over 30 years. Half in the study had received two doses of Oxford-AstraZeneca vaccine, and the rest had received the Pfizer/BioNTec vaccine.\nThe trial was designed to evaluate the safety and efficacy of seven booster vaccines developed by AstraZeneca, Pfizer/ BioNTech, Novavax, Johnson & Johnson, Moderna, Valneva and Curevac.\nWhile all seven vaccines except Valneva’s (VALN) boosted immunity in those who had received initial doses of Pfizer/ BioNTech, all seven had upped the immunity level when given 10 – 12 weeks after the initial regimen of the AstraZeneca vaccine.\nNotably, Moderna COVID-19 shot had generated the strongest booster effect leading to an over 32-fold rise in antibody level in the AstraZeneca group and over 11-fold increase in the Pfizer/ BioNTech group, The Guardian reported.\nIn addition,Britain said on Wednesday it had agreed deals to buy 114 million more Pfizer/BioNTech and Moderna COVID-19 vaccine shots, saying it had sped up signing the new contracts in light of the emergence of the new Omicron variant.\nThe deal involves an additional 60 million Moderna shots and 54 million Pfizer doses for next year and 2023, and will also include access to any modified vaccinations if they are needed to combat the Omicron strain or any other variant, the British health ministry said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":33,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872639074,"gmtCreate":1637499082008,"gmtModify":1637499082158,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872639074","repostId":"2184782893","repostType":4,"repost":{"id":"2184782893","pubTimestamp":1637464884,"share":"https://www.laohu8.com/m/news/2184782893?lang=&edition=full","pubTime":"2021-11-21 11:21","market":"us","language":"en","title":"3 Top Chip Stocks Ready for Bull Runs","url":"https://stock-news.laohu8.com/highlight/detail?id=2184782893","media":"Motley Fool","summary":"ASML, UMC, and Micron could all still have a lot of upside potential.","content":"<p>The global chip shortage has been generating strong tailwinds for the semiconductor sector over the past year. However, it might be difficult for investors to separate the winners from the losers if they don't understand how the semiconductor supply chain works.</p>\n<p>Today, I'll highlight three chip stocks that operate in very different parts of the semiconductor market, why they're all growing, and why they could still generate even bigger returns next year.</p>\n<h2>1. ASML</h2>\n<p><b>ASML Holding</b> (NASDAQ:ASML) is a Dutch semiconductor equipment maker. It's the world's largest manufacturer of lithography machines, which are used to etch circuit patterns onto silicon wafers. It's also the only manufacturer of high-end extreme ultraviolet (EUV) lithography machines, which are required to manufacture the world's smallest chips.</p>\n<p>The world's most advanced chip foundries -- including <b>Taiwan Semiconductor Manufacturing</b> (NYSE:TSM), <b>Samsung</b>, and <b>Intel</b> (NASDAQ:INTC) -- all use ASML's EUV machines, which cost about $150,000 each and require several planes to ship. ASML's dominance of this crucial chipmaking technology, which it refined over the past three decades, makes it a linchpin of the global semiconductor market.</p>\n<p>ASML's revenue rose 8% in 2019 and 18% in 2020, and it anticipates about 35% growth this year. It's selling EUV systems as rapidly as it can produce them, and a growing mix of those higher-margin devices boosted its gross margin from 44.7% in 2019 to 52.2% in the first nine months of 2021.</p>\n<p>ASML's stock price has more than doubled over the past 12 months, and it isn't cheap at 45 times forward earnings. However, this stock could still have plenty of upside potential as the chip shortage drags on -- since it will be impossible to resolve the crisis without buying significantly more machines from ASML.</p>\n<h2>2. UMC</h2>\n<p>ASML's top client is TSMC, the world's largest contract chipmaker and another linchpin of the semiconductor market. However, TSMC's smaller rival <b>United Microelectronics</b> (NYSE:UMC) is a more underrated play on the same trend.</p>\n<p>Unlike TSMC -- which manufactures the world's smallest chips for fabless chipmakers like <b>Advanced Micro Devices</b> and<b> Apple</b> -- UMC primarily manufactures older, larger, and cheaper chips for cars, Internet of Things (IoT) devices, and other gadgets.</p>\n<p>These chips aren't as powerful as TSMC's top-tier chips, but they're arguably just as essential. UMC's plants are already operating at their maximum capacities, but the company faces less pressure to aggressively upgrade its plants than TSMC, Samsung, or Intel, which are all engaged in the costly \"process race\" to manufacture smaller and more advanced chips.</p>\n<p>UMC ranks a distant third in the foundry market behind TSMC and Samsung, but it still generates impressive growth: Its revenue rose 4% in 2019 and jumped 25% in 2020, and analysts expect 18% growth this year.</p>\n<p>UMC's stock has more than doubled over the past 12 months, but it still looks reasonably valued at 22 times forward earnings. Like ASML, UMC will continue to profit from the chip shortage. Moreover, the traffic jam at TSMC and other top foundries could eventually divert more lower-end orders to UMC.</p>\n<h2>3. Micron</h2>\n<p>Lastly, I believe <b>Micron Technology </b>(NASDAQ:MU) -- <a href=\"https://laohu8.com/S/AONE.U\">one</a> of the world's leading producers of DRAM and NAND memory chips -- is currently undervalued at eight times forward earnings. Micron's stock has risen nearly 30% over the past 12 months, but it's stalled out in recent months amid fears of a cyclical slowdown.</p>\n<p>Micron's revenue fell 8% in fiscal 2020 (which ended last September) as a global glut of memory chips caused market prices to plunge. But in fiscal 2021, its revenue rose 29% as those supplies and prices stabilized.</p>\n<p>Micron wasn't directly affected by the chip shortage, since it manufactures its own chips instead of outsourcing them to third-party foundries. However, it expects shortages of other PC components -- including CPUs and GPUs -- to indirectly curb the market's near-term demand for its memory chips. That warning, along with a softer-than-expected forecast for the first quarter, spooked investors last month.</p>\n<p>Nonetheless, analysts still expect Micron's revenue and earnings to rise 15% and 44%, respectively, this year, as it benefits from the secular expansion of the gaming, data center, cloud, 5G, and automotive markets. Those catalysts might also spark a \"super cycle\" in memory chip upgrades, which could last much longer than previous cycles and propel Micron's stock to fresh highs next year.</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>3 Top Chip Stocks Ready for Bull Runs</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n3 Top Chip Stocks Ready for Bull Runs\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-21 11:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/11/20/3-top-chip-stocks-ready-for-a-bull-run/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The global chip shortage has been generating strong tailwinds for the semiconductor sector over the past year. However, it might be difficult for investors to separate the winners from the losers if ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/11/20/3-top-chip-stocks-ready-for-a-bull-run/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4512":"苹果概念","BK4548":"巴美列捷福持仓","BK4529":"IDC概念","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4515":"5G概念","INTC":"英特尔","BK4553":"喜马拉雅资本持仓","BK4534":"瑞士信贷持仓","BK4147":"半导体设备","BK4533":"AQR资本管理(全球第二大对冲基金)","UMC":"联电","BK4566":"资本集团","BK4535":"淡马锡持仓","03165":"华夏欧优股对冲","MU":"美光科技","BK4527":"明星科技股","TSM":"台积电","BK4550":"红杉资本持仓","BK4526":"热门中概股","BK4141":"半导体产品","ASML":"阿斯麦","BK4503":"景林资产持仓","03145":"华夏亚洲高息股","BK4505":"高瓴资本持仓"},"source_url":"https://www.fool.com/investing/2021/11/20/3-top-chip-stocks-ready-for-a-bull-run/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2184782893","content_text":"The global chip shortage has been generating strong tailwinds for the semiconductor sector over the past year. However, it might be difficult for investors to separate the winners from the losers if they don't understand how the semiconductor supply chain works.\nToday, I'll highlight three chip stocks that operate in very different parts of the semiconductor market, why they're all growing, and why they could still generate even bigger returns next year.\n1. ASML\nASML Holding (NASDAQ:ASML) is a Dutch semiconductor equipment maker. It's the world's largest manufacturer of lithography machines, which are used to etch circuit patterns onto silicon wafers. It's also the only manufacturer of high-end extreme ultraviolet (EUV) lithography machines, which are required to manufacture the world's smallest chips.\nThe world's most advanced chip foundries -- including Taiwan Semiconductor Manufacturing (NYSE:TSM), Samsung, and Intel (NASDAQ:INTC) -- all use ASML's EUV machines, which cost about $150,000 each and require several planes to ship. ASML's dominance of this crucial chipmaking technology, which it refined over the past three decades, makes it a linchpin of the global semiconductor market.\nASML's revenue rose 8% in 2019 and 18% in 2020, and it anticipates about 35% growth this year. It's selling EUV systems as rapidly as it can produce them, and a growing mix of those higher-margin devices boosted its gross margin from 44.7% in 2019 to 52.2% in the first nine months of 2021.\nASML's stock price has more than doubled over the past 12 months, and it isn't cheap at 45 times forward earnings. However, this stock could still have plenty of upside potential as the chip shortage drags on -- since it will be impossible to resolve the crisis without buying significantly more machines from ASML.\n2. UMC\nASML's top client is TSMC, the world's largest contract chipmaker and another linchpin of the semiconductor market. However, TSMC's smaller rival United Microelectronics (NYSE:UMC) is a more underrated play on the same trend.\nUnlike TSMC -- which manufactures the world's smallest chips for fabless chipmakers like Advanced Micro Devices and Apple -- UMC primarily manufactures older, larger, and cheaper chips for cars, Internet of Things (IoT) devices, and other gadgets.\nThese chips aren't as powerful as TSMC's top-tier chips, but they're arguably just as essential. UMC's plants are already operating at their maximum capacities, but the company faces less pressure to aggressively upgrade its plants than TSMC, Samsung, or Intel, which are all engaged in the costly \"process race\" to manufacture smaller and more advanced chips.\nUMC ranks a distant third in the foundry market behind TSMC and Samsung, but it still generates impressive growth: Its revenue rose 4% in 2019 and jumped 25% in 2020, and analysts expect 18% growth this year.\nUMC's stock has more than doubled over the past 12 months, but it still looks reasonably valued at 22 times forward earnings. Like ASML, UMC will continue to profit from the chip shortage. Moreover, the traffic jam at TSMC and other top foundries could eventually divert more lower-end orders to UMC.\n3. Micron\nLastly, I believe Micron Technology (NASDAQ:MU) -- one of the world's leading producers of DRAM and NAND memory chips -- is currently undervalued at eight times forward earnings. Micron's stock has risen nearly 30% over the past 12 months, but it's stalled out in recent months amid fears of a cyclical slowdown.\nMicron's revenue fell 8% in fiscal 2020 (which ended last September) as a global glut of memory chips caused market prices to plunge. But in fiscal 2021, its revenue rose 29% as those supplies and prices stabilized.\nMicron wasn't directly affected by the chip shortage, since it manufactures its own chips instead of outsourcing them to third-party foundries. However, it expects shortages of other PC components -- including CPUs and GPUs -- to indirectly curb the market's near-term demand for its memory chips. That warning, along with a softer-than-expected forecast for the first quarter, spooked investors last month.\nNonetheless, analysts still expect Micron's revenue and earnings to rise 15% and 44%, respectively, this year, as it benefits from the secular expansion of the gaming, data center, cloud, 5G, and automotive markets. Those catalysts might also spark a \"super cycle\" in memory chip upgrades, which could last much longer than previous cycles and propel Micron's stock to fresh highs next year.","news_type":1},"isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876290660,"gmtCreate":1637314470609,"gmtModify":1637314470974,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/876290660","repostId":"1143344231","repostType":4,"repost":{"id":"1143344231","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637312557,"share":"https://www.laohu8.com/m/news/1143344231?lang=&edition=full","pubTime":"2021-11-19 17:02","market":"us","language":"en","title":"Longeveron continued to climb over 50% in premarket trading as FDA approved its Lomecel-B for rare pediatric disease designation","url":"https://stock-news.laohu8.com/highlight/detail?id=1143344231","media":"Tiger Newspress","summary":"Longeveron continued to climb over 50% in premarket trading as FDA approved its Lomecel-B for rare p","content":"<p>Longeveron&nbsp;continued&nbsp;to&nbsp;climb&nbsp;over&nbsp;50%&nbsp;in&nbsp;premarket&nbsp;trading&nbsp;as&nbsp;FDA&nbsp;approved its Lomecel-B for rare pediatric disease designation.<img src=\"https://static.tigerbbs.com/6b1cd0f83b93e7a6c6bdcdbba2cdbaa6\" tg-width=\"772\" tg-height=\"566\" width=\"100%\" height=\"auto\">The&nbsp;company&nbsp;announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome (HLHS), a rare and life-threatening congenital heart defect in infants. Lomecel-B, an investigational allogeneic, bone marrow-derived medicinal signaling cell (MSC) product, is currently being evaluated in a Phase 2 trial.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Longeveron continued to climb over 50% in premarket trading as FDA approved its Lomecel-B for rare pediatric disease designation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLongeveron continued to climb over 50% in premarket trading as FDA approved its Lomecel-B for rare pediatric disease designation\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-19 17:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Longeveron&nbsp;continued&nbsp;to&nbsp;climb&nbsp;over&nbsp;50%&nbsp;in&nbsp;premarket&nbsp;trading&nbsp;as&nbsp;FDA&nbsp;approved its Lomecel-B for rare pediatric disease designation.<img src=\"https://static.tigerbbs.com/6b1cd0f83b93e7a6c6bdcdbba2cdbaa6\" tg-width=\"772\" tg-height=\"566\" width=\"100%\" height=\"auto\">The&nbsp;company&nbsp;announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome (HLHS), a rare and life-threatening congenital heart defect in infants. Lomecel-B, an investigational allogeneic, bone marrow-derived medicinal signaling cell (MSC) product, is currently being evaluated in a Phase 2 trial.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"LGVN":"Longeveron Inc"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1143344231","content_text":"Longeveron continued to climb over 50% in premarket trading as FDA approved its Lomecel-B for rare pediatric disease designation.The company announced that the U.S. Food and Drug Administration (FDA) has granted Rare Pediatric Disease (RPD) designation for Lomecel-B for the treatment of Hypoplastic Left Heart Syndrome (HLHS), a rare and life-threatening congenital heart defect in infants. Lomecel-B, an investigational allogeneic, bone marrow-derived medicinal signaling cell (MSC) product, is currently being evaluated in a Phase 2 trial.","news_type":1},"isVote":1,"tweetType":1,"viewCount":277,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":873704148,"gmtCreate":1636984290992,"gmtModify":1636984295616,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/873704148","repostId":"1124063419","repostType":4,"repost":{"id":"1124063419","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1636981410,"share":"https://www.laohu8.com/m/news/1124063419?lang=&edition=full","pubTime":"2021-11-15 21:03","market":"us","language":"en","title":"Toplines Before US Market Open on Monday","url":"https://stock-news.laohu8.com/highlight/detail?id=1124063419","media":"Tiger Newspress","summary":"Stock futures pointed to a higher open Monday morning as investors awaited key retail sales and earn","content":"<p>Stock futures pointed to a higher open Monday morning as investors awaited key retail sales and earnings results out from major U.S. companies later this week.<img src=\"https://static.tigerbbs.com/9bd814193ce3a21c26ecb73c6e576fc6\" tg-width=\"1080\" tg-height=\"511\" referrerpolicy=\"no-referrer\">At 8:00 a.m. ET, S&amp;P 500 e-minis were up&nbsp;10.75&nbsp;points, or 0.23%, Nasdaq 100 e-minis&nbsp;were up&nbsp;34.5&nbsp;points, or 0.21%, and Dow e-minis&nbsp; were&nbsp;up&nbsp;118&nbsp;points, or 0.33%.</p>\n<p>Investors this week are also&nbsp;set to receive new data&nbsp;from the Commerce Department on U.S. retail sales. The report is likely to show a 1.3% month-on-month jump in sales for October after a more sanguine 0.7% rise in September. And retail earnings results from major names including Walmart, Target, Home Depot and Lowe's will offer additional details on the state of the consumer.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><a href=\"https://laohu8.com/S/OTLY\">Oatly Group AB</a> – The oat milk producer lost 7 cents per share for its latest quarter, smaller than the 10 cents a share loss anticipated by analysts. Revenue came in below forecasts, however, and its shares tumbled 14.1% in premarket action. Oatly said it faced challenges related to various Covid-related restrictions, but that it continues to scale up production.</p>\n<p><a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> – Tesla slid 2.1% in premarket trading after a weekly loss last week ended an 11-week winning streak. Tesla CEO Elon Musk sold nearly $7 billion in stock last week.</p>\n<p><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> – Dollar Tree surged 8.3% in the premarket after activist investor Mantle Ridge took a stake in the discount retailer. The Wall Street Journal reports that Mantle Ridge wants Dollar Tree to take action to boost its stock price and is focusing on pricing strategies at the company’s Family Dollar chain. The news prompted Deutsche Bank to upgrade the stock to “buy” from “hold,” citing potential improvements.</p>\n<p><a href=\"https://laohu8.com/S/TSN\">Tyson</a> – The beef and poultry producer earned $2.30 per share for its fiscal fourth quarter, 27 cents a share above estimates. Revenue topped Wall Street forecasts as well. Tyson also announced a new productivity program that it says will save $1 billion annually by the end of 2024.</p>\n<p><a href=\"https://laohu8.com/S/AMT\">American Tower</a> – The communications infrastructure real estate investment trust is buying data center REITCoreSite Realty(COR) for $170 per share in cash, or about $10.1 billion. CoreSite rose 2.6% in premarket action.</p>\n<p><a href=\"https://laohu8.com/S/DE\">John Deere</a> – The heavy equipment maker and striking workers reached a third tentative contract agreement after the first two were rejected. Neither side gave details on the new agreement and it is not yet clear when a vote will take place. Workers have been off the job since Oct. 14.</p>\n<p><a href=\"https://laohu8.com/S/EVGO\">EVgo Inc.</a> – The operator of public EV charging networks saw its stock tank by 7.7% in the premarket, after Credit Suisse downgraded it to “neutral” from “outperform.” The company said a recent rally in the stock has likely priced in benefits from the infrastructure bill as well as recent partnership announcements.</p>\n<p><a href=\"https://laohu8.com/S/RDS.A\">Royal Dutch Shell PLC</a> – Royal Dutch Shell plans to scrap its dual share structure and also drop the “Royal Dutch” part of its corporate name. The announcement comes amid calls by activist investor Third Point to split up the energy giant into several companies to increase shareholder value. Class “A” shares gained 1.5% in premarket action, while class “B” shares rose 1.1%.</p>\n<p><a href=\"https://laohu8.com/S/BA\">Boeing</a> – Boeing Senior Vice President Ihssane Mounir said the jet maker is “getting close” to resuming deliveries of its 787 Dreamliner, after suspending them to deal with production issues. Mounir said the exact timing depends on the outcome of ongoing talks with regulators. The stock added 2.7% in the premarket.</p>\n<p><a href=\"https://laohu8.com/S/WOOF\">Petco Health and Wellness Company, Inc.</a> – The pet products retailer’s stock slid 2.9% in premarket trading after Jefferies downgraded it to “hold” from “buy.” Jefferies cited valuation after a 26% rise over three months, as well as challenging labor conditions in Petco’s veterinary business.</p>\n<p><a href=\"https://laohu8.com/S/CRWD\">CrowdStrike Holdings, Inc.</a> – Morgan Stanley began coverage of the cybersecurity company with an “underweight” rating, noting increasing competition and pricing pressure. Crowdstrike slid 4.6% in the premarket.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Monday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Monday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-15 21:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Stock futures pointed to a higher open Monday morning as investors awaited key retail sales and earnings results out from major U.S. companies later this week.<img src=\"https://static.tigerbbs.com/9bd814193ce3a21c26ecb73c6e576fc6\" tg-width=\"1080\" tg-height=\"511\" referrerpolicy=\"no-referrer\">At 8:00 a.m. ET, S&amp;P 500 e-minis were up&nbsp;10.75&nbsp;points, or 0.23%, Nasdaq 100 e-minis&nbsp;were up&nbsp;34.5&nbsp;points, or 0.21%, and Dow e-minis&nbsp; were&nbsp;up&nbsp;118&nbsp;points, or 0.33%.</p>\n<p>Investors this week are also&nbsp;set to receive new data&nbsp;from the Commerce Department on U.S. retail sales. The report is likely to show a 1.3% month-on-month jump in sales for October after a more sanguine 0.7% rise in September. And retail earnings results from major names including Walmart, Target, Home Depot and Lowe's will offer additional details on the state of the consumer.</p>\n<p><b>Stocks making the biggest moves in the premarket:</b></p>\n<p><a href=\"https://laohu8.com/S/OTLY\">Oatly Group AB</a> – The oat milk producer lost 7 cents per share for its latest quarter, smaller than the 10 cents a share loss anticipated by analysts. Revenue came in below forecasts, however, and its shares tumbled 14.1% in premarket action. Oatly said it faced challenges related to various Covid-related restrictions, but that it continues to scale up production.</p>\n<p><a href=\"https://laohu8.com/S/TSLA\">Tesla Motors</a> – Tesla slid 2.1% in premarket trading after a weekly loss last week ended an 11-week winning streak. Tesla CEO Elon Musk sold nearly $7 billion in stock last week.</p>\n<p><a href=\"https://laohu8.com/S/DLTR\">Dollar Tree</a> – Dollar Tree surged 8.3% in the premarket after activist investor Mantle Ridge took a stake in the discount retailer. The Wall Street Journal reports that Mantle Ridge wants Dollar Tree to take action to boost its stock price and is focusing on pricing strategies at the company’s Family Dollar chain. The news prompted Deutsche Bank to upgrade the stock to “buy” from “hold,” citing potential improvements.</p>\n<p><a href=\"https://laohu8.com/S/TSN\">Tyson</a> – The beef and poultry producer earned $2.30 per share for its fiscal fourth quarter, 27 cents a share above estimates. Revenue topped Wall Street forecasts as well. Tyson also announced a new productivity program that it says will save $1 billion annually by the end of 2024.</p>\n<p><a href=\"https://laohu8.com/S/AMT\">American Tower</a> – The communications infrastructure real estate investment trust is buying data center REITCoreSite Realty(COR) for $170 per share in cash, or about $10.1 billion. CoreSite rose 2.6% in premarket action.</p>\n<p><a href=\"https://laohu8.com/S/DE\">John Deere</a> – The heavy equipment maker and striking workers reached a third tentative contract agreement after the first two were rejected. Neither side gave details on the new agreement and it is not yet clear when a vote will take place. Workers have been off the job since Oct. 14.</p>\n<p><a href=\"https://laohu8.com/S/EVGO\">EVgo Inc.</a> – The operator of public EV charging networks saw its stock tank by 7.7% in the premarket, after Credit Suisse downgraded it to “neutral” from “outperform.” The company said a recent rally in the stock has likely priced in benefits from the infrastructure bill as well as recent partnership announcements.</p>\n<p><a href=\"https://laohu8.com/S/RDS.A\">Royal Dutch Shell PLC</a> – Royal Dutch Shell plans to scrap its dual share structure and also drop the “Royal Dutch” part of its corporate name. The announcement comes amid calls by activist investor Third Point to split up the energy giant into several companies to increase shareholder value. Class “A” shares gained 1.5% in premarket action, while class “B” shares rose 1.1%.</p>\n<p><a href=\"https://laohu8.com/S/BA\">Boeing</a> – Boeing Senior Vice President Ihssane Mounir said the jet maker is “getting close” to resuming deliveries of its 787 Dreamliner, after suspending them to deal with production issues. Mounir said the exact timing depends on the outcome of ongoing talks with regulators. The stock added 2.7% in the premarket.</p>\n<p><a href=\"https://laohu8.com/S/WOOF\">Petco Health and Wellness Company, Inc.</a> – The pet products retailer’s stock slid 2.9% in premarket trading after Jefferies downgraded it to “hold” from “buy.” Jefferies cited valuation after a 26% rise over three months, as well as challenging labor conditions in Petco’s veterinary business.</p>\n<p><a href=\"https://laohu8.com/S/CRWD\">CrowdStrike Holdings, Inc.</a> – Morgan Stanley began coverage of the cybersecurity company with an “underweight” rating, noting increasing competition and pricing pressure. Crowdstrike slid 4.6% in the premarket.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite",".DJI":"道琼斯"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1124063419","content_text":"Stock futures pointed to a higher open Monday morning as investors awaited key retail sales and earnings results out from major U.S. companies later this week.At 8:00 a.m. ET, S&P 500 e-minis were up 10.75 points, or 0.23%, Nasdaq 100 e-minis were up 34.5 points, or 0.21%, and Dow e-minis  were up 118 points, or 0.33%.\nInvestors this week are also set to receive new data from the Commerce Department on U.S. retail sales. The report is likely to show a 1.3% month-on-month jump in sales for October after a more sanguine 0.7% rise in September. And retail earnings results from major names including Walmart, Target, Home Depot and Lowe's will offer additional details on the state of the consumer.\nStocks making the biggest moves in the premarket:\nOatly Group AB – The oat milk producer lost 7 cents per share for its latest quarter, smaller than the 10 cents a share loss anticipated by analysts. Revenue came in below forecasts, however, and its shares tumbled 14.1% in premarket action. Oatly said it faced challenges related to various Covid-related restrictions, but that it continues to scale up production.\nTesla Motors – Tesla slid 2.1% in premarket trading after a weekly loss last week ended an 11-week winning streak. Tesla CEO Elon Musk sold nearly $7 billion in stock last week.\nDollar Tree – Dollar Tree surged 8.3% in the premarket after activist investor Mantle Ridge took a stake in the discount retailer. The Wall Street Journal reports that Mantle Ridge wants Dollar Tree to take action to boost its stock price and is focusing on pricing strategies at the company’s Family Dollar chain. The news prompted Deutsche Bank to upgrade the stock to “buy” from “hold,” citing potential improvements.\nTyson – The beef and poultry producer earned $2.30 per share for its fiscal fourth quarter, 27 cents a share above estimates. Revenue topped Wall Street forecasts as well. Tyson also announced a new productivity program that it says will save $1 billion annually by the end of 2024.\nAmerican Tower – The communications infrastructure real estate investment trust is buying data center REITCoreSite Realty(COR) for $170 per share in cash, or about $10.1 billion. CoreSite rose 2.6% in premarket action.\nJohn Deere – The heavy equipment maker and striking workers reached a third tentative contract agreement after the first two were rejected. Neither side gave details on the new agreement and it is not yet clear when a vote will take place. Workers have been off the job since Oct. 14.\nEVgo Inc. – The operator of public EV charging networks saw its stock tank by 7.7% in the premarket, after Credit Suisse downgraded it to “neutral” from “outperform.” The company said a recent rally in the stock has likely priced in benefits from the infrastructure bill as well as recent partnership announcements.\nRoyal Dutch Shell PLC – Royal Dutch Shell plans to scrap its dual share structure and also drop the “Royal Dutch” part of its corporate name. The announcement comes amid calls by activist investor Third Point to split up the energy giant into several companies to increase shareholder value. Class “A” shares gained 1.5% in premarket action, while class “B” shares rose 1.1%.\nBoeing – Boeing Senior Vice President Ihssane Mounir said the jet maker is “getting close” to resuming deliveries of its 787 Dreamliner, after suspending them to deal with production issues. Mounir said the exact timing depends on the outcome of ongoing talks with regulators. The stock added 2.7% in the premarket.\nPetco Health and Wellness Company, Inc. – The pet products retailer’s stock slid 2.9% in premarket trading after Jefferies downgraded it to “hold” from “buy.” Jefferies cited valuation after a 26% rise over three months, as well as challenging labor conditions in Petco’s veterinary business.\nCrowdStrike Holdings, Inc. – Morgan Stanley began coverage of the cybersecurity company with an “underweight” rating, noting increasing competition and pricing pressure. Crowdstrike slid 4.6% in the premarket.","news_type":1},"isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":870853757,"gmtCreate":1636603792510,"gmtModify":1636603792620,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/870853757","repostId":"2182213053","repostType":4,"isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840395512,"gmtCreate":1635585059441,"gmtModify":1635585059585,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/840395512","repostId":"1160516340","repostType":4,"repost":{"id":"1160516340","pubTimestamp":1635576015,"share":"https://www.laohu8.com/m/news/1160516340?lang=&edition=full","pubTime":"2021-10-30 14:40","market":"sh","language":"en","title":"5 Stocks For Halloween: Will They Be Tricks Or Treats?","url":"https://stock-news.laohu8.com/highlight/detail?id=1160516340","media":"Benzinga","summary":"Halloween will be celebrated on Sunday and could see significant changes from the 2020 event in the ","content":"<p>Halloween will be celebrated on Sunday and could see significant changes from the 2020 event&nbsp;in the middle of a COVID-19 pandemic that saw many cancel parties and plans to trick or treat.</p>\n<p>Here’s a look at what the data is pointing to for 2021 Halloween spending and five stocks to keep on the radar that could turn in strong quarters that include the holiday.</p>\n<p><b>Halloween Sales Expectations:</b>Consumers feel more comfortable resuming normal Halloween activities according to theNational Retail Federation.</p>\n<p>“This year, two-thirds (65%) of consumers plan to celebrate <a href=\"https://laohu8.com/S/AONE.U\">one</a> of America’s favorite holidays, up from 58% in 2020,” NRF said.</p>\n<p>The NRF sees consumers spending an average of $102.74 this year on Halloween, which would be the first time the figure has hit triple digits. Estimates last year were for spending of $92.12 by each consumer.</p>\n<p>Research points to candy and costumes as big winners by the return of Halloween activities along with decorations. Spending on decorations is expected to hit $3.3 billion, an all-time high.</p>\n<p>Is <a href=\"https://laohu8.com/S/KO\">Coca-Cola</a>'s Stock Overvalued OrUndervalued?</p>\n<p>Halloween 2021 will also see a higher number of people without kids celebrating than in 2020. Estimates call for 55% of homes without children to celebrate, compared to 49% in 2020. The figure falls in line with pre-pandemic levels of anticipated adult costume spending.</p>\n<p><b><a href=\"https://laohu8.com/S/TR\">Tootsie Roll</a>:</b>Candy company<b><a href=\"https://laohu8.com/S/TR\">Tootsie Roll</a> Industries Inc</b></p>\n<p>TR-0.47%is a popular option for anyone handing out candy to trick or treaters. If you’ve ever gone trick or treating, chances are you got a ton of tootsie rolls, given their lower cost for anyone buying for a large number of visitors.</p>\n<p>The companyreportedthird-quarter sales of $183.1 million, up 17% year-over-year. The company saw a dip in fourth-quarter revenue last year compared to the prior year. Look for Tootsie Roll to see a rebound in the fourth quarter.</p>\n<p><b><a href=\"https://laohu8.com/S/HSY\">Hershey</a>:The <a href=\"https://laohu8.com/S/HSY\">Hershey</a> Co</b></p>\n<p>HSY-2.28%has diversified its products to include several snack brands, but candy remains the big revenue driver. The company owns many of the popular brands that will be sought out by trick or treaters. Hershey’sthird-quarterrevenue of $2.4 billion was the highest it has seen in years on a quarterly basis.</p>\n<p>“Consumer demand for our brands has remained robust,” Hershey Company CEO<b>Michele Buck</b>said. The company raised full-year sales guidance and a strong Halloween could help meet or exceed the updated expectations.</p>\n<p><b><a href=\"https://laohu8.com/S/JAKK\">Jakks Pacific</a>:</b>Toy company<b><a href=\"https://laohu8.com/S/JAKK\">Jakks Pacific</a> Inc</b></p>\n<p>JAKK-4.38%finds itself on the Halloween list thanks to its ownership of Disguise, the world’s leading costume design and manufacturing company. With more adults dressing up and a return of trick or treat activities, the company could be in for a strong quarter.</p>\n<p>The company’sthird-quarterrevenue was $237&nbsp;million, which included $64&nbsp;million in revenue for the costumes segment. Costume sales were up 16.4% year-over-year and the fourth quarter could continue that trend. Jakks Pacific had revenue of $128.3 million in the fourth quarter last year, a decline from the prior year. Last year’s fourth quarter featured a 91% year-over-year increase in costumes segment revenue. The third and fourth quarters are the company’s two biggest quarters for revenue.</p>\n<p><b>Party <a href=\"https://laohu8.com/S/CHCO\">City</a>:</b>Retailer<b>$Party <a href=\"https://laohu8.com/S/CHCO\">City</a> Holdco(PRTY)$ Inc</b></p>\n<p>PRTY+2.97%could be a popular destination for Halloween costumes and decorations. The company ended thesecond quarterwith 749 locations and is also a provider of third-party products to other retailers.</p>\n<p>Second-quarter revenue was up 110% year-over-year for the company.</p>\n<p>“We saw sequential acceleration of the business as the economy opened up and restrictions subsided, driving increased consumer ability to celebrate,” Party City CEO<b>Brad Weston</b>said. The company will report third-quarter earnings on Nov. 9, which could provide a better look at how the Halloween shopping looked.</p>\n<p><b><a href=\"https://laohu8.com/S/AMCX\">AMC Networks</a>:</b>Media company<b><a href=\"https://laohu8.com/S/AMCX\">AMC Networks</a></b></p>\n<p>AMCX-2.04%finds itself on the Halloween stock list thanks to its ownership of “The Walking Dead” franchise, horror film programming and as owner of horror focused streaming platform Shudder. AMC isairing“FearFest” from Oct. 1 through Oct. 31 on its namesake AMC and AMC+ channels, which could turn into a subscriber boosting event.</p>\n<p>“The Walking Dead” returned to the network with its final season beginning Oct. 10, which could be another October event to watch. Shudder, which is the largest horror focused streaming platform, is available for $4.75 a month on major streaming platforms. The platformhitone million subscribers in 2020. Pizza Hut, a<b><a href=\"https://laohu8.com/S/YUM\">Yum</a> Brands Inc</b></p>\n<p>YUM-0.75%company,partneredwith Shudder to offer a promotion for 30 days free.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks For Halloween: Will They Be Tricks Or Treats?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks For Halloween: Will They Be Tricks Or Treats?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-30 14:40 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/small-cap/21/10/23762347/5-stocks-for-halloween-will-they-be-tricks-or-treats><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Halloween will be celebrated on Sunday and could see significant changes from the 2020 event in the middle of a COVID-19 pandemic that saw many cancel parties and plans to trick or treat.\nHere’s a ...</p>\n\n<a href=\"https://www.benzinga.com/news/small-cap/21/10/23762347/5-stocks-for-halloween-will-they-be-tricks-or-treats\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TR":"Tootsie Roll Industries Inc","AMCX":"AMC网络公司","HSY":"好时","CHCO":"City Holding Company","JAKK":"杰克仕太平洋"},"source_url":"https://www.benzinga.com/news/small-cap/21/10/23762347/5-stocks-for-halloween-will-they-be-tricks-or-treats","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1160516340","content_text":"Halloween will be celebrated on Sunday and could see significant changes from the 2020 event in the middle of a COVID-19 pandemic that saw many cancel parties and plans to trick or treat.\nHere’s a look at what the data is pointing to for 2021 Halloween spending and five stocks to keep on the radar that could turn in strong quarters that include the holiday.\nHalloween Sales Expectations:Consumers feel more comfortable resuming normal Halloween activities according to theNational Retail Federation.\n“This year, two-thirds (65%) of consumers plan to celebrate one of America’s favorite holidays, up from 58% in 2020,” NRF said.\nThe NRF sees consumers spending an average of $102.74 this year on Halloween, which would be the first time the figure has hit triple digits. Estimates last year were for spending of $92.12 by each consumer.\nResearch points to candy and costumes as big winners by the return of Halloween activities along with decorations. Spending on decorations is expected to hit $3.3 billion, an all-time high.\nIs Coca-Cola's Stock Overvalued OrUndervalued?\nHalloween 2021 will also see a higher number of people without kids celebrating than in 2020. Estimates call for 55% of homes without children to celebrate, compared to 49% in 2020. The figure falls in line with pre-pandemic levels of anticipated adult costume spending.\nTootsie Roll:Candy companyTootsie Roll Industries Inc\nTR-0.47%is a popular option for anyone handing out candy to trick or treaters. If you’ve ever gone trick or treating, chances are you got a ton of tootsie rolls, given their lower cost for anyone buying for a large number of visitors.\nThe companyreportedthird-quarter sales of $183.1 million, up 17% year-over-year. The company saw a dip in fourth-quarter revenue last year compared to the prior year. Look for Tootsie Roll to see a rebound in the fourth quarter.\nHershey:The Hershey Co\nHSY-2.28%has diversified its products to include several snack brands, but candy remains the big revenue driver. The company owns many of the popular brands that will be sought out by trick or treaters. Hershey’sthird-quarterrevenue of $2.4 billion was the highest it has seen in years on a quarterly basis.\n“Consumer demand for our brands has remained robust,” Hershey Company CEOMichele Bucksaid. The company raised full-year sales guidance and a strong Halloween could help meet or exceed the updated expectations.\nJakks Pacific:Toy companyJakks Pacific Inc\nJAKK-4.38%finds itself on the Halloween list thanks to its ownership of Disguise, the world’s leading costume design and manufacturing company. With more adults dressing up and a return of trick or treat activities, the company could be in for a strong quarter.\nThe company’sthird-quarterrevenue was $237 million, which included $64 million in revenue for the costumes segment. Costume sales were up 16.4% year-over-year and the fourth quarter could continue that trend. Jakks Pacific had revenue of $128.3 million in the fourth quarter last year, a decline from the prior year. Last year’s fourth quarter featured a 91% year-over-year increase in costumes segment revenue. The third and fourth quarters are the company’s two biggest quarters for revenue.\nParty City:Retailer$Party City Holdco(PRTY)$ Inc\nPRTY+2.97%could be a popular destination for Halloween costumes and decorations. The company ended thesecond quarterwith 749 locations and is also a provider of third-party products to other retailers.\nSecond-quarter revenue was up 110% year-over-year for the company.\n“We saw sequential acceleration of the business as the economy opened up and restrictions subsided, driving increased consumer ability to celebrate,” Party City CEOBrad Westonsaid. The company will report third-quarter earnings on Nov. 9, which could provide a better look at how the Halloween shopping looked.\nAMC Networks:Media companyAMC Networks\nAMCX-2.04%finds itself on the Halloween stock list thanks to its ownership of “The Walking Dead” franchise, horror film programming and as owner of horror focused streaming platform Shudder. AMC isairing“FearFest” from Oct. 1 through Oct. 31 on its namesake AMC and AMC+ channels, which could turn into a subscriber boosting event.\n“The Walking Dead” returned to the network with its final season beginning Oct. 10, which could be another October event to watch. Shudder, which is the largest horror focused streaming platform, is available for $4.75 a month on major streaming platforms. The platformhitone million subscribers in 2020. Pizza Hut, aYum Brands Inc\nYUM-0.75%company,partneredwith Shudder to offer a promotion for 30 days free.","news_type":1},"isVote":1,"tweetType":1,"viewCount":5,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":862519132,"gmtCreate":1632889163113,"gmtModify":1632889163406,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/862519132","repostId":"2170606281","repostType":2,"isVote":1,"tweetType":1,"viewCount":2,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":691772419,"gmtCreate":1640252639399,"gmtModify":1640253062489,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/691772419","repostId":"1184389618","repostType":4,"repost":{"id":"1184389618","pubTimestamp":1640230223,"share":"https://www.laohu8.com/m/news/1184389618?lang=&edition=full","pubTime":"2021-12-23 11:30","market":"us","language":"en","title":"Grab Stock May Be Down But It Isn’t Out","url":"https://stock-news.laohu8.com/highlight/detail?id=1184389618","media":"InvestorPlace","summary":"When Southeast Asian ride-hailing and delivery company Grab Holdings(NASDAQ:GRAB) completed a revers","content":"<p>When Southeast Asian ride-hailing and delivery company&nbsp;<b>Grab Holdings</b>(NASDAQ:<b><u>GRAB</u></b>) completed a reverse merger with special purpose acquisition company Altimeter Growth Corp. in early December it made history as the largest company to go public via a SPAC merger. Yet, this didn’t stop GRAB stock from&nbsp;plummeting more than 20%&nbsp;on the day of the merger.</p>\n<p>Since then, investors have continued to give GRAB stock the cold shoulder, with shares falling another 16% to trade at $7.34 at the time of this writing.</p>\n<p>Now, before you write off an investment in Grab Holdings, consider that the company is still in the early innings and let’s consider where GRAB stock could go from here.</p>\n<p><b>What’s Behind Grab’s Cool Reception?</b></p>\n<p>Grab is the largest ride-hailing and delivery company in Southeast Asia, with&nbsp;operations in Singapore,&nbsp;Malaysia, Cambodia,&nbsp;Indonesia, Myanmar,&nbsp;Philippines,&nbsp;Thailand and Vietnam and serving more than 187 million users.</p>\n<p>There are a number of plausible explanations for why GRAB stock has not been well-received by investors.</p>\n<p>For starters, growth estimates for the Southeast Asian region have been lowered recently primarily due to the coronavirus pandemic. In September, the Asian Development Bank&nbsp;dropped its 2021 growth forecast&nbsp;for the region to 3.1% from 4.4% previously.</p>\n<p>Widespread lockdowns in the region due to recurring waves of COVID-19 have hurt demand for Grab’s ride-hailing services and weighed on revenue despite an increase in food-delivery volumes.</p>\n<p>Grab reported its&nbsp;third-quarter results&nbsp;on Nov. 11. Revenue fell 9% year over year to $157 million, with the company citing “a decline in mobility due to the severe lockdowns in Vietnam.” Falling revenue is obviously not something investors want to see, especially from a company that has yet to turn a profit.</p>\n<p>Yet, the company did report a 32% year-over-year increase in gross merchandise value, with the dollar value of transactions from Grab’s services rising to $4.04 billion thanks to strength in the company’s deliveries segment.</p>\n<p><b>There’s Reason for Optimism</b></p>\n<p>The deal to go public through the merger with Altimeter Growth Corp. valued Grab at close to $40 billion, which as I mentioned, was a record. The fact that three weeks later GRAB stock has a market cap of about $27.5 billion tells us that perhaps things got a bit too heated. However, there is reason for optimism.</p>\n<p>The ride-hailing platform has secured the backing of significant players across related industries, including&nbsp;<b>DiDi Global</b>(NYSE:<b><u>DIDI</u></b>),<b>Toyota</b>(NYSE:<b><u>TM</u></b>) and&nbsp;<b>SoftBank’s</b>(OTCMKTS:<b><u>SFTBY</u></b>) Vision Fund.</p>\n<p>Grab Holdings also has some positive catalysts on the horizon. For example, the company recently announced that it&nbsp;will be purchasing&nbsp;<b>Jaya Grocer</b>, a premium supermarket chain in Malaysia.</p>\n<p>This acquisition fits nicely with the ride-hailing and delivery business model the company seeks to expand. Management refers to the model as a “superapp” focus, whereby users can access multiple services in a single, convenient location.</p>\n<p><b>The Bottom Line on GRAB Stock</b></p>\n<p>I can’t say Grab Holdings can immediately turn things around. But its potential in the burgeoning Southeast Asian market means it remains relevant and has a long runway.</p>\n<p>Of the six analysts following GRAB stock, two rate it a “buy” and there are no “sell” ratings,according to&nbsp;<i>The Wall Street Journal</i>. Meanwhile, the consensus price target stands at $12.25, which represents upside of 67% from current levels.</p>\n<p>GRAB stock is very cheap now, so it’s hardly a dangerous speculative play. There’s a good argument to be made for investing now and hoping that the company continues to expand its footprint. Profitability should follow.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Grab Stock May Be Down But It Isn’t Out</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGrab Stock May Be Down But It Isn’t Out\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-12-23 11:30 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/12/grab-stock-may-be-down-but-it-isnt-out/><strong>InvestorPlace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>When Southeast Asian ride-hailing and delivery company Grab Holdings(NASDAQ:GRAB) completed a reverse merger with special purpose acquisition company Altimeter Growth Corp. in early December it made ...</p>\n\n<a href=\"https://investorplace.com/2021/12/grab-stock-may-be-down-but-it-isnt-out/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"GRAB":"Grab Holdings"},"source_url":"https://investorplace.com/2021/12/grab-stock-may-be-down-but-it-isnt-out/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1184389618","content_text":"When Southeast Asian ride-hailing and delivery company Grab Holdings(NASDAQ:GRAB) completed a reverse merger with special purpose acquisition company Altimeter Growth Corp. in early December it made history as the largest company to go public via a SPAC merger. Yet, this didn’t stop GRAB stock from plummeting more than 20% on the day of the merger.\nSince then, investors have continued to give GRAB stock the cold shoulder, with shares falling another 16% to trade at $7.34 at the time of this writing.\nNow, before you write off an investment in Grab Holdings, consider that the company is still in the early innings and let’s consider where GRAB stock could go from here.\nWhat’s Behind Grab’s Cool Reception?\nGrab is the largest ride-hailing and delivery company in Southeast Asia, with operations in Singapore, Malaysia, Cambodia, Indonesia, Myanmar, Philippines, Thailand and Vietnam and serving more than 187 million users.\nThere are a number of plausible explanations for why GRAB stock has not been well-received by investors.\nFor starters, growth estimates for the Southeast Asian region have been lowered recently primarily due to the coronavirus pandemic. In September, the Asian Development Bank dropped its 2021 growth forecast for the region to 3.1% from 4.4% previously.\nWidespread lockdowns in the region due to recurring waves of COVID-19 have hurt demand for Grab’s ride-hailing services and weighed on revenue despite an increase in food-delivery volumes.\nGrab reported its third-quarter results on Nov. 11. Revenue fell 9% year over year to $157 million, with the company citing “a decline in mobility due to the severe lockdowns in Vietnam.” Falling revenue is obviously not something investors want to see, especially from a company that has yet to turn a profit.\nYet, the company did report a 32% year-over-year increase in gross merchandise value, with the dollar value of transactions from Grab’s services rising to $4.04 billion thanks to strength in the company’s deliveries segment.\nThere’s Reason for Optimism\nThe deal to go public through the merger with Altimeter Growth Corp. valued Grab at close to $40 billion, which as I mentioned, was a record. The fact that three weeks later GRAB stock has a market cap of about $27.5 billion tells us that perhaps things got a bit too heated. However, there is reason for optimism.\nThe ride-hailing platform has secured the backing of significant players across related industries, including DiDi Global(NYSE:DIDI),Toyota(NYSE:TM) and SoftBank’s(OTCMKTS:SFTBY) Vision Fund.\nGrab Holdings also has some positive catalysts on the horizon. For example, the company recently announced that it will be purchasing Jaya Grocer, a premium supermarket chain in Malaysia.\nThis acquisition fits nicely with the ride-hailing and delivery business model the company seeks to expand. Management refers to the model as a “superapp” focus, whereby users can access multiple services in a single, convenient location.\nThe Bottom Line on GRAB Stock\nI can’t say Grab Holdings can immediately turn things around. But its potential in the burgeoning Southeast Asian market means it remains relevant and has a long runway.\nOf the six analysts following GRAB stock, two rate it a “buy” and there are no “sell” ratings,according to The Wall Street Journal. Meanwhile, the consensus price target stands at $12.25, which represents upside of 67% from current levels.\nGRAB stock is very cheap now, so it’s hardly a dangerous speculative play. There’s a good argument to be made for investing now and hoping that the company continues to expand its footprint. Profitability should follow.","news_type":1},"isVote":1,"tweetType":1,"viewCount":658,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":693018529,"gmtCreate":1639926450163,"gmtModify":1639926450395,"author":{"id":"3579759306103275","authorId":"3579759306103275","name":"hpt","avatar":"https://static.tigerbbs.com/986ef7c951112f7be64cfd5d6c1672c5","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good","listText":"Good","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/693018529","repostId":"2192903795","repostType":4,"isVote":1,"tweetType":1,"viewCount":180,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}